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ABSTRACT
Dendritic cells (DCs) function at the interphases of innate and adaptive
immunity. The ability ofDCs to control the responses ofeffector T cells, B cells and
NK cells are due, in part, to cell contacts and DC cytokines. Different DC subsets
exist, that appear to have different biological roles in vivo. Cannulation of the
'pseudoafferent' lymphatics is one of the few methods of obtaining differentiated
DCs ex vivo. Lymph DCs are not a homogenous population, and this study tested the
hypothesis that discrete populations exist in vivo, that differentially express
immunomodulatoiy molecules. Two lymph DC populations were defined by
expression of signal regulatory protein-a (SIRPa). SIRPa+ DCs were CD58+,
CD1 la+, WC6+, CD45RA", expressed CD16, CD14, CD206, CD4 and CD8 at low
levels or on minor sub-populations, and as a single population expressed higher
levels of CDllc, CD40, CD80, CD86 and MHC II than did SIRPa DCs. SIRPa"
DCs were CD 16", CD 14", CD206", CD4", CD8", CD1 la+ and displayed heterogeneity
of expression of CD58, CD1 lc, WC6 and CD45RA. Importantly, freshly isolated
SIRPa+ DCs expressed IL-12 p40 and IL-18 mRNA, whereas SIRPa" DCs were
negative for these transcripts. Neither IL-6 nor IL-10 mRNA were detected by PCR
in the DC populations. Differential expression of molecules involved in antigen
uptake (CD14, CD16, CD206), interactions with lymphocytes (CD54, CDlla,
CD40) and antigen presentation and T cell activation (MHC II, CD80, CD86, IL-12,
IL-18), suggests that the lymph DC populations may have different funtions in vivo.
This knowledge would support therapeutic strategies to target particular DC
populations in vivo, to enhance, or to suppress their natural role in the immune
response.
In order to perform multiple cytokine analysis on the lymph DCs, a
multiprobe RNase protection assay (RPA) was developed for eleven cytokines. First,
sheep interleukin-18 (IL-18) was cloned and sequenced. By inducing the production
of interferon gamma, IL-18 is an important regulator of T cell immunity. This was
the first description of IL-18 expression patterns in sheep. Second, standardisation
analysis showed that the RPA could reliably quantify levels of IL-1 p, IL-4, IL-6,
IL-10, IL-12 p40, IL-18, GM-CSF, IFNyand TGF0 mRNA. IL-8 and TNFa -
specific riboprobes require optimisation for use with the developed protocol. The
amount of RNA required for analysis using the RPA exceeded what was isolated
from the DC subsets. However, the RPA makes it possible to evaluate levels ofnine
cytokine mRNA transcripts in single RNA samples isolated from sheep. This will
help support studies of ovine immunology and immunopathology, where cytokine
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Chapter 1 Introduction
Chapter 1: Introduction
Dendritic cells (DCs) are crucial components of the immune response, owing
to their essential role in the induction and control of T cell immunity, and modulating
the function of B cells and NK cells. DCs comprise a diverse group of cell subsets
with different functions. Functional diversity is related to the DC anatomical
location, differentiation state, antigenic stimulus and interactions with effector cells
(Banchereau et al., 2000).
Obtaining DCs for analysis is not straightforward, and may explain why DCs
are one of the most recently identified leucocyte types (Steinman and Cohn, 1973).
DCs comprise less than 2% of cells in peripheral lymphoid organs, and their isolation
from these sites requires enzymatic digestion of the collagenase matrix (Steinman,
Lustic and Cohn, 1974). DC precursors are resident in haematopoietic tissue and
circulate in blood (Caux et al., 1992), and can be propagated in vitro in the presence
of cytokine growth factors. These techniques likely modulate DC phenotype and
function. There are few models where differentiated DC can be obtained ex vivo
with minimal manipulation. One technique involves the cannulation of the
lymphatics and collection of lymph DCs. Leucocytes defending epidermal and
mucosal tissues migrate to the lymph nodes via the afferent lymphatics. This project
utilised the 'psuedoafferent' lymphatic cannulation model in sheep (Hall, 1966)
(Section 2A.2). This model was so named because it involves the ablation of the
draining lymph node. Over a period of 4-6 weeks the numerous afferent lymphatics
re-anastomose with the single efferent lymphatic. Afferent lymph now flows into the
efferent lymphatic that is fitted with a cannula allowing lymph cells to be collected
externally. Afferent lymph is the principal pathway for DC and macrophage entry to
the lymph nodes (Vestweber, 2003). The advantage of assessing afferent lymph DCs
is that they represent these cells in vivo. This thesis is primarily a descriptive study
of ovine afferent lymph DC populations. Constitutive attributes of lymph DCs were
assessed, such as surface phenotype and cytokine expression. An assay for cytokine
expression analysis was developed to support the studies of DC function. This





At least four populations of DCs have been described in murine lymphoid
organs, which can be separated by expression of CD1 lc and the CD8aa homodimer
(CD8a) (Anjuere et al., 1999; Kamath et ah, 2000; Asselin Paturel et ah, 2001).
Three DC populations in peripheral lymph nodes have been defined by CD8a
expression: two of these are CD8a+ and CD8a" DCs, that have been termed
'lymphoid' and 'myeloid' DCs, respectively (Section 1.2), and are also present in the
spleen. The third express intermediate levels of CD8a (CD8amt), and derive from
epidermal Langerhans cells (LCs) that up-regulate CD8a expression in the lymph
node (Anjuere et ah, 1999), and unless otherwise stated will be grouped with the
CD8a+ DC population. These DCs all express CD1 lc, have a mature phenotype, and
are potent stimulators of T cell activation and proliferation (Kamath et ah, 2000).
The DC populations however, differ in localisation and function. In the spleen and
lymph nodes (LN), CD8a+ DCs are found primarily in the periarteriolar lymphatic
sheaths (PALS), that are rich in T cells, whereas CD8a" DCs are situated at the
marginal zones (Pulendran et ah, 1997; Leenen et ah, 1998). Endotoxin induces
CD8a" DC migration to the PALS where they present processed antigen collected in
the periphery (Reis e Sousa and Germain, 1999). CD8a+ DCs produce higher
amounts of interleukin- (IL-) -12p70 favouring a T helper- (Th-)l response, and are
less phagocytic than CD8a" DCs (Maldonado-Lopez et ah, 1999; Hochrein et ah,
2001). Ultimately, DCs function as potent inducers of T cell proliferation and
differentiation to support adaptive immunity. The CD8a subsets show considerable
plasticity in the type of T cell responses they induce. This is discussed further in
Section 1.8.
A fourth murine DC population, identified as CD lie'0 CD8cT with
expression of the CD45 isoform B220 are functionally equivalent to plasmacytoid
DCs (pDC) described in humans (Asselin Paturel et al., 2001). These DCs will
subsequently be termed B220+ pDCs. pDCs have an immature phenotype, are poor
stimulators of T cells, and induce the generation of regulatory T cells in vitro
(Bilsborough et ah, 2003). It has therefore been hypothesised by a number of
investigators (Martin et ah, 2002; Bilsborough et ah, 2003), that pDCs function in
2
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vivo to support peripheral T cell tolerance (Section 1.7). B220+ pDCs express CD8a
at various levels, and it is likely that they are responsible for the attributes of CD8a+
DCs ascribed with tolerogenic / suppressive function (Steinman et al., 2000). pDCs
are the major interferon (IFN) -a producers in vivo during infection with virus, and
rapidly mature and produce IL-12 following stimulation with cytosine-phosphatase-
guanine oligodeoxynucleotides (CpG DNA), that mimic bacterial DNA sequences
(Asselin Paturel et ah, 2001).
1.1.2 Human DCs
The majority of studies of human DCs are performed on cells derived from
precursors in umbilical cord blood (CD34+) (Romani et ah, 1996) or from CD14+
blood monocytes cultured with cytokines such as granulocyte monocyte colony
stimulating factor (GM-CSF), tumour necrosis factor-a (TNFa) (Caux et ah, 1992)
and IL-4. There is a lack of CD8a expression on human DCs (Banchereau et ah,
2000), so direct analogies with mouse DC subsets are not plausible. CD 14'
monocytes cultured in the presence of GM-CSF and IL-4 give rise to DCs, termed
DC1, that produce high levels of IL-12 after activation, and preferentially induce the
generation of Thl cells (Sallusto and Lanzavecchia, 1994; Romani et ah, 1996).
DC1 thus resemble murine CD8a+ DCs. pDCs were termed DC2 because of a
propensity to induce Th2 differentiation that is unaffected by IL-4 or IL-12 (Rissoan
et ah, 1999). Similar to murine DC subsets, human DC1 and DC2 have subsequently
been found to exhibit plasticity of responses, which probably reflects more closely
the biology of DCs in vivo (Section 1.8).
1.1.3 Cutaneous DCs
DCs are most numerous in tissues underlying body surfaces (skin, trachea,
gut). Represented in the epidermis by LCs, skin DCs act as sentinels and sequester
antigen for presentation to T cells in the draining lymph nodes (Inaba et ah, 1986;
Larsen et ah, 1990; Romani et ah, 1989; Weinlich et ah, 1998; Ruedl et ah, 2000),
and LCs are particularly potent at inducing T cell proliferation in primary mixed
leukocyte reactions (MLRs) (Schuler and Steinman, 1985; Inaba et ah 1986). To
enable efficient DC:lymphocyte interactions, peripheral DCs are required to travel to
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secondary lympoid tissues. The lymphatic cannulation model in sheep demonstrated
that DCs undergo steady-state migration to lymph nodes via afferent lymph draining
the skin (Hopkins et al., 1985). DC migration is discussed further in Section 1.5.
Afferent lymph DCs are largely comprised of LCs (Brand et al., 1999; Hoefsmit,
Duijvestijn and Kamperdijk, 1982). Moreover, a number of studies indicated that
mature LCs comprise a significant proportion of DCs in murine LNs. These studies
utilised fluorescent labels in skin sensitisers (Anjuere et al., 1999; Kamath et al.,
2000; Salomon et al., 1998; Ruedl et al., 2000); BrdU uptake in vivo (Kamath et al.,
2000); and specific LC phenotypic markers, E-cadherin and Birbeck granules (Ruedl
et al., 2000). The mature form of LCs have the slowest turnover rate of the LN DC
populations, with a half-life of around 15 days (Salomon et al., 1998; Kamath et al.,
2000; Ruedl et al., 2000). This increases the chance of interacting with rare antigen
specific T cells, and mounting a specific adaptive response against antigens collected
in the skin. Mechanisms of DC / LC antigen uptake and presentation are discussed
in more detail in Section 1.3.
DCs situated in the dermis (dermal DC; DDC) have an immature phenotype
and weak T cell stimulatory potential (Nestle et al., 1993). In the LN, the mature
form of DDCs have been proposed to be a CD8a" DC population with immature
phenotype, that turn over with faster kinetics than LCs (Kamath et al., 2000). Given
that the mature forms of both LCs and DDCs are found in significant numbers in
cutaneous-draining lymph nodes (Kamath et al., 2000), it is likely they both
contribute to immunological protection of the skin.
1.2 DC Ontogeny
DCs originate from bone marrow (BM) precursors (Katz, Tamaki and Sachs,
1979; Steinman, 1991; Inaba et al., 1993). Haematopoietic reconstitution studies in
mice, and in vitro studies using murine and human DCs, suggest a plasticity of both
myeloid and lymphoid pathways that lead to the generation of various DC subtypes.
1.2.1 A Myeloid Lineage for DCs
Early studies demonstrated a common myeloid precursor cell for most DCs.
Inaba et. al. (1993) demonstrated that DCs, monocyte / macrophages and
4
Chapter 1 Introduction
granulocytes can be generated from haematopoietic precursors when cultured with
GM-CSF. In addition, in vhroderived CD14+ precursor cells (Caux et al., 1996) or
CD 14 blood monocytes (Sallusto and Lanzavecchia, 1994) differentiate into DCs.
This has also been demonstrated in vivo (Randolph et ah, 1999).
1.2.2 A Lymphoid Lineage for DCs
The identification of murine CD4)o thymic precursors that generated DCs, T
and B lymphocytes and NK cells demonstrated a lymphoid-related lineage for DCs
(Wu et ah, 1991). Transfer of these precursors into irradiated recipients led to the
development of T lymphocytes and a subset of CD8a+ DCs that lacked myeloid
markers in the spleen, thymus and lymph nodes (Ardavin et ah, 1993).
1.2.3 Common DC Precursors
However, the concept of different DC lineages and functions has
subsequently been challenged by several findings. Injection of MHC II" common
myeloid precursors (CMPs) into irradiated recipients has shown that they give rise to
both CD8a+ and CD8a" DCs (Traver et ah, 2000). Moreover, common lymphoid
precursors (CLPs) produce CD8a+ and CD8a" DCs following in vivo transfer (Manz
et ah, 2001). Martin and colleagues (2002) have also demonstrated a common
precursor for CD8oT and CD8a" DCs. These workers cited the use of negative
selection for the removal of contaminating cells as an explanation as to why the
common precursors had not been identified in earlier studies. The experimental data
suggests that both myeloid- and lymphoid-lineage multi-potential precursors can give
rise to CD8a+ and CD8a" DCs in vivo, and that these cells types are not lineage
restricted. Whether the mature DC populations are exclusive, or represent
differentiation stages of each other is debatable. Using in vivo reconstitution, Manz
et ah (2001) concluded that CMPs and CLPs contribute equally to thymic DCs,
whereas peripheral DCs were in the most part derived from CMPs. This is supported
as CMP:DC precursors express fms-related tyrosine kinase 3 (Flt3) (D Amico and
Wu, 2003). Flt3 is a potent growth factor for DCs in vivo and in vitro (Pulendran et
ah, 1997; McKenna et ah, 2000), and is required for DC development in mice (Brasel
et ah, 2000). A common DC precursor demonstrates the plasticity of DCs during
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development. Accumulating experimental evidence indicates that the environment
the cell finds itself has a strong effect on DC biology (Section 1.8). Although they
no longer denote separate lineages, the terms of 'lymphoid' and 'myeloid' DCs are
still widely used
The development of B220~ pDCs differs from that of other DCs in vitro.
B22CT pDCs do not require GM-CSF in culture and depend on IL-3, this contrasts
with the requirement of in vitro derived human (Romani et ah, 1994) and murine
(Sallusto and Lanzavecchia, 1994) CD8a" DCs. However, reconstitution
experiments demonstrate that B220+ pDCs derive from the same blood (del Hoyo et
ah, 2002) or haematopoietic Flt3+ precursor (D Amico and Wu, 2003) as both
CD8a+ and CD8a' DCs. Therefore, it seem that B22(f pDCs, like other DC
populations may be generated from both CMPs and CLPs.
A separate developmental pathway, however, has been described for
epidermal LCs. Bone-marrow chimera experiments demonstrated host LCs 18
months following the transfer of syngeneic, congenic haematopoietic cells (Merad et
ah, 2002). It seemed that LCs derive from a local precursor that populates the skin
under steady state conditions (Merad et ah, 2002), which may be the CD14+ DDC
(Larregina et ah, 2001). MHC II" precursors were previously identified to give rise
to LCs or DCs depending on the cytokines they were cultured with (Caux et ah,
1996). Therefore, although the bone marrow precursor may be the same as other DC
populations in vivo, the developmental pathway of LCs does appear different from
other DC populations.
1.3 Antigen Capture, Processing and Presentation by DCs
Although DCs comprise multiple subsets, the potency they exhibit in
inducing T cell activation depends on their ability to capture, process and present
antigenic peptide on MHC molecules to specific T cells. DCs in the periphery are
ideally placed to capture antigen and act as the 'sentinels of the immune surveillance
sytstem' (Steinman and Inaba, 1989). These cells are situated in essentially all
tissues (with the possible exception of the brain and testes) in the form of immature
interstitial DCs and as LCs in the epidermis. Inflammatory stimuli and pathogens or
their products induce DC maturation. This, in a co-ordinated manner, regulates the
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ability of DCs to capture, process and present antigen, the expression of- co-
stimulatory and accessory molecules, cytokine production and migration of the DCs
to the secondary lymphoid tissue.
Four stages of DC maturational development have been described based on
the anatomical location (Austyn, 1996). These include DC progenitors in the BM
and blood; immature DCs capable of processing antigen in peripheral non-lymphoid
sites; maturing DCs migrating in the afferent lymph and blood; and mature DCs that
present antigen in secondary lymphoid tissue. Immature DCs are present in
lymphoid and non-lymphoid tissue in the human foetus and newborn rats (Fossum,
1989). DC migration from the BM to peripheral tissue therefore appears to occur in
steady state and a pathogen-independent manner.
Immature DCs are very efficient at antigen capture and may use several
uptake pathways. These include macropinocytosis, which is constitutive in DCs, and
allows continuous uptake of large volumes of fluid that contain particulate antigen
(Sallusto et ah, 1995). Phagocytosis enables uptake of larger particles such as
apoptotic cells (Rubartelli, Poggi and Zocchi, 1997) or virus and bacteria. Finally,
receptor-mediated endocytosis via the C-type lectin receptors CD206 and DEC-205
(Jiang et ah, 1995; Sallusto et ah, 1995; Tan et ah, 1997) or Fey receptors types I
(CD64), II (CD32) and III (CD 16), permits uptake of mannosylated antigen and
antibody-antigen immune complexes (IC), respectively. Occupation and activation
of FcyRs and C-type lectins on DCs results in a number of maturational changes
including the modulation of surface molecule expression, and the transcription of
cytokines such as IL-12 and TNFa (delaSalle et ah, 1997; Lefkowitz et ah, 1997;
Yamamoto, Klein and Friedman, 1997; Lanzavecchia, 1998).
Once the maturation process of DCs is triggered in the periphery by
encounter with pathogen and / or inflammatory cytokines, DCs downregulate
expression of endocytic / phagocytic receptors and switch roles from antigen capture
to antigen presentation. DCs restrict antigen presentation to those antigens
internalised during maturation thus favouring the stimulation of T cells specific for
pathogenic agents. Immature DCs accumulate MHC II molecules in lysosome-
related intracellular compartments called MHC class II-rich compartments (MIIC),
which have a multivesicular and multilamellar structure (Kleijmeer et ah, 1995;
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Nijman et al., 1995). Soluble and particulate antigens captured by DCs are targeted
to MIIC (Inaba et al., 1997). In immature DCs, MHC II molecules are rapidly
internalised and have a short half-life. Maturation or inflammatory stimuli increase
MHC II molecule synthesis and translocation of MHC II-peptide complexes to the
cell surface where they have a high-life of days and are situated for T cell interaction
and recognition (Cella et al., 1997; Inaba et al., 1997; Inaba et al., 2000). Mature
DCs change expression of other molecules such as increased surface expression of
adhesion (CDlla, CDllc), co-stimulatory (CD40, CD80 and CD86) molecules, and
the production of cytokines such as IL-12 are also enhanced (Macatonia et al., 1995;
Cella et al., 1996; Koch et al., 1996; Reis e Sousa et al., 1997).
1.4 Cross-presentation of Antigen
DCs are capable of shunting cell-associated antigen from endocytic
compartments to the MHC class I processing pathway, and presenting that antigen to
CD8+ T cells (Heath and Carbone, 2001). This function is termed 'cross-
presentation'. Cross presentation is particularly important for the initiation of
immune responses against tumours and viruses that do not have access to the
classical pathways for MHC class I presentation by antigen presenting cells (APCs).
CD8cT DCs are primarily responsible for cross-presenting antigen associated with
captured apoptotic cells in vivo (den Haan, Lehar and Bevan, 2000). Fc receptors
(FcRs) on the cell surface, are particularly efficient at shuttling antigens to the MHC
I processing pathway (Regnault et al., 1999), and den Haan and Bevan (2002)
demonstrated that CD8a" DC can also cross-present exogenous peptide (ovalbumin)
in an immune complex / FcR -dependant manner. FcRs are widely expressed on
DCs (Regnault et al., 1998) and enable CD8a" DCs, that are not constitutively
capable of cross-presenting antigen, to do so in the event of a humoral protective
response in response to pathogens.
1.5 DC Migration
Transport of antigen from the periphery to the regional lymph node for
presentation of T cells depends on DC migration. Generally, DCs enter peripheral
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lymphoid tissue via the afferent lymphatics that drain peripheral tissues. Studies of
epidermal LCs have shown that various mediators such as LPS (Banchereau and
Steinman, 1998), heat shock proteins (HSPs) (Binder et al., 2000) and CpG DNA
(Ban et al., 2000), as well as the cytokines IL-ip and TNFa promote LC maturation
and migration. Molecular events identified during the migration of LCs from the
epidermis include down-regulation of E-cadherin, allowing detachment from
keratinocytes (Schwarzenberger and Udey, 1996), the up-regulation and activation of
adhesion molecules, induction of metalloproteinases which breakdown the
extracellular matrix (Kobayashi et al., 1999), and the expression of the chemotactic
cytokine receptor 7 (CCR7). The ligands for CCR7 (secondary lymphoid tissue
chemokines [SLC] and macrophage inflammatory protein-3a [MIP-3a]) are found in
lymphatic endothelium and in secondary lymphoid tissue and are fundamental in the
initial stages of LC translocation to the regional lymph nodes (Saeki et al., 1999).
The migratory function of DCs is tightly regulated by sequential modulation of
chemokines and chemokine receptors (Sallusto etal., 1998; Sallusto et al., 1999).
Once present in the lymph node, integrins expressed on the DCs interact with
intercellular adhesion molecule (ICAM) molecules on T cells, promoting adhesion
and stimulation, and lowering the concentration of antigen required for stimulation of
T cells. DCs receive additional maturation signals from T cells via CD40 ligand
(CD40L). DCs attract and cluster with naive or resting T cells in an antigen-
independent manner in order to select rare MHC-peptide-specific T lymphocytes
which may be present at a frequency of <1/100 000 (Banchereau and Steinman,
1998).
Using the 'psuedoafferenf lymphatic cannulation model, Hopkins and
colleagues (1985) demonstrated that DCs undergo steady-state migration to lymph
nodes via afferent lymph draining the skin, but are completely absent in efferent
lymph; indicating that DCs terminate in the lymph nodes and die there. Moreover,
DCs have been directly observed disappearing from the lymph nodes 24-48 hours
following interactions with T cells (Ingulli et al., 1997). Clearing of DCs may be
contributed to by MHC II cross-linking- induced apoptosis, whereas, CD40-cognate
interactions protect antigen-bearing DC from apoptosis (McLellan et al., 2000), thus
retaining DCs during antigen presentation to specific T cells.
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1.6 Direct and Indirect Mechanisms of Pathogen Activation of DCs
During the initial stages of a primary infection, DCs constitute an important
part of the innate protective response which comprises both immune and non¬
immune cells. Innate recognition of pathogens is thought to be mediated by
pathogen recognition receptors (PRRs) that mediate cell activation (Medzhitov and
Janeway, 1997). An important and well-described class of innate receptors are the
Toll-like receptors (TLRs), which are members of the IL-1 receptor / TLR
superfamily (O'Neill and Greene, 1998). Pathogenic interactions of TLRs on DCs
often induce DC maturation (Schnare et al., 2001) (Sections 1.3 and 1.6) and in this
manner, DCs function as a link between innate and adaptive immunity. It has been
proposed that in addition to carrying antigen for MHC-restricted presentation to T
cells (signal 1) and providing co-stimulatory signals (B7 family molecules, signal 2),
DC migration from the periphery also carries a third signal (Kalinski et al., 1999).
This so-called "signal 3" can be mediated by soluble molecules including IL-12
(Trinchieri, 1998), IL-18 (Micallef et al., 1996), and IFNa (Sareneva, et al., 1998),
and polarises the type of immune response generated by the naive T cell residing in
the secondary lymphoid tissue. Different TLR ligands have been shown to induce
different cytokine responses in DC. In this manner, the type of pathogen mediates
the type of T cell response that develops.
Eleven TLRs have so far been identified (Zhang et al., 2004). Their
identified ligands are shown in Table 1. Different TLRs share intracellular signalling
pathways and ligation and activation of TLRs triggers DC maturation involving two
signalling pathways: ERK kinase, promoting DC survival; and NFkB promoting
increased expression of co-stimulatory molecules and pro-inflammatory cytokines
(IL-1, TNFa, IL-12) (Rescigno et al., 1998). Interaction and activation of TLRs with
different PAMPs or through endogenous mediators (see below) affects DC
maturation and the subsequent signals for T cell development. The TLR3 and TLR4
agonists dsRNA and LPS, respectively, trigger DC maturation to a phenotype that
produce high levels of bioactive IL-12 p70 and strongly supports the development of
Thl cells (Cella et al., 1999; Pulendran et al., 2001; de Jong et al., 2002). Similarly,
TLR7 activation by imiquimod (a compound with potent anti-viral and anti-tumour
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properties) (Hemmi et al., 2002), or TLR9 activation by CpG DNA (Hemmi et al.,
2002) induces immature CD1 lc+ DC to support the development of Thl cells from
nai've T cells, mediated by IL-12, or in the case of pDC, IFNa (Krug et al., 2001; Ito
et al., 2001). However, monocyte-derived DCs primed with TLR2 stimuli do not
promote strong Th 1 responses, and produce low levels of IL-12 upon stimulation (Re
and Strominger, 2001). TLR2 forms heterodimers with TLR6 during recognition of
mycoplasma derived lipopeptides, proteoglycans and the yeast cell wall component
zymosan (Underhill et al. 1999). In comparison with LPS primed monocyte DCs,
mycoplasma-derived lipopeptide 2 does not induce IL-12 production, but IL-10
(Weigt et al., 2003), and induces unpolarised T cell responses (Qi, Denning and
Soong; 2003). Similarly, proteoglycans induce relatively low levels of IL-12
production and high levels of IL-10 (Re and Strominger, 2001). These data imply
that TLRs may mediate distinct cytokine profiles in DCs with different consequences
for T cell activation.








Table 1 Toll-like receptors and their ligands
Differential expression of TLR by human DC populations confers
responsiveness or hyporesponsiveness to the corresponding ligands. For example,
TLR9 is expressed by pDCs but not CD1 lc+ or monocyte-derived DCs. pDCs do
not express most other TLR that are expressed by CD1 lc+ or monocyte-derived DCs,
such as the LPS receptor TLR4 (Bauer et al., 2001; Kadowaki et al., 2001; Jarrossay
et al., 2001). Accordingly pDCs produce large amounts of IL-12 in response to CpG
DNA, and do not respond to LPS; whereas CD11 c1 DCs respond strongly to LPS and
not CpG DNA (Kadowaki et al., 2001). This is one situation where the type of DC
determines the response outcome (Section 1.8).
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During infection DCs not only become activated directly by pathogens and
PAMPs, but indirectly by endogenous factors of inflammation and tissue damage,
signalling 'danger' to the immune system (Matzinger, 1998). These include pro- or
anti-inflammatory cytokines, chemokines, heat shock proteins (HSPs), eicosanoids,
intercellular lipids associated with necrotic cells, and extracellular matrix breakdown
components. Although controversy still exists, evidence is accumulating that these
danger-associated endogenous ligands activate PRRs (Beg, 2002), examples include
mammalian HSPs inducing intracellular signalling and cytokine secretion by TLR-
dependant mechanisms (Basu et al., 2000; Ohashi et al. 2000; Vabulas 2002). The
ability of different PAMPs and endogenous mediators to polarise DC responses and
the subsequent T cell response may well yet be defined.
1.7 DCs and Peripheral Tolerance
A body of data suggests that DCs may also support peripheral tolerance. DCs
efficiently present endogenous antigen in context with MHC II in secondary
lymphoid organs (Inaba et al., 1997). Importantly, DCs loaded with apoptotic bodies
migrate under steady state conditions from the gut to mesenteric lymph nodes
(Huang et al., 2000). In addition, DCs have been visualised taking up apoptotic cells
in vivo before migration to the T cell areas of the spleen (Morelli et al., 2003). These
observations suggest that tissue-resident DCs take up apoptotic cells, process
endogenous antigens contained within them and constitutively migrate via the
afferent lymphatics to the lymph nodes. In the absence of direct or indirect
activation by pathogens (Section 1.6), DCs are thought to support tolerance to self-
antigen by inducing anergy / deletion of self reactive T cells or through the
generation of T-regulatory (T-reg) cells (Leenen et al., 1998; Dhodapkar et al., 2001;
Hawiger et al., 2001).
1.8 DC Plasticity
Early studies on the biological roles of human DC populations indicated that
different populations had different roles in vivo. Mature DC1, when activated in
vitro with CD40 ligand (CD40L), produced large amounts of IL-12 and
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preferentially induced Thl development. CD40L-activated DC2, when cultured with
IL-3, produced lower amounts of IL-12 and preferentially induced Th2 development
(Rissoan et al., 1999; Ito et al., 2001). Furthermore, activated pDC2 produced IFNa
and primed naive T cells to produce IFNy (Grouard et al., 1997; Olweus et al., 1997;
Siegal et al., 1999; Cella et al., 2000).
The opposite to these functions was observed in murine DCs using a different
model of DC antigen presentation. Pulendran et al. (2001) used DCs loaded in vitro
with an ovalbumin (OVA) peptide injected into syngeneic mice reconstituted with
OVA-specific T cells. The OVA peptide-pulsed adoptively transferred CD8a+
subset induced high levels of IFNy, and the CD8a" subset induced IL-4 and IL-10, as
well as IFNy and IL-2. Selective expansion of these subsets in vivo resulted in an
increase in antigen-specific titres with different isotypes (Pulendran et al., 2001).
Maldonado Lopez et al. (1999) used murine DCs pulsed ex vivo with keyhole limpet
haemocyanin and showed that different DC subsets directed the development of
distinct Th cells. The hypothesis arose that in the mouse CD8a+ lymphoid DCs
promote Thl responses, and CD8a" myeloid DCs preferentially induce Th2 immune
responses.
Certain difficulties arose with this hypothesis of DC subset - immune
response determination. The nature of the immune response should depend on the
nature of the pathogen (Section 1.6), abundance of the pathogen and tissue
microenvironment, and not the sub-population of DC that has captured and presented
that antigen. High antigen doses induce myeloid DCs and B220+ pDCs to induce
Thl differentiation, whereas Th2 cells are generated with low antigen doses
(Boonstra et al., 2003). IFNy enhances a Thl-promoting capacity in both CD8a and
CD8a" DCs (Maldonado Lopez et al., 2001). DCs from the respiratory tract
(Stumbles et al., 1998), Peyer's patches (Iwasaki and Kelsall, 2001), and liver
(Khanna et al., 1998) preferentially induce a Th2 response, whereas splenic CD11 c
DCs preferentially induce a Thl response. This difference may be explained by
tissue-specific cytokine microenvironments and exposure to particular pathogens.
In humans, multiple factors have been found to influence DC effector
function, including maturation status and signal, DC:T cell ratio and duration of DC
activation. Mature DC1 induce a Thl response and a strong CTL response (Rissoan
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et al., 1999), while immature DC1 induce CD4+ and CD8+ T cells which produce IL-
10 (Jonuleit et al., 2000; Dhodapkar et al., 2001; Gilliet and Liu, 2002). Immature
DC1 stimulated with Staphylococcus aureus, CpG, dsRNA, or the T cell signals
CD40L and IFNy induce a Thl response (Kalinski et al., 1999). However, immature
DC1 stimulated in the presence of IL-10, transforming growth factor-(3 (TGF|3) or
steroids induce a Th2 response (Kalinski et al., 1999). pDC2 cultured with IL-3
promote a Th2 response, while pDC2 activated by virus prime naive T cells to
produce IFNy and IL-10 (Kadowaki et al., 2001). A high DC:T cell ratio induces
DC1 to promote Thl responses, whereas low ratios promote a Th2 response (Tanaka
et al., 2000). DC produce large amounts of IL-12 and induce a Thl response during
the early stages of activation, but DC that become "exhausted" after prolonged
activation no longer produce IL-12 and induce a Th2 response (Langenkamp et al.,
2000).
These experiments show that the capacity of DCs to skew the immune
response is dependant on the antigen, length of antigen exposure, subtype of DC,
tissue of residence, and extent of T lymphocyte interaction. The net result of
pathogenic onslaught is a DC system that stimulates, and also regulates the ensuing
immune response.
1.8.1 'Suppressor' cell activity
CD8a+ splenic DCs have been demonstrated to be particularly efficient at
inducing antigen-specific tolerance in vivo (Liu et al., 2002; Legge et al., 2002), and
it is CD8a+ DCs in pancreatic islets that maintain local T cell tolerance to
endogenous antigen (Belz et al., 2002). Fas-dependant apoptosis is one mechanism
of deleting self-reactive T cells in the periphery (Ferguson et al., 2002), and it is the
CD8a+ DC subset that mediates Fas-induced apoptosis (Suss and Shortman, 1996).
Immature DCs loaded with peptide induce T cell proliferation, but no Th cytokine
profiles (Dhodapkar et al., 2001). In addition, DCs that have taken up apoptotic
bodies (Albert et al., 1998) or antigen in the presence of IL-10 (Corinti et al., 2001)
retain an immature phenotype with low expression of CD80 and CD86. Repetitive
stimulation of CD4+ T cells with peptide-loaded immature DCs induces T cell anergy
(Jonuleit et al., 2000). It appears that the phenotype associated with suppressor DC
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function implies a plasticity, and is not the function of a particular population. This
is elegantly illustrated for B220+ pDCs from mouse lymph nodes, which have an
immature phenotype when analysed ex vivo (Anjuere et al., 1999) and are potent
inducers of T cell tolerance in vitro (Martin et al., 2002). If, however, B220+ pDCs
are matured with CpG DNA, they acquire potent Thl-inducing activity (Boonstra et
al., 2003). Different DC subsets have demonstrated plasticity for activation /
suppression of T cell responses in vitro. However the function of ex vivo DCs
appears more stringent, and in vivo functions remain to be fully elucidated.
1.9 Ovine Lymph DC
The 'psuedoafferent' lymphatic cannulation model system has allowed
investigators unique insight into the function of the immune system in associated
tissues (Haig, Hopkins and Miller, 1999). Afferent lymph contains lymphocytes
(primarily CD4+ memory T cells) and DCs (Hall, 1966; Hopkins et al., 1989;
Bujdoso et al., 1989) involved in the immune surveillance of the tissues. Dendritic
cells in afferent lymph (lymph DCs) are a mixed population from various sources
migrating to draining lymph nodes. Lymph DCs carry antigen from the tissues from
which they originate. They are generally equipped for interactions with
lymphocytes, and induce responses specific to the antigens they carry.
A role for lymph DCs transporting antigen to lymph nodes for presentation of
T cells was demonstrated by Budjoso et al. (1989). Sheep were immunised
intradermally at the lymphatic cannulation site with OVA and purified protein
derivative of tuberculin (PPD). At different time points following antigen
administration, lymph DCs were collected and added to T cell lines specific for OVA
or PPD. DCs isolated after OVA immunisation could only stimulate the proliferation
of OVA-specific T cells, and DCs isolated after PPD immunisation could only
activate PPD-specific T cells. This experiment demonstrated that antigen in the skin
is taken up and transported by DCs via the afferent lymphatics to be used to activate
T cells in an antigen-specific manner. A mechanism for antigen uptake by sheep
lymph DCs was demonstrated by Harkiss et al. (1990) using in vitro and in vivo
methods. They showed that freshly isolated lymph DCs constitutively take up
protein antigen at low levels. However, antigen uptake was markedly enhanced in
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the presence of IgGi or IgG2 antibodies in vitro and in vivo, but not F(ab)2 fragments,
suggesting that uptake was mediated via FcRs. FcyR engagement induced a
reduction of expression of MHC II, CD1, CD44, very late antigen (VLA)-4,
leucocyte functional antigen (LFA)-1 and LFA-3 after 8 hours, but an increase of
these molecules after 24 hours (Coughlan et al. 1996b). The modulation of MHC
molecules and adhesion molecules may concordantly function to maximise
presentation of antigen in ICs captured in vivo for presentation to T cells in the LN.
Further studies demonstrated that T cell stimulatory function was enhanced up to
169-fold when DCs were incubated with antigen in the presence of specific antibody
(Couglan et al. 1996a). Presentation of antigemlg complexes were mediated via
MHC II, demonstrated by the ability of MHCII-specific antibody to block T cell
stimulation in these experiments (Couglan et al. 1996a).
Sheep lymph DCs express high levels of MHC I and MHC II as a
homogenous population (Budjoso et al., 1990), and levels of MHC II are increased 1
- 2 days following secondary antigen challenge (Hopkins et al., 1989). These
experiments demonstrated that lymph DCs change phenotype and function in
response to antigen in vivo. Using immune complex binding and CD1 expression,
Harkiss et al. (1990) demonstrated the existence of four discrete lymph DC
populations. Demonstrating heterogeneity of lymph DCs and a complexity of lymph
DC populations, which may reflect intrinsic functions of these cells.
1.10 Summary and Project Aims
DCs orchestrate the immune response in both a stimulatory and tolerogenic
manner. Discrete DC populations migrate via the lymphatics draining cutaneous
tissue in sheep (Harkiss et al., 1990). Studies on the function of particular DC
subsets have been conflicting depending on the tissue of residence, DCdymphocyte
ratio, and type and preparation of antigen. Isolating DCs, and analysing their
biological characteristics ex vivo, minimises the modulation of DC biology during
experimental manipulation. Determining the molecular characteristics of DCs
provides insights into the biological functions of the cells. For example, DCs with a
mature phenotype (MHC II hl, CD86+ CD40+) are extremely efficient at driving naive
T cell proliferation, whereas immature DCs (MHC Il'°, CD86", CD40") are poor
stimulators of T cells (Banchereau and Steinman, 1998). Also, DC IL-10 and IL-6
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support Th2 responses (Rincon et al. 1997), whereas IL-18 promotes Thl
development and NK cell activation (Okamura et al. 1998). Determining the ex vivo
characteristics of sheep lymph DCs may provide insight of the function of these cells
in vivo.
Project Hypothesis; Subpopulations of sheep lymph DCs differ in function.
Functional differences will be evident at the molecular level, such as surface
molecule expression and expression of immune modulatory cytokines.
Aim one: Phenotypically characterise sheep lymph DCs. This was achieved using
specific antibodies and two-colour flow cytometry. The classes of molecules
evaluated included: phenotypic / lineage-associated markers (CD 11c, CD4, CD8,
CD45RA, WC6 antigen); receptors used for antigen sampling and uptake (CD 14,
CD 16, CD206); molecules involved in interactions with T cells (CD54, CD 11 a,
CD40, signal regulatory protein-a [SIRPa]); antigen presentation (MHC II); and co-
stimulation (CD80, CD86). DC expression of SIRPa in cattle (previously termed
MyD-1) identifies two distinct populations (Howard et al., 1997). Whether SIRPa
expression on sheep DCs is relevant to the determination of individual sub-
populations was also addressed in this project.
Aim two: Determine constitutive cytokine expression by sheep lymph DCs. A
multiprobe RNase protection assay (RPA) was developed to measure eleven ovine
cytokines (IL-1|3, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-18, IFNy, GM-CSF, TGF0,
TNFa) and two housekeeping genes (ATPase, GAPDH). The ovine RPA enabled
the anlaysis of cytokines involved in innate inflammatory responses (IL-1 (3,
TNFa, IL-8, GM-CSF), and adaptive immune responses (IL-4, IL-6, IL-10, IL-
12p40, IL-18, IFNy, TGF(3). The cytokines included in the RPA have pleitrophic
affects on the immune system, both in action, and the responding cell type. In
addition to supporting studies in the current project, the ovine cytokine RPA could be
further utilised in a wide array of cytokine studies of ruminants.
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Chapter 2: Materials and Methods
The companies supplying the reagents used in this work are referred to in the
text. All company addresses are listed in Appendix 2. Cell cultures were carried out
at 37°C in 5% carbon dioxide. Fetal calf serum (FCS) (Invitrogen LT) used in the
culture media was heat inactivated (56°C, 30 min). All cell culture techniques were
carried out in an aseptic manner inside microbiological (class II) safety cabinets
using sterile equipment and solutions. Oligonucleotide primers were synthesized by
MWG biotech.
2.1 Animals
Male and female Blackface x Finnish Landrace sheep of 1-2 years of age
obtained from Edinburgh University Veterinary Faculty were used for the collection
of blood, lymph and lung washes.
2A Preparation of Cells
2A.1 Alveolar Macrophages (AM)
Alveolar macrophages (AM) were used for optimising many experimental
techniques as these belong to the myeloid cell lineage, and large numbers are
relatively easy to obtain using the bronchoalveolar lavage (BAL) technique. Based
on the protocol described by Mayer and Lam (1984) lungs, heart and intact trachea
were completely removed, and the outer surface washed with H2O. The
bronchoalveolar cells were washed out of the lung using ice-cold sterile (s) Hank's
buffered salt solution (HBSS) in 3-4 washes (1.5-2 litres) while the lungs were gently
massaged. Alternatively, euthanised animals were intubated with 9.5 - 10.5 mm
cuffed endotracheal tubes, and the lung lumen flushed with ice-cold sHBSS while
massaging the thoracic cavity. BAL cells were transferred by pipette into 250 ml
flasks (Beckman) in order to separate the cells from floating mucus and cell debris
from the top of the cell suspension, and then centrifuged at 800 x g for 15 - 25 min at
4°C. Cells were washed twice in sHBSS and recovered at 300 x g for 5 min. Cell
viability was determined as described in Section 2A.5 and was always over 70%.
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AM-enriched BAL cells were prepared by adherance to plastic tissue culture
flaks (Nunc) according to the method of Koretzky et al. (1982). BAL cells were
cultured in warm (37°C) RPMI-Mac medium (RPMI-1640, 10% FCS, 2 mM L-
glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 pg/ml streptomycin, 2.5
pg/ml fungizone), at a concentration of lxlO6 cells/ml, at 37°C in an atmosphere of
5% CC>2:95% air in tissue culture flasks kept in an horizontal position, the cap
loosely fitting. The adherent cell population was harvested by removing the non¬
adherent cells, washing the adherent cells with sPBS and recovering them with sterile
phospate buffered saline (sPBS) containing 0.02% ethylenediaminetetraacetic acid
(EDTA) and incubating at 37°C for 15 min. Cells were removed from the flask by
vigorous pipetting. Cell yield and viability was determined as described in Section
2A.5. Harvested cells were washed twice with sPBS before extracting the RNA.
Alternatively, total RNA was isolated directly from the adherent cells as described in
section 2B1.1.
2A.2 Afferent Lymph Cells
Afferent lymph cells were obtained by the chronic cannulation of the
prefermoral psuedo-afferent lymph ducts (Hall, 1966; Hopkins et al., 1985). Briefly,
the prefermoral lymph node was surgically removed. Within six to eight weeks the
afferent lymphatics reanastomose with the single efferent duct which remained intact
at removal of the lymph node. All surgery was performed by Professor J. Hopkins,
(Edinburgh University). Afferent lymph was collected into sterile siliconised plastic
bottles containing 400 U of heparin, 1000 U penicillin and 1 mg streptomycin, and,
where indicated, actinomycin D (Sigma Aldrich) to a final concentration of 1 pg/ml.
Collections were performed at 24 hour intervals to record lymph volume and cell
counts. To obtain cell populations as near to physiologically normal, animals were
allowed at least seven days postoperative recovery and lymph assessed to be absent
of erythrocytes and inflammatory cells (polymorphonulear cells [PMN]) using flow
cytometry (Section 2B.8).
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2A.3 Enrichment of Afferent DC and AM.
Afferent lymph and BAL were enriched for DCs and AM, respectively using
centrifugation through a stepped sucrose gradient (Optiprep™ [Axis-shield]).
During experiments evaluating cytokine expression, the buffers were supplemented
with 1 ug/ml actinomycin D (Sigma Aldrich). Cells were washed in separation
buffer (HBS, 0.5% bovine serum albumin [BSA], 1 mM EDTA), harvested and re-
suspended in the same medium. Cell suspensions did not exceed 2 xlO7 cells/ml,
volumes of 2.5 mis or 10 mis were transferred to 50 ml tubes (Nunc). Optiprep was
added to the cells to a final concentration of 29% v/v, and mixed by swirling. These
were overlaid with 4 ml or 7.5 ml 25% v/v Optiprep prepared in separation buffer
respectively, followed by 10 ml or 20 ml 20% v/v Optiprep respectively, then 1ml
HBS. The gradient solutions were centrifuged at 600 x g for 25 min at room
temperature (rt), no brake was applied on deceleration. DCs and AM were collected
from the interphase of 20% Optiprep and HBS, and washed in twice in sHBSS.
Proportions of DCs or AM were consistently greater than 65% or 80% respectively
as determined by cell morphology. Morphological analyses are shown in Figure 2.1.
2A.4 Peripheral Blood Mononuclear Cells
Peripheral blood mononuclear cells (PBMCs) were utilised for titrating
monoclonal antibodies (mAb) used in flow cytometry experiments (2B.8.5). Blood
was collected from the jugular vein into 50 ml tubes (Nunc) containing 5 U/ml
heparin and diluted by addition of an equal volume of sPBS. The diluted blood was
layered onto an equal volume of rt Lymphoprep (Axis-shield) and centrifuged at 870
x g for 20 min at rt, with no break applied on deceleration. PBMCs were collected
from the Lymphoprep:PBS interphase and washed twice in sPBS before cell surface
immuno-labelling for flow cytometric analysis.
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2A.5 Cell Viability and Counting
Cell viability was determined using trypan blue exclusion. Cells were
suspended in 0.1% trypan blue (Sigma Aldrich), and counted in a haemocytometer.
The number of unstained viable cells was counted per 1 mm square. The cell count
represented the number of cells x 104 / ml of cell suspension.
2A.6 Cytospin Preparation and Staining
Morphological analyses of fractionated or un-fractionated cells were carried
out by preparing cytospins of single cell suspensions. 50 pi of cell suspension
(lxlO6 cells/ml) was spun onto pre-chilled silane-prep™ microscope slides (Sigma
Aldrich) at 300 rpm for 3 min using a Cytospin-2 (Shandon). Cytospins were fixed
in ice cold acetone for 5 min and stained by covering in Gurr® Giemsa's stain
solution (improved R66, Merck) for 15 min. Following staining, cytospins were




The mAb used in this thesis are listed in Appendix 3. This illustrates their
isotype, specificity, source and working dilutions for immuno-labelling and flow
cytometric analysis. The mAb were obtained from in house stocks (John Hopkins,
Edinburgh University), clones purchased from the European Collection of Cell
Cultures (IL-A24), or kind gifts of Dr. Jan Naessens, (International Livestock
Institute; Nairobi) (3.29B1, ILA-156, ILA-159, ILA-190). mAb specificity was
confirmed by analysing reactivity with afferent lymph cells (ALC) or PBMC using
flow cytometry.
2B.2 Production of Saturated Culture Supernatants
In some instances B hybridoma monoclonal cell lines were grown in culture
and the culture supernatant rich in monoclonal antibodies harvested. The hybridoma
cells were stored under liquid nitrogen in 1 ml aliquots and were recovered by
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thawing in a water bath at 37°C for 2 min. Cell suspensions were gradually added to
20 mis warm (37°C) culture medium (RPMI-1640, 20% FCS, 2 mM L-glutamine, 1
mM sodium pyruvate). Cells were collected by centrifugation at 400 x g for 5 min,
re-suspended in 5 mis culture medium and maintained at 37°C in an atmosphere of
5% CC>2:95% air, culture flask caps loosely fitting. Hybidoma cells grew as non¬
adherent aggregates and were passaged when required. Once the cells were
established in culture, FCS content in the culture medium was reduced by half with
each passage and replaced with Ultradoma PF serum free medium (BioWhittaker).
The saturated culture supernatant was harvested from passage 5 onwards after
removing the cell debris at 1500 x g for 15 min, and stored at -20°C in the presence
of 0.01% sodium azide.
2B.3 Purification of Ascitic Fluid and Saturated Supernatant
Immunoglobulin (Ig) from ascitic fluid or hybridoma supernatant was
purified by ammonium sulphate precipitation according to the method of Hardy
(1986). Briefly, Ig was precipitated with ammonium sulphate (pH 6 - 7) at 45%
saturation (volume / volume [v/v]) for 30 min at rt. The preparations were
centrifuged at 10 000 x g for 20 mins. Solidified precipitate was washed twice with
saturated ammonium sulphate and re-dissolved in PBS. For dialysis, cellulose tubing
(Fisher) was cut into strips and boiled in 0.1 mM EDTA for 5 min, washed in
distilled H2O and boiled for a further 5 mins in 0.1 mM EDTA. The strips were
washed again and stored in distilled H2O at 4°C until required. Dissolved Ig was
extensively dialysed into PBS for 12 hours at 4°C. The protein concentration was
determined by spectrophotometry OD280, with an absorbance reading being
equivalent to 0.715 mg/ml protein. mAb were stored at -20°C in the presence of
0.01% sodium azide.
2B.4 Biotinylation of Monoclonal Antibodies
Ig solutions were adjusted to 1 mg/ml by dilution or concentration using a
protein G-capture column (HiTrap™ Protein G Sepharose™ HP, Amerhsam PB),
following the manufacturers instructions. Ig's were exchanged into 0.1 M NaHCOj
(pH 8.3) using a Sephadex G 25 (PD-10) column (Amersham PB) to ensure no
sodium azide remained in the solution, as this would inhibit down-stream biotin
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conjugation. Biotinylation was then carried out by incubating the Ig (at 1 mg/ml) for
5 hours with biotin (biotin-amido caproate N-hydroxysuccinimide ester) in
dimethylsulphoxide (DMSO) (2.5 mg/ml) at a biotin to protein ratio of 75 pg : 1 mg.
Biotinylated Ig was then extensively dialysed against PBS, 0.01% w/v sodium azide,
ph 7.2 for 12 hours at 4°C before a final 3 hour dialysis against PBS-azide containing
20% v/v glycerol. Biotinylated mAbs (in 20% glycerol) were stored at -80°C.
2B.5 Polyacrylamide Gel Electrophoresis (PAGE)
When new mAb preparations were used, Ig content was analysed by
fractionating the proteins by polyacrylamide gel electrophoresis (PAGE) and
visualised by staining or western blotting. Proteins were fractionated by
discontinuous PAGE through Tris-glycine buffer containing SDS (255 mM glycine,
0.1% SDS, 50 mM Tris HC1). Gels comprised of a stacking gel and a resolving gel.
The resolving gel consisted of 12% w/v acrylamide, 375 mM Tris pH 8.8, 0.1% w/v
SDS, 0.5% w/v ammonium persulphate (APS) and 0.5% TEMED. The stacking gel
consisted of 3% w/v acrylamide, 125 mM Tris pH 6.8, 0.1% w/v SDS, 0.5% w/v
APS, 0.1% w/v TEMED. Samples were boiled for three min at 100°C in sodium
dodecyl sulphate (SDS) sample buffer (Appendix 1) before electrophoresis through
vertical slab gels using Bio-Rad Mini Protean II gel equipment. Gels were run at 140
Volts for 1.5 hours or until the dye front reached the bottom of the gel. Bio-Rad low
molecular weight markers (range 111 - 20.5 kd) were run on each gel.
2B.6 Staining of SDS-PAGE Gels
Gels were stained in 0.25% Coomassie brilliant blue-R in 50% v/v methanol,
10% v/v acetic acid for 30 mins. Gels were then destained in several changes of 20%
v/v methanol, 10% v/v acetic acid and dried onto wet 3 mm filter for 2 hours at 80°C
on a vacuum drier (Biorad Labs, gel drier).
2B.7 Western Blot
Western blot was used for the visualisation of fractionated Ig that was
obscured by serum proteins of approximately 60 kDa, and could not be visualised by
Coommassie staining. After electrophoretic separation on SDS-PAGE, proteins were
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transferred onto nitrocellulose membrane (Hybond-C, 0.45 pm, Amersham PB PB)
at 0.8 mA per cm2 for 45 min in buffer containing 48 mM Tris base, 39 mM glycine,
0.037% w/v SDS and 20% v/v methanol. The nitrocellulose membrane was washed
several times with H2O followed by PBS, then blocked with a solution of PBS, 5%
w/v marvel non-fat dried milk powder, 0.2% v/v tween20® and 0.02% w/v sodium
azide Blocked membranes were washed several times with PBS and incubated for 1-
4 hrs with primary antibody then washed several times in PBS. Membranes were
then incubated with second antibody or substrate for 1 hour, washed several times in
H2O and air-dried.
2B.8 Flow Cytometry
For phenotypic analysis, cell preparations were washed twice in FACS buffer
(PBS, 2% w/v BSA, 0.1% w/v sodium azide, pH 7.2, filter sterilised) and cell
concentration adjusted to 106/ml for immuno-labelling of cell surface antigens.
2B.8.1 Single Immuno-labelling
To block non-specific binding, cells were incubated with 1% normal lamb
serum (NLS) for 10 mins on ice before being washed twice with FACS buffer.
Because afferent DC were the target cell population in these experiments, 10 X the
number of ALC than ALC-enriched DC were labelled (DC comprise 1-5% ALC).
5xl03 ALC or PBMC or 5xl04 DC were incubated for 30 mins on ice with 50 pi
mAb diluted appropriately in FACS buffer (Appendix 3). Unbound antibody was
removed by washing twice with 1 ml FACS buffer. The cells were then incubated
with 50 pi florescein isothiocyanate (FITC) -conjugated anti-mouse Ig (Sigma
Aldrich) in the dark for 30 mins on ice. Cells were washed three times in FACS
buffer, and re-suspended in FACS buffer or fixed with 2% w/v paraformaldehyde
and stored at 4°C overnight before analysis. The control samples were treated with
1:500 normal mouse serum (NMS) (Scottish blood transfusion service) instead of
primary antibody.
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2B.8.2 Double Immuno-labelling
For the staining of two surface molecules using mAbs from different species,
cells were incubated withNLS and dispensed as above and incubated simultaneously
with 25 pi of each mAb (one of which was biotinylated). They were incubated and
washed twice in FACS buffer as above. The biotinylated primary mAb was rat Ig
(SW73.2, Appendix 3), and was detected with streptavidin-phycoerithrin (SA-PE)
(Sigma Aldrich). Other primary antibodies were detected with a species-specific
FITC-conjugated second antibody (goat anti-mouse IgG Fab specific) (Sigma
Aldrich). Cells were incubated with 25 pi each of SA-PE and Ig-FITC in the dark
for 30 mins on ice. Cells were washed and prepared for flow cytometric analysis as
above. Negative controls were stained with 1:500 NMS and 1:100 biotinylated
normal rat serum (NRSbio) or biotinylated (NMSbio) as first antibodies depending
on the species (mouse or rat) in which the primary mAb were raised.
For double staining using antibodies raised in the same species, cells were
stained separately with each antibody; first with the mAb to be labelled with FITC.
After incubation, cells were washed twice and then incubated with FITC-antiglobulin
conjugate as above and washed three times. Cells were then stained with the second
biotinylated antibody prior to labelling with SA-PE as above.
2B.8.3 Flow Cytometer Settings
The immunofluorescence studies described were carried out using the
FACScan, or FACScaliber cytometers (Becton Dickinson). Different cytometers
were used during the project depending on the availability of machines. Data was
analysed using the WinMDI software. In each case data was derived by analysing
10 000 cells (or events) per sample. Duplicate or triplicate samples were used in
each experiment. After staining, the fluorescence measurements were made on
homogenous populations of cells by setting gates on cell size and complexity dot
plots (Figure 2.2) that were distinguished using appropriate linear photo multiplier
tube (PMT) voltage amplifications for forward (FSC) and side (SSC) scatter
parameters excluding unwanted cells. These FSC and SSC parameters define cell
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Cell size and complexity
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Figure 2.2 Gates used in flow cytometric analysis. Freshly
isolated afferent lymph cells or peripheral blood mononuclear
cells were prepared for flow cytometric analysis as described in
Chapter 2. Cell populations were defined by light scatter
properties.
a) Afferent lymph cell populations. Dendritic cells were defined
by high forward scatter (FSC) and high side scatter (SSC) (Rl)
and lymphocytes with low to medium FSC and low SSC (R2).




Figure 2.3 Cell phenotyping negative controls. Cells were
stained with 1:500 NMS or 1:100 NMSbio and secondary
conjugates to determine the background fluorescence for FL1 and
FL2 parameters, respectively.
a) Negative control cells. The quadrants were adjusted so 99% of
the cells were in the lower left quadrant.
b) Marker (Ml) was set to determine the percentage positive cells
in relation to 1% of negative control cells.
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2B.8.5 Titration of Monoclonal Antibodies
The mAbs, conjugates and secondary reagents used in the flow cytometry
experiments were titrated to establish optimal working conditions. Sheep ALC and
DC were stained with various dilutions of mAb preparations. A range of primary
mAb incubation times was tested (20 mins - 45 mins), maximal staining was evident
after 30 min incubation on ice (not shown). Purified antibodies and fluorochromes
(SA-PE and Ig-FITC) were tested at a range of concentrations, live cell populations
were gated and fluorescence analysed. The optimal working dilution of each of the
secondary reagents chosen was which gave the strongest fluorescence intensity and
clear distinction between the positive and negative populations within the normal
range. The optimal working dilution of the primary antibody giving strongest
specific fluorescence and lowest background staining of the negative control cells
was chosen. An example is shown in Figure 2.5.
2B.9 Negative Selection of DC: Magnetic Activated Cell Sorter (MACS).
Afferent lymph lymphocyte depletion protocols involved mAb staining and
separation using a magnetic activated cell sorter (MACS) (Miltenyl Biotec). DC
enriched afferent lymph cells (Section 2A.3) were washed twice in buffer 1 (PBS,
1% w/v BSA, 0.05% w/v sodium azide 5pM EDTA) and 5x10s cells incubated with
50 pi of biotin-conjugated mAb at optimal staining concentration for 30 min at 4°C.
Un-bound antibody was removed by washing the cells twice in buffer 1, the cells
were then labelled with 10 pi strepatividin-coated microbeads (Miltenyl Biotec) in
100 pi with buffer 1 for 20 min at 4°C. Cells were washed as above and re-
suspended in 500 pi buffer 2 (PBS, 0.5% w/v BSA, 2mM EDTA) before magnetic
selection using an equilibrated vario MACS column (Miltenyl Biotec) fixed in a
magnetic stand. The column was washed with 2 mis buffer 2 and the elute collected
as the negative cell fraction. After removing the column from the magnet, the
positive cell fraction was eluted with buffer 2.
The cell fractions were analysed by flow cytometry. The un-selected (negative) cell
fraction should be absent of cells expressing markers used for magnetic separation,
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the mAb used in MACS selection as described in Section 2B.8.2. The positive cell
fraction should only contain cell expressing the markers used for selection, and as
such be 100% positive. Biotin-conjugated mAb were used for the primary antibodies
and were labelled with biotin-coated beads. This labelling does not engage all free
biotin-streptavidin binding sites, so bound primary mAb conjugates can be directly
labelled with SA-PE and analysed by flow cytometry. Cells from the positive
fraction were incubated with SA-PE (Sigma Aldrich) at 4°C for 30 mins, and washed
twice. Cells were analysed on a FACSscan (Becton Dickinson).
2C Molecular Biology
All DNA sequencing was carried out by Mr. I. Bennet (University of Edinburgh) on
a LI-COR DNA sequencer (model 4000L)
2C.1 RNA Extraction and Methods
Precautions were taken to preserve the integrity of RNA transcripts
throughout the following procedures. Particular emphasis was placed on avoiding
contamination with RNases. Commercially available RNase free solutions and sterile
nuclease-free plastic wear were used. Glass wear was treated with RNase ZAP
(Sigma Aldrich), and rinsed with nuclease-free H2O (Sigma Aldrich). Gloves were
changed frequently. Nuclease-free H2O (Sigma Aldrich) was used to prepare
solutions. Solutions were stored at -20°C and retained on ice throughout use.
2C.1.1 Isolation of Total RNA
Total RNA was isolated using one of two methods:
For less than 5xl06 cells, SV Total RNA Isolation System (Promega) was
used following the manufacturers instructions.
For more than 5xl06 cells RNAzol B (Biogenesis) was used to extract RNA.
Adherent cells in tissue culture flasks were washed twice with PBS then lysed
directly by addition of RNAzol B to the flask. Non-adherent cells were washed
twice, the medium removed then re-suspended in RNAzol B at 1 ml per 5xl07 cells.
Following lysis, O.lv of chloroform was added, samples vigorously shaken and
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stored on ice for 5 min. Samples were centrifuged at 12000 x g for 15 min, the upper
aqueous phase transferred to a fresh tube and an equal volume of ice-cold
isopropanol added. Precipitation was carried out for 30 min on ice, or overnight at
4°C. The samples were then centrifuged at 12000 x g for 15 min. RNA pellets were
washed with 75% ethanol, air dried then re-suspended in nuclease-free H2O. To
ensure complete removal of cellular DNA, samples were treated with DNase I. RNA
(1 - 10 qg) was incubated with 10 U of RQ1 RNase-free DNase (Promega) at 37°C
for 30 min. The sample was then extracted with phenol/chloroform/isoamyl alcohol
(pH 4.7, 25:24:1) (Sigma Aldrich), followed by chloroform/isoamyl alcohol (24:1,
Sigma Aldrich), and precipitated with 0.5v of 7.5M NH4 acetate at -70°C for 30 min.
Following centrifugation at high speed for 5 min, the RNA pellet was washed and re-
suspended as previously mentioned. If not for immediate use, RNA samples were
stored in nuclease-free H2O at -70°C.
2C.1.2 RNA Analysis
The concentration of RNA samples was determined by spectrophotometry
with an OD260 of 1.0 being equivalent to 40 qg/ml RNA. Absorbance readings at
A280 were also measured to check sample purity; pure RNA preparations have a
A260/A280 ratio of >1.9.
Gel electrophoresis was also used to demonstrate the intact nature of the
RNA. 28S and 18S bands were required to indicate that the RNA had not undergone
degradation. Approximately 2 \ig of RNA was denatured by heating to 80°C for 3
min then chilled on ice for 3 min, and then run on a 1% agarose gel (Section 2C.3.4),
1 p.g of the EcoR I/Hind III digested lambda DNA markers was run on each gel. Gels
were visualised under ultra violet (U.V.) light.
Where indicated, RNA was analysed using the RNA 6000 Nano assay system
(Agilent Technologies) to demonstrate the intact nature of the RNA samples.
Samples containing 5 - 500 ng RNA were analysed according to the manufacturers
instructions.
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2C.2 cDNA Synthesis
Unless otherwise indicated, cDNA synthesis was carried out using
Superscript II RNase H" Reverse Transcriptase (RT) (Invitrogen LT) according to the
manufacturers instructions. Oligo (dT)i5 primer (Promega) were used to initiate the
cDNA synthesis from total RNA as follows; 1 pg of total RNA plus 500 ng oligo-dT
was made up to 12 pi with H2O, heated to 70°C for 10 min then chilled on ice. The
following constituents were then added; 4 pi of 5 X transcription buffer (final cone.
50 mM Tris-HCl pH 8.3, 75 mM KC1, 3 mM MgCl2), 20 mM dithiothreitol and 100
pM of each dNTP. The mixture was incubated at 42° for 2 min prior to addition of
200 U RT and incubation at 42°C for 50 min. The reaction was then inactivated by
heating at 70°C for 15 min. Negative controls were included for genomic DNA
contamination; cDNA synthesis was carried out omitting reverse transcriptase
enzyme. Theses samples were then analysed by PCR (Section 2C.4).
2C.3 Rapid Amplification of cDNA Ends (RACE)
cDNA synthesis was also carried out to allow the 'rapid amplification of
cDNA ends' (RACE) using the 573' RACE system (Roche). This technique utilised
the 3' polyA-tail of eurkaryotic mRNA for cDNA syntheis directed by an oligo (dT)-
anchor primer. The 5' region was obtained by synthesising cDNA with a specific
anti-sense primer. After purification, the cDNA was polyA-tailed, and amplified by
PCR using the oligo (dT)-anchor primer. Anchor primers were used in subsequent
PCR reactions. The protocol is as follows: for the synthesis of cDNA, final reaction
volumes of 20 pi consisted of 1 pg total RNA, 250 pM specific primer or 1.2
pM oligo (dT)-anchor primer, 100 pM of each dNTP, 1 X reaction buffer (50 mM
Tris-HCl, 8 mM MgCl2, 30 mM KC1, 1 mM dithiothreitol), and 20 units AMV RT.
The reaction was incubated at 55°C for 1 hour, and heat inactivated at 65°C for 10
min. For amplification of the 5' region, cDNA synthesised in the presence of the
specific primer was purified using the High Pure PCR product purification system
(Roche), following the manufacturers instructions. The purified cDNA was then
subject to a polyA-tailing reaction that consisted of 19 pi cDNA, 2.5 pi 2 mM dATP,
and 2.5 pi 10 X buffer (final concentration 10 mM Tris-HCl, 1.5 mM MgCl2, 50 mM
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KC1, pH 8.3). The reaction mixture was incubated at 94°C for 3 min, and briefly
chilled on ice before the addition of 10 U terminal transferase and incubation at 37°C
for 30 min. The reaction was heat inactivated at 70°C for 10 min.
2C.4 Polymerase Chain Reaction (PCR)
Care was taken throughout the preparation of PCR reactions to avoid
contamination of samples with amplified products, or unwanted DNA. Gloves were
worn and changed regularly, and sterile tubes and aerosol resistant tips were used
throughout the procedure. All PCR reagents were aliquotted and stored in smaller
volumes.
PCR reactions were carried out in sterile 0.2 ml thin walled tubes with final
reaction volume of 50 pi The basic components of the PCR reaction were as
follows, lx PCR buffer (50 mM KC1, 10 mM Tris-HCl pH8.3, 1.5 mM MgCl2), 200
pM of each dNTP, DNA template (2 pi of a cDNA synthesis reaction or 10 ng
pDNA), 10-50 pmoles of each primer. These constituents were mixed then
collected by pulse high speed centrifugation. To avoid ambiguous primer binding,
'hot start' PCR was used; reaction tubes were heated to 94°C for 3 min prior to the
addition of 1 unit of Taq (Thermus aquaticus DNA) polymerase enzyme. Different
types of commercially available Taq were used in different experiments,
manufacturers are listed in the relevant sections. Cycling was carried out in a Hybaid
Sprint Thermocycler. Oligonucleotide primer sequences are listed in Appendix 4.
Each primer pair was optimised for [MgCl2], an example is shown in Figure 2.6.
Cycling parameter varied according to the primers and as such are described in the
relevant sections.
2C.5 Agarose Gel Electrophoresis
Following PCR, 20% of the reaction was analysed on a 1 - 1.5% w/v agarose
gel (Type I: low EEO, Biogene). Agarose was melted in TAE buffer (Appendix 1)
containing 1 pg/ml ethidium bromide. Samples were mixed with 1/5 volume of 5 X
DNA sample buffer, loaded and the gel run at 70-80V for 60-90 min. For DNA
fragments 100 b.p. - 1 k.b., lOObp. DNA ladders (MWG Biotech) were used; DNA
fragments > 1 k.b. EcoR I/Hind III digested lambda DNA markers were used, 1 pg of
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Figure 2.6 MgCl2optimisation for PCR primers. MgCl2
concentration was optimised for each primer pair used in this project, an
example is shown;
Lanes 1-5 IL-6 (Primers X68723F & X68723R; Appendix 4)
Lanes 6-10 IL-12 p40 (Primers AF004024F2 & AF004024R; Appendix
4)
Lanes 11-15 IL-10 (Primers Z29362F & Z29362R; Appendix 4)
PCR reaction [MgCL] was 0.5 mM lanes 1,6, 11;
1.5 mM lanes 2, 7, 12
2.5 mM lanes 3, 8, 13
3.5 mM lanes 4, 9, 14
4.5 mM lanes 5, 10, 15.
Templates were 10 ng plasmid DNA containing the appropriate
cytokine cDNA sequence. Reactions were incubated for 30 cycles of
amplification (94 1'; 55 1'; 72 1') followed by 1 extension cycle (72 7').
Optimal MgOf concentration for each primer set was 1.5 mM.
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the marker was run on each gel. DNA concentration was determined using
spectrophotometry, with an OD260 of 1.0 being equivalent to 50 pg/ml DNA.
Absorbance readings at A280 were also measured to check sample purity; pure DNA
preparations have a A260/A280 ratio of over 1.7.
2C.6 Purification of DNA
Vector DNA or DNA amplified by PCR which were to be subsequently used
for cloning were subject to one of the two purification methods:
DNA fragments excised from agarose gels were purified using a
DNA:agarose-gel extraction kit following the manufacturers instructions. Following
purification the concentration of the DNA sample was determined using
spectrometry.
Single PCR products, or linearised vector DNA were purified using spin-bind
column (QiAquick®, Qiagen) following the manufacturers instructions. To check
the procedure 10 pi of the sample was run on an agarose gel, and the concentration
of the DNA sample determined using spectrometry.
2C.7 Cloning of PCR Products
PCR products which had been purified as described above were cloned using
the pGEM®-T Easy vector system (Promega) that utilises TA cloning. Briefly,
ligations were set up as 3:1 to 1:3 molar ratio of vector : PCR insert. Competent
JM109 cells (Promega) were then transformed with 2 pi of the ligation reaction and
the transformed cells were plated onto LB/ampicillin/X-gal plates (Section 2C.9) and
incubated overnight at 37°C. Transformed colonies were identified by blue/white
selection and positive clones were picked and grown overnight in 10 ml LB
containing 50 pg/ml ampicillin.
2C.8 Competent Cells
The E. coli strains used in these studies were JM109 (TA cloning kit) or
DH5a that were made competent according to the method of Inoue et al. (1990).
Single colonies were picked into 10 ml SOB medium (Appendix 1) and grown for 5
hours then 2.5 ml of the culture diluted to 250 ml and grown to midlog OD(,oo=0.6.
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Cultures were rapidly chilled, the cells collected at 2800 x g for 15 min then re-
suspended in 80mls ice cold TB buffer (Appendix 1) and chilled for 10 min. Cells
were centrifuged again at 15000 x g for 10 min then gently re-suspended in 5 mis
TB, 0.3 ml DMSO (high grade, Sigma Aldrich) before being aliquoted into pre-
chilled eppendorf tubes (Nunc) and snap frozen in liquid nitrogen. Competent cells
were then stored at -80°C.
2C.9 Bacterial Cultures
E. coli bacterial strains were cultured in Luria Bertani (LB) broth (Appendix
1). The medium was supplemented with ampicillin (100 pg/ml) since the vectors
used in this study all contained ampicillin resistance gene. LB / agar plates were
made up with 1.5% bacteriological agar supplemented with 50 pg/ml ampicillin and
were stored at 4°C. When plating JM109 cells with the vector pGEM-T-easy, each
10 cm plate was supplemented with 50 pg/ml 5-bromo-4-chloro-3-indolyl-(3-
galactoside (X-gal) and 0.5 pM isopropyl-|3-thiogalactopyranoside (IPTG) to allow
blue-white selection.
2C.10 Preparation of Plasmid DNA
Plasmid DNA for sequencing was isolated, depending on bacterial culture
volume, using QIAprep-spin columns (Qiagen) or the QIAfilter plasmid midi kit
(Qiagen) following the manufacturers instructions.
Plasmid DNA that was analysed for insert size was isolated as follows; 1 ml
of overnight culture was centrifuged at 400 x g for 10 min and re-suspended in 25
mM Tris pH 8, 10 mM EDTA pEI 8, 50 mM glucose. Cells were then lysed in 0.2
mM NaOH, 1% SDS for 5 min at rt. Precipitation of bacterial DNA was carried out
by addition of 5 M potassium acetate, 19% glacial acetic acid, incubation on ice for 5
min and high speed centrifugation for 3 min. The supernatant was then extracted
with phenol/chloroform/isoamyl alcohol (25:24:1), precipitated with 100% ethanol,
washed in 70% ethanol and re-suspended in 20 - 50 pi TE buffer (Appendix 1). Any
bacterial RNA was degraded using 0.5 pg RNase A (Sigma Aldrich) by incubating at
37°C for 30 min, and then at 70°C for 5 min to inactivate the reaction.
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2C.11 Restriction Endonuclease Digestion of DNA Samples
Restriction endonuclease digests of plasmid DNA to allow analysis of inserts
was carried out as follows. The reaction was typically carried out in a 20 pi volume
containing 10 pi plasmid DNA, 10 units of enzyme and the appropriate enzyme
buffer (New England Biolabs). Digests were carried out at 37°C for 1-2 hours.
Following digestion, inserts were analysed by running 10 pi of the reaction on an
agarose gel (as in section 2C.3.4.).
2C.12 RNase Protection Assay (RPA)
An RPA was developed to analyse the expression of eleven ovine cytokines.
Radiolabeled antisense RNA (riboprobes) were synthesised from a set of specific
cDNA subclones, which were then hybridised with target RNA samples. Single
stranded RNA species and excess probes are enzymatically digested and annealed
species analysed by PAGE. A schematic illustrating the RPA methodology is shown
in Figure 2.7. Inclusion of a probe for a housekeeping gene (GAPDH) enables
normalisation between samples, and relative levels of hybridised RNA species can be
calculated. As such, the RNase protections assay is a specific, highly sensitive,
method for evaluating the levels of target mRNA. The development of the RPA is
described in Chapter 5, the following sections describe the methodology of the
RNase protection assay.
2C.12.1 Linearisation of Riboprobe Templates
Cytokine sub-clones were used as templates for riboprobe and positive
control RNA synthesis, these are listed in Appendix 5. Plasmid DNA was linearised
by restriction endonuclease digest, as described in Section 2C.8 and the samples then
extracted with phenol/chloroform/isoamyl alcohol (25:24:1) pH 7.5, followed by
chloroform/isoamyl alcohol (24:1), washed in ethanol and precipitated with 3 M
sodium acetate pEl 5.2. Following high speed centrifugation for 15 min, DNA pellets
were washed in 70% ethanol, air dried and re-suspended in 10 mM Tris pH 8.5.
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2C.12.2 Preparation of Positive Control RNA
RNA was produced to use as controls for probe hybridisation. Transcription
reactions were set up in 100 pi volumes containing 1-2 pg linearised template DNA,
100 mM DTT, 100 U RNasin (Promega), 2.5 mM each rATP, rGTP, rCTP, rUTP, 40
U T7 RNA polymerase and 1 X enzyme buffer, which were then incubated at 37°C
for 2 hours. DNA template was removed by adding RQ1 RNase free DNase (1 U/pg
DNA) (Promega), and incubating the sample at 37°C for 15 min. The sample was
then extracted with TE-saturated phenol/chloroform/isoamyl alcohol (25:24:1) pH
4.5 followed by chloroform /isoamyl alcohol (24:1), precipitated with 0.5 volume 7.5
M ammonium acetate in the presence of 2.5 volumes of 100% ethanol and incubated
at -70°C for 30 min. After high-speed centrifugation for 20 min, the pellet was
washed with 0.5 ml 70% ethanol, air dried and re-suspended in 100-200 pi H2O.
2C.12.3 Generation of Radiolabeled Probes
Antisense riboprobes were synthesised from a pool of cDNA templates
(2C.12.1). Quantification of target mRNA is achieved when the riboprobes are at
molar excess. So that the riboprobes would be present in the hybridisation mixtures
at equivalent amounts, quantities were normalised to the GAPDH probe. The
optimal quantity of GAPDH riboprobe to achieve riboprobe excess vs. cellular
mRNA was 1.66 ng (Dr. A. Gossner; Edinburgh University). The quantity (ng) of
template DNA required was determined by the formula; quantity of probe (ng) =
quantity of vector (ng) x (insert size (kb.) / vector size (kb.)).
Unless otherwise stated, reagents used in probe synthesis were from
Promega's Riboprobe Combination System SP6/T7. During synthesis, [32P]UTP
nucleotides were incorporated into the anti-sense RNA (riboprobe). The synthesis
reaction was set up in a sterile tube containing lyophilised rUTP (10 pM), 2.5 mM
each rGTP, rATP, rCTP and 120 pCi 5'-[a32P] UTP (Amersham PB PB). The
reaction was set up in a 10.5 pi volume containing an equimolar pool of linearised
template DNA (Section 2C9.1), 10 mM DTT, 1.2 U RNasin, 20 U SP6 RNA
polymerase and the enzyme buffer. Reactions were incubated at 37°C for 1 hour and
terminated by adding 2 U RQ1-DNase and incubating at 37°C for 30 min.
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Figure 2.7 The RNase protection assay. The RNase protection
assay is a highly sensitive and specific method for the quantitation
of mRNA species. The strategy for the development of a multiprobe
RNase protection assay was to generate a series of ovine cytokine
cDNA sub-clones. To generate probe templates the plasmids were
linearised with an appropriate restriction endonuclease, purified, and
combined in a set. The templates were used for RNA polymerase
directed synthesis of 32P-labelled anti-sense RNA (cRNA). The
purified-labelled riboprobes were hybridised (at probe molar excess)
with the target RNA. After hybridisation was completed,
ribonucleases specific for single stranded RNA digested un-
hybridised RNA and probe. The "RNase-protected" probes were
resolved on a denaturing PAGE and were visualised by
phosphorimaging. As the entire target mRNA was in solution and
available for hybridisation the quantity of each mRNA species in the
original RNA sample could be determined based on the intensity of
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Chapter 2 Materials & Methods
Radiolabeled riboprobes were purified after adding 4 pg yeast tRNA as
carrier, using ProbeQuant G-560 spin columns (Amerhasm PB) following the
manufacturers instructions. The quantity of incorporated probe was determined by
adding 1 pi of the synthesis reaction to 1 ml HISAFE scintillation fluid (National
Diagnostis), and using a P counter. Probes with an activity >106 cpm were used.
2C.12.4 Riboprobe:RNA Hybridisation
Total cellular RNA and positive control RNA were hybridised with specific
riboprobes which bind by homologous interactions. Target RNA was lyophilised at rt
for 1 hour in a DNA speed vacuum after incubation at -70°C for 15 min. After re-
suspension in 8 pi hybridisation buffer (80% formamide, 1 mM EDTA, 400 mM
NaCl, 40 mM PIPES, pH 6.7), 2 pi of the labelled probes were added to each RNA
sample. Samples were vortexed and incubated at 90°C in a heated block, which was
immediately turned down to 56°C overnight.
2C.12.5 Removal of Single Stranded RNA
Target mRNA species of interest were bound by complementary
radiolabeled probes. These hybridised molecules are protected from enzymatic
digestion using single-strand-specific RNase's which degrade 'un-protected' RNA.
Following hybridisation, 100 pi RNase cocktail (10 mM Tris pH 7.5, 0.3 M NaCl, 5
pM EDTA, 33% v/v RNase cocktail™ (15 U RNase A, 606 U RNase Tl) (Ambion)
was added to the samples and incubated at 30°C for 45 min. The reaction was then
inactivated by adding 18pl proteinase K (0.3% SDS, 600pg proteinase K) and 120
pg yeast tRNA (2 mg/ml) as a carrier, and incubating at 37°C for 15 min.
The samples were extracted with phenol: cholorform: isoamyl alcohol
(25:24:1) pH 7.5, precipitated with 4 M ammonium acetate and 650 pi ethanol and
centrifuged at high speed for 15 min. After the RNA pellets were washed in 100 pi
90% ethanol and air dried, each sample was re-suspended in 5pl loading buffer (80%
formamide, 1 mM EDTA, 50 mM Tris-borate, pH 8.3, 0.05% w/v xylene cyanole
and bromophenol blue), and stored on ice.
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2C.12.6 Gel Resolution of Protected Probes
To quantify the abundance of hybridised radiolabeled probes, samples were
resolved on denaturing acrylamide gels, and scanned with phosphorimaging. Each
gel was prepared with 100 mis 5% acrylamide mix (National diagnostics) according
to the manufacturers instructions. Immediately prior to casting, 300 pi 10%
ammonium persulphate was added to polymerise the gel solution. Prior to assembly,
sequencing gel plates were thoroughly cleaned, buffed with isopropanol, and one of
the two siliconised. Plates were separated with 0.2 mm spacers, clamped and the gel
poured at 10° angle. Once the well comb was inserted, the end of the gel was
covered in clingfilm and cast overnight. Gels were run in TBE buffer and heated to
50°C before loading the samples. Prior to loading on a polyacrylamide gel, the
samples were incubated at 90°C for 3 min then immediately chilled on ice for 3 min.
Gels were run at 50°C at 80 to 85 Watts for 1.5-2 hours or until the leading dye
front reached the bottom of the gel.
2C.12.7 Phosphorimaging
Gels were dried on 3MM filter paper on a vacuum drier, and exposed
overnight against a phosphorimaging screen (Kodak). Screens were scanned on an
imager (Molecular Dynamics).
2C.12.8 Densitometric Analysis
Data were collected after phosphorimaging scanning and pixel levels of
radioactivity were analysed using Image Master 3D software (Pharmacia). The
background levels in each lane were determined by the minimum level of density,
and subtracted. This package allows the detection of bands of different intensities on
the same gel image by adjusting the levels of contrast and intensity. The software
automatically detected bands, and bands of interests were manually identified.
Limits of band width were adjusted so that pixels of highest intensity were included;
the same constraints were used for particular bands throughout the samples. Band
volumes determined by the software package were presented as arbitrary values of
pixel density. The values were exported into excel, and the ratio of intensity of each
band (Ig) was calculated to the density level of the housekeeping gene GAPDH (Ihg)
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and represented as a 'normalised volume' according to the formula: x = (Ig / Ihg) x
100. The normalised volumes were imported into GraphPad Prism version 3.00 for
statistical analysis, and production of graphs. Individual data were used for analysis
of the kinetics of cytokine gene expression. Mean values were determined by
compiling the data obtained from separate donor animals that undergone similar
experimental conditions.
2D Statistical Analysis
Data from individual experiments were pooled, and T tests (un-paired, two-
tailed) and non-linear regression analyses were performed using the GraphPad Prism
version 3.00 package. Results are expressed as mean ± standard error of the mean.
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Chapter 3: Cloning and Sequencing of Sheep Interleukin-18
3.1 INTRODUCTION
Interleukin-18 (IL-18) was initially described as a factor produced in
Propionibacterium acnes (P. acnes) primed, and LPS-challenged mice that induced
high levels of IFNy production above that of IL-12 alone, and was thus designated as
IFNy-inducing factor (IGIF) (Okamura et al., 1995a). IL-18 has subsequently been
characterised in a variety of mammals and vertebrates. It is expressed by a wide
variety of immune and non-immune cells including monocytes, macrophages and
MoDCs (Stoll et al., 1998; Gardella et al., 1999). Studies using knock out mice
demonstrated IL-18 as critical for the regulation of NK cellular and Thl-type
immunity (Takeda et al., 1998), and augments CD3-stimulated T cell proliferation in
a MLR (Yoshimoto et al., 1998). In addition, IL-18 enhances Fas ligand (FasL)
(Okamura et al., 1995a) expression and cytotoxicity of natural killer cells (NK) and T
lymphocytes (Hashimoto et al., 1999), which mediate IL-18 anti-tumour activity. IL-
18 has also been shown to induce the production of tumour necrosis factor-a (TNFa)
and IL-113, the chemokines IL-8 and macrophage inflammatory protein-a (MlP-la)
(Puren, Fantuzzi and Dinarello, 1999; Fehniger et al., 1999; Netea et al., 2000), and
enhance GM-CSF production (Micallef et al., 1996; Ushio et al., 1996).
Human IL-18 is a 18 kDa non-glycosylated protein and production of active
IL-18 requires that its precursor (pro-IL-18) is processed by caspase 1 (Gu et al.,
1997; Ghayur et al., 1997). The 5' region of the human IL-18 gene contains one LPS
/ phorobol 12-myristate 13-acetate (PMA) -regulated promoter and another
constitutive promoter (Tone et al., 1997). The inducible promoter contains a number
of transcription factor recognition sequences such as for activator protein-1 (AP-1)
and Nuclear factor-kappa B (NFkB) (Tone et al., 1997).
3.1.2 Chapter Aims
At the outset of this project, sheep IL-18 cDNA had not been cloned. This
cytokine plays an important role in regulating T cell responses, as well as
participating in the early stages of cell-mediated immunity. It was therefore
important to examine its expression by sheep DCs. This chapter describes the
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cloning of ovine IL-18 by rtPCR and the rapid amplification of cDNA ends (RACE)
technique, using LPS stimulated alveolar macrophages as a source of RNA.
Cattle IL-18, similar to human and rodent has been demonstrated to induce
IFNy production in synergy with IL-12 and independently of IL-12, and enhance T
cell proliferation (Shoda et al., 1999). The experiments presented in this and
subsequent chapters aim to: 1) evaluate the regulation of IL-18 expression in sheep,
and 2) extend the knowledge of dendritic cell function.
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3.2 RESULTS
3.2.1 Primer Design
Primers for the generation of ovine IL-18 were designed based on the
nucleotide sequences of IL-18 from different species (human, porcine, canine,
bovine). A 5' degenerate primer was designed based on a consensus sequence of rat,
human, canine, porcine and murine IL-18 cDNA sequences. Sequences of the
primers used in this chapter are presented in Appendix 4. Figure 3.1 shows the
region of the IL-18 nucleotide sequence that were chosen for the generation of the
PCR primers. Comparisons of nucleotide sequences presented in this Chapter were
performed using GAP comparison software (Genetic Computer Group, Version 10
[GCG 10]; Madison, WI. USA). GAP uses the algorithm of Needleman and Wunsch
(1970) to find the alignment of two sequences by maximizing the number of matches
and minimizing the number of gaps. Default settings for gap weight and gap length
(5.0 and 3.0 for nucleotide comparisons, 0.3 and 0.1 for amino acid comparisons,
respectively) were used.
3.2.2 Cloning of Sheep IL-18
Templates, primer sets and amplification conditions utilised for all PCR
reactions described in this Chapter are presented in Table 3.1. All PCR's were 'hot
started' to reduce primer oligomerisation. cDNA was synthesised from 1 pg total
RNA isolated from adherent alveolar cells cultured for 4 hours with 1 pg/ml LPS
(Salmonella typhimurium lipopolysaccharide, Sigma) or 5 ng/ml PMA (Sigma) as
template and oligo (dT) as primer, as described in Section 2C.2. The cDNA was
then analysed by PCR utilising primers specific for the ATPase gene as a positive
control for cDNA synthesis. The ATPase message should be detectable in all tissues
(Shull, Schwartz and Lingrel, 1985) and any samples that were negative for this PCR
product were not utilised further. In addition, cDNA synthesis reactions were set up
with the RNA samples in the absence of reverse transcriptase enzyme, and 1 pi used
in PCR reactions with ATPase primers.
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Figure 3.1 Comparison and consensus of IL-18 sequences. Sequence alignment of IL-18
cDNA sequences using GAP software (Genetic Computer Group, Version 10 [GCG 10];
Madison, WI. USA). IL-18 sequences analysed were as follows: rat brain, AJ222813; human
liver, D49950; canine macrophages, Y11133; porcine macrophages, AB010003; cattle
macrophages AF124789; mouse cell line AJ002364. A dot (.) indicates gaps which were
introduced to maintain alignment. A dash (-) indicates no consensus nucleotide between
sequences. Sequences on which the PCR primer sets were based are shown; primer set 1 are
shown in blue; primer set 2 are shown in orange; primer set 3 contains the sense primer of set 2





Human liver GCCTGGACAG TCAGCAAGGA ATTGTCTCCC AGTGCATTTT GCCCTCCTGG
Dog macrophages — — —-— —
Pig macrophages —- -—-—
Cattle macrophages . —AC AGTTCTGCTC TCCAATGCTT
Mouse cell line -AAGCTTTAT AAAACGGGGC TGTTTCCAGG
Consensus GCCTGGACAG TCAGCAAGGA A-G T-AC AGTTC-G-TC TCC-TCC-GG
51 100
Rat brain — — —
Human liver CTGCCAACTC TGGCTGCTAA AGCGGCTGCC ACCTGCTGCA GTCTACACAG
Dog macrophages — —
Pig macrophages — — —
Cattle macrophages TCAGCGCTCC TGGCTGCCTG CTTCTGCTGC TGAAGGGGCT GCCGTCTTCT
Mouse cell line CCACTGAGAA GTAAATCTGT AGAGCTTCTA GCAAGTGTCA TGTGACACCA
Consensus CCACCGA--C TGGCTGCT— AG-GC-T—C -CAAG-GGCA G-CGACACCG
101 150
Rat brain ——-—-—-—-— —~~—.
Human liver CTTCGGGAAG AGGAAAGGAA CCTCAGACCT TCCAGATCGC TTCCTCTCGC
Dog Macrophages — ~— —~
Pig macrophages —
Cattle macrophages GTAAGGAAAA GAAAGGGACC TCAAACCTTT CATATCACGT TTCCTCTCCT
Mouse cell line TGTTGAGCCT GGGAAAGTAA AATCCTGAAT AAGATCTTAA AGAGGAAGAA
Consensus -TTCGGGAA- GGGAAAG-AA -CTCA T -A-ATCTCG- TTCCTCTC—
151 200
Rat brain ~~~~~~~ATG GCTGCCATGT CAGAAGAAGG
Human liver AACAAACTAT TTGTCGCAGG AATAAAGATG GCTGCTGAAC CAGTAGAAGA
Dog macrophages — ATG GCTGCTAACC TAATAGAAGA
Pig macrophages — ATG GCTGCTGAAC C...GGAAGA
Cattle macrophages AAGAAGCTAT TGAGCACAGG CATAAAGATG GCTGCAGAAC AAGTAGAAGA
Mouse cell line AGAAAACACT ATACAAAAGT TATTTTGTTA CCCCCCCAAA AATAATATAT
Consensus AACAAACTAT TTATCACAGG -ATAAAGATG GCTGCTGAAC -AG-AGAAGA
201 250
Rat brain CTCTTGTGTC AACTTCAAAG AAATGATGTT TATTGACAAC ACACTTTACC
Human liver CAATTGCATC AACTTTGTGG CAATGAAATT TATTGACAAT ACGCTTTACT
Dog macrophages CAATTGCATC AACCTTGTGA AAATGAAATT TGTTAACAAT ACACTGTACT
Pig macrophages CAATTGCATC AGCTTTGTGG AAATGAAGTT TATTAACAAT ACACTTTACT
Cattle macrophages TTATTGCATC AGCTTTGTGG AAATGAAATT TATTAACAAT ACACTTTATT
Mouse cell line TTTATATATA ATGGCTATAT TATAAAAATT ACTACAGTAT GACTGTTGTT
Consensus CAATTGCATC AACTTTGTGG -AATGAAATT TATTGACAAT AC-CTTTACT
251 300
Rat brain TTATACCTGA AGATAATGGA GACTTGGAAT CAGACCACTT TGGCAGACTT
Human liver TTATAGCTGA AGATGATGAA AACCTGGAAT CAGATTACTT TGGCAAGCTT
Dog macrophages TTAAAGCGGA AAGTGATGAA GGCCTGGAAT CAGATTACTT TGGCAAGCTT
Pig macrophages TTGTAGCTGA AAACGATGAA GACCTGGAAT CGGATTACTT TGGCAAGCTT
Cattle macrophages TTGTAGCTGA AAATGATGAA GACCTGGAAT CAGATCACTT TGGCAAACTT
Mouse cell line CAGTGGTTTT AGATAAAAAA ATATTTCATG CTGAAGTGTG CAAGAGCCTC












































































































































































































































CTGATAACAT CAAGGATACA AAAAGTGACA TCATATTCTT TCAGAGAAGT
CGGATAGTAT CAATGATGAA GGAAATGACA TCATATTCTT TCAGAGAAGT
CTGATAATAT TGATGATGAA GGAAATGACA TCATATTCTT TCAGAGAAGT
CTGATAACAT TGATAATGAA GAAAGTGACA TCATATTCTT TCAAAGAAGT
CCTTTGCCTG CCTTCTTCCT CATTCTTGTG CCTTGGTATC ACAG.GCGCA






















































































AAAGGAAGGA TGAAAATGGG GATAAATCTG TAATGTTCAC TCTTACTAAC
AAAAAGAGGA TGAATTGGGG GATAGATCTA TAATGTTCAC TGTTCAAAAC












AAGAAAAGGA TGAATGTGGA GATAAATCTA TAATGTTCAC TGTTCAAAAC
AAAAACAGGA TGATAATAGA GATAAATCTG TAATGTTCAC TGTTCAAAAC
ATCAGGACAA AGAAAGCCGC CTCAAACCTT CCAAATCACT TCCTCTTGAC
AAAAAGA GGA TGAA—TGG- GATAAATCTA TAATGTTCAC TGTTCAAAAC
751 800
TTACATCAAA GTTAGGTATT AAGGTTTCTG TATTCCAGAA AGACGATTAG





















Table 3.1 Sheep IL-18 cloning parameters
Template Primers Cycle
No.





































35 94 1various 55-








































40 94 0.25', 55 0.5',
72 0.5'
72 7'
















(94 0.25', 60 0.25',
72 0.5') x 10








40 94 0.25', 55.5 0.5',
72 0.5'
72 7'
Details of the PCR reaction templates, primer usage, cycling parameters and
commercially available Taq enzyme used. Primer sequences are listed in Appendix
4.
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3.2.3 RT-PCR for the IL-18 Coding Region
Primer sets 1 and 2 initially utilised various PCR cyling parameters (Table
4.1). No product was obtained in any reaction. These primers were designed from
human and porcine sequences, and possibly contain regions of non-homology for the
ovine IL-18 sequence. Therefore an antisense 'degenerate' primer was designed as
described above, and used in conjunction with the sense primer from set 2, and a
newly designed sense primer based on the canine IL-18 sequence, and designated
primer set 3 and 4 respectively. To test the efficiency of primer sets 3 and 4, PCR
reactions were performed using plasmid DNA containing canine IL-18 cDNA as
template (Argyle et al., 1999) (10 ng). Primer set 3 resulted in no PCR product,
whereas set 4 produced a product of expected size (533 bp) (not shown). Primer set
4 was utilised to amplify ovine cDNA with the condition outlined Table 3.1 and
generated non-specific products. PCR reactions using primer set 4 were optimised
for MgCf concentration (not shown); 0.2 mM MgCf was found to be optimal and
used in subsequent reactions. To complement for ATPase amplification as positive
control, the cDNA PCR templates were analysed for IL-ip and IL-12 p40 message
using primers X54796F & X54796R, and AF004024F & AF004024R, respectively.
IL-ip and IL-12 p40 gene transcription is strongly induced by LPS (Dinarello, 1998)
(Trinchieri, 1998). The IL-1 (3-specific primers generated a product of expected size
(123 bp.) using a number of cDNA templates (not shown), and these were utilised
subsequent reactions. Analysis of two of these samples using primer set 4 produced
multiple products ranging from 200 bp. to 800 bp. These were excised and purified
using a spin-bind column (Section 2C.6). The purified products were cloned into
pGEM-T-easy using TA cloning (Section 2C.7), amplified and purified using Qiagen
spin columns (Section 2C.10). Positive clones were analysed by endonuclease
digestion of the plasmid clones with EcoR I. The plasmids containing inserts of
expected size were sequenced.
Comparison analysis using GAP software (GCG 10) showed that none of the
cloned inserts displayed any significant homology to canine or human IL-18,
strongly indicating that the products were not ovine IL-18 (not shown).
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Primer set 5 was designed based on the bovine sequence (AF124789). These
primers generated a PCR product of expected size (Figure 3.2). The product was
purified using a spin-bind column and cloned as before using the TA cloning kit.
Following plasmid DNA purification, the clone was sequenced across both sense and
antisense strands. Analysis of this insert using GAP software revealed >98%
homology with the bovine IL-18 gene. Based on sequence comparisons to other
species (cattle, human, canine; Section 3.2.5), the clone was considered to represent
the ovine IL-18 coding region. Subsequently, four ovine IL-18 cDNA clones were
obtained from two separate RT reactions using cDNA from LPS and PMA
stimulated macrophages as templates.
3.2.4 'RACE'PCR
The ovine IL-18 coding region obtained by RT-PCR using Primer set 5,
which were based on bovine IL-18, incorporated the initiation and stop codons. It
was necessary to sequence through these regions to obtain the primary sheep
sequence, so the rapid amplification of cDNA ends (RACE) technique was
employed. This was achieved using the 5'3' RACE system (Roche Molecular
Biochemicals) (Section 2C.3). A schematic representation of the RACE technique is
shown in Figure 3.3. Manufacturers control primers were used to analyse the cDNA
synthesis and 5' polyA-tailing reactions (not shown), samples that produced positive
results were utilised further. RNA samples were analysed by RT-PCR utilising
ATPase primers (as previously described), and Primer set 5 to demonstrate the
presence of IL-18 message (not shown). Positive samples were utilised in the RACE
strategy.
Both the 3' and 5' end amplification utilised nested primer PCR strategies.
Figure 3.4 shows the results of primary and secondary PCR for the 3' region of ovine
IL-18. The first round of PCR used 1 pi of cDNA as template, the primers anchor
and RACE4 and a 'touchdown' PCR strategy (Don et al., 1991) to increase the
abundance of specific product. A nested PCR was carried out using 0.4 pi of this
DNA as template. Agarose gel electrophoresis analysis of the nested PCR reactions
utilising primers anchor and RACE5 are shown in Figure 3.4b. Multiple bands were
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Figure 3.2 PCR amplification of EL-18 cDNA from LPS
stimulated macrophage RNA.
M = Marker DNA
Lane 1: PCR product using primer set 5 (for details see Table
3.1). The single product of 609 bp. (indicated by the arrow), was
purified, cloned and sequenced and concluded to be ovine IL-18
based on strong homolgy with published IL-18 sequences.
Lane 2: negative control (template DNA omitted) for reaction
utilising primer set 5.
Lane 3: ATPase internal control using primers X02813F &
X02813R1 (Table 3.1), produced a product of the expected size;
118 bp. (indicated with an asterix)
Lane 4: negative control (template DNA omitted) for reaction
utilising ATPase-specific primers.
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Figure 3.3 Amplification of the 5'/3' ends of sheep IL-18 cDNA
using the Roche RACE system
a) Specific primers were designed based on the consensus nucleotide
sequence of the ovine IL-18 coding region. The positions of the RACE
primers are shown. Primers are shown in blue. RT-PCR reactions
were performed using stimulated macrophage RNA as template.
b) Amplification of the 5' region was achieved by synthesising cDNA
utilising the specific primer RACE 1. This product was purified using
a spin-bind column, dA-tailed, and was used as template for a primary
PCR reaction utilising primers oligo(dT)-anchor and RACE2. A nested
PCR strategy was then utilised using the primary PCR product as
template and primers anchor and RACE3.
c) The 3' region was amplified by performing a cDNA synthesis
reaction using the oligo(dT)-anchor primer. This product was used as
template for a primary PCR reaction utilising primers RACE4 and
anchor. Nested PCR was performed on a purified fragment of
expected size (~400bp.), utilising the RACE5 and anchor primers.
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Figure 3.4 Amplification and cloning of the 3' region of sheep IL-
18 cDNA
M: marker DNA. -ve: template omitted as negative control
a) PCR using macrophage cDNA as template
1, 2 and 3: individual PCR reactions using primers oligo(dT)-anchor
and RACE4 (See Table 3.1 for details)
b) Nested PCR utilising DNA generated with primers oligo(dT)-anchor
and RACE4 (Figure 3.4a) as template
1, 2 and 3: individual PCR reactions utilising corresponding DNA
template samples, using primers anchor and RACE5
Band of expected size (401 bp.) is indicated with an arrow.
c) Cloning of the 400 bp. product in Figure 3.4b, which is indicated by
the arrow: EcoR I digest of one positive clone per individual
amplification reaction (1,2 and 3).
Amplification parameters are shown in Table 3.1
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a) Primary PCR reactions






b) Nested PCR reactions
M 1 2 3
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present in all reactions, the size of the PCR product of interest based on the full
cDNA sequence of bovine IL-18, was the strongest product of approximately 400 bp.
This was excised, purified and cloned as previously described. Restriction digests of
purified plasmid DNA for the three clones are shown (Fig. 3.4c). For the 5' ends, 1
pg of total RNA was reverse transcribed using the specific primer RACE1 and the
dA-tailed cDNA was amplified for two rounds of PCR using the specific primers
RACE2 and RACE3 with the oligo(dT)-anchor and anchor primer respectively.
Templates for the reactions were 5 pi of cDNA for the primary PCR and 1 pi of that
reaction for the nested PCR reaction. The results are shown in Figure 3.5. The
nested PCR reaction produced a single product of expected size that was purified
with a spin-bind column, purified and cloned as above. Sequencing and analysis of
the 3' and 5' RACE clones confirmed these were sheep IL-18 (discussed below).
3.2.5 Sequence Analysis
The nucleotide sequence of three overlapping cDNA fragments, representing
the coding region of IL-18, 5' and 3' RACE, each from at least two independent
RNA samples and multiple secondary PCR reactions, were analysed using GCG 10.
Consensus sequence was deduced using the PILEUP programme to compare
multiple overlapping clones. PILEUP creates a multiple sequence alignment using
progressive pairwise alignments. Figure 3.6 shows an alignment of representative
clones containing the 3' region, coding region and 5' region of ovine IL-18. Where
nucleotide ambiguities existed, three out of four identical residues were taken as the
consensus sequence.
Figure 3.7 shows the nucleotide sequence of sheep IL-18 and predicted amino
acid composition of the protein. Sheep IL-18 has a coding sequence of 582 base
pairs, including stop codon, encoding a precursor peptide length of 193 amino acids.
The nucleotide sequence has been submitted to EMBL/GenBank Data Libraries
under accession number AJ401033.
Production of bioactive human IL-18 is associated with cleavage of the full-
length precursor protein (proIL-18) between Asp36 and Try37 by caspase-1 (also
known as IL-ip converting enzyme [ICE]) (Ghayur et al., 1997). Based on
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Figure 3.5 Amplification of the 5' region of sheep ILrl8 cDNA
a) PCR using macrophage polyA-cDNA produced with primer
RACE1 as template
M: marker DNA, 1: negative control, 2: PCR product using primers
oligo(dT)-anchor and RACE2
b) Nested PCR utilising DNA generated with primers oligo(dT)-
anchor and RACE2 (Figure 4.5a) as template
M: marker DNA, 1: PCR product using primers anchor and RACE3,
2: negative control
Amplification parameters are shown in Table 3.1
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Figure 3.6 Alignment of cDNA fragments representing the coding, 5' and 3'
regions of sheep IL-18. The overlapping fragments were aligned using the
PILEUP programme of GCG 10. Internal clones containing the start and stop
codons are indicated in red (Clone 1 & 2), 5' clones in purple (Clone 3 & 4), and 3'
clones in green (Clone 5 & 6). The positions of the PCR primers used to obtain the













































CTCTAGTCGG ATCCGGACTG GCAGAGAGTT CTGCTTTCCA GTGCTTTCAG
-TCTAGTCGG ATCCGGACTG GCAGAGAGTT CTGCTTTCCA GTGCTTTCAG
51 100
CTCTCCTGGG GGTCTGCTTC TGCTGCTGAA GGGGCTGCCG TCTTCTATAA
CTCTCCTGGC GGTCTGCTTC TGCTGCTGAA GGGGCTGCCG TCTTCTATAA
101 150
GGAAAAGAAA AGGACCTCAA ACCGTTCAGA TCACGTTTCC TCTCCTAGGA
GGAAAAGAAA AGGACCTCAA ACCGTTCAGA TCACGTTTCC TCTCCTAGGA
151 200
AGCTATTGAG CACAGGCATA AAGATGGCTG CAGAACCAGT AGAAGACAAT
























































































































CAGGGAAATC AACCTGTCTT TGAGGATATG CCTGATTCTG ACTGTTCAGA
CAGGGAAATC AACCTGTCTT TGAGGATATG CCTGATTCTG ACTGTTCAGA
CAGGGAAATC AACCTGTCTT TGAGGATATG CCTGATTCTG ACTGTTCAGA
CAGGGAAATC AACCTGTCTT TGAGGATATG CCTGATTCTG ACTGTTCAGA





TAATGCACCC CAGACCATaT TTATcAtATA TATGTATAAG
TAATGCACCC CAGACCATAT TTATCATATA TATGTATAAG
TAATGCACCC CAGACCATAT TTATCATATA TATGTATAAG



























































































































































Figure 3.7 Nucleotide and predicted amino acid sequence for sheep IL-18 un¬
processed polypeptide. The nucleotide sequence shown in upper case letters
represents the coding region of 582 bp. encoding a precursor protein of 193 amino
acids. Start codon is underlined and the stop codon is marked with an asterisk. The
predicted caspase-1 (ICE) cleavage site is written in orange, the arrow indicates the
amino acid terminus of the mature cleavage site 3' to the N-terminal leader









GCT GCA GAA CCA GTA GAA GAC AAT TGC ATC AGC TTT GTG GAA ATG
AAE PVEDNC I S FVEM
20 30
AAA TTT ATT AAC AAT ACA CTT TAT TTT GTA GCT GAA AAT GGC GAA
KFINNTLYFVAENCA
40
GAC CTG GAA GGC GAA TCA GAT CAC TTT GGC AAG CTT GAA CCT AAG
G E D L E S D >H F G K L E P K
50 60
CTC TCA ATC ATA CGA AAT TTG AAC GAC CAA GTT CTC TTC ATT AGC
LSI IRNLNDQVLFIS
70
CAG GGA AAT CAA CCT GTC TTT GAG GAT ATG CCT GAT TCT GAC TGT
QGNQPVFEDMPDSDC
80 90
TCA GAT AAT GCA CCC CAG ACC ATA TTT ATC ATA TAT ATG TAT AAG
SDNAPQT I F I IYMYK
100
GAC AGC CTC ACT AGA GGT CTG GCT GTA ACC ATC TCT GTG CAG TGT
DSLTRGLAVT I SVQC
110 120
AAG AAA ATG TCT ACT CTC TCC TGT GAG AAC AAA ATT ATT TCC TTT
KKMSTLSCENKI ISF
130
AAG GAA ATG AAT CCT CCT GAT AAC ATT GAT AAT GAA GGA AGT GAC
KEMNPPDNI DNEGSD
140 150
ATC ATA TTC TTT CAG AGA AGT GTT CCA GGA CAT GAT GAT AAG ATA
I I F FQRSVPGHDDKI
160
CAA TTT GAG TCT TCA TTG TAC AAA GGG TAC TTT CTA GCT TGT AAA
QFESSLYKGYFLACK
170 180
AAA GAG AAT GAC CTT TTC AAA CTC ATT TTG AAA AGA CAG GAT GAT
KENDLFKLILKRQDD
190
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comparisons with human IL-18, the predicted ovine IL-18 peptide has a leader
sequence of 36 amino acids terminating in Asp. When cleaved, ovine IL-18 would
yield a mature protein of 157 amino acids, with a molecular weight of 18 KDa, as
predicted by the The ExPASy (Expert Protein Analysis System) package (Swiss
institute of Bioinformatics; http://ca.expasv.org/tools/pi_tool.html).
Analysis using the Seqsee vl.l (University of Alberta, Canada;
www.pence.ualberta.ca/ftp/seqsee/index.html) package has predicted that the ovine
IL-18 amino acid sequence, like IL-18 from all other species investigated, contains
the IL-1 signature sequence, F-(X12)-FES-(X6)-FL, and no predicted hydrophobic
sequence at position nt. 138 - 161. In addition, the predicted mature IL-18 peptide of
sheep contains four cysteine residues, and like all other species but cattle (Shoda et
al., 1999), it possesses no N-glycosylation site (N-X-S/T).
Ovine IL-18 was compared at the nucleotide and amino acid sequence level
to other known IL-18 sequences using the GAP programme of GCG 10. Figure 3.8
shows the alignment of the predicted amino acid sequence of sheep, cattle, porcine,
human and mouse IL-18, the ovine sequence differs to other IL-18 amino acid
sequences at two positions; Gly3o and Ser59. Table 3.2 shows the percentage identity
at both nucleotide and amino acid level of unprocessed ovine IL-18 sequence to the
equivalent sequences in other species. A high degree of identity (97% - 71%) is seen
between all mammalian IL-18 sequences; but sheep IL-18 displays only 42% identity
with chicken IL-18 (Table 3.2).
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ovine MAAEPVEDNC ISFVEMKFIN NTLYFVAENG EDLESDHFGK LEPKLSIIRN
cattle Q. . .Y D E
porcine - DE Y
human N..A....D I...D E Y S...V...
mouse ...MS-..S. VN.K D IP. EN G N..R LHCTTAV. . .
ovine LNDQVLFISQ GNQPVFEDMP DSDCSDNAPQ TIFIIYMYKD SLTRGLAVTI
cattle N
porcine N. .H.A V
human D. . . R. L T R R S QP. .M
mouse I VDK -R D.T .I.Q.ASD.. . RL EV L
ovine SVQCKKMSTL SCENKIISFK EMNPPDNIDN EGSDIIFFQR SVPGHDDKIQ
cattle V E
porcine K.KTL S D ..N
human ..K.E.I KD TK N. M.
mouse . . KDS K E ..D..E...D IQ..L....K R....-N.ME
ovine FESSLYKGYF LACKKENDLF KLILKRQDDN RDKSIMFTVQ NKN*
cattle V Q.*
porcine EK.EC G *
human ....S.E E..R KE.ELG.R ED*
mouse E.H. ...Q..D.A KK.E. G...V...LT . LHQS*
Figure 3.8 Alignment of the predicted un-processed IL-18 amino acid sequences derived
from ovine, cattle (Shoda et al., 1999), porcine (Muneta et al., 1999), human (Ushio et al.,
1996), and mouse (Okamura et al., 1995b) mRNA samples. Non-consensus amino acids
are indicated, a dot (.) represents consensus to the sheep amino acid sequence, an asterix




















Comparison of the percentage identity at the nucleotide and amino acid level
between ovine IL-18 and other IL-18 sequences. The species and Genbank accession
number of the individual sequences is shown. These results were obtained using the
GAP programme of GCG 10.
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3.3 DISCUSSION
The inability of primer sets 1 - 4 to detect IL-18 cDNA in the stimulated
macrophage samples could have arisen for a variety of reasons. The Tm°C of the
sense and antisense primers of sets 1 and 2 were not optimally matched, and although
various annealing temperatures were used, simultaneous binding of the primers to
target DNA may not have occurred. In addition, subsequent analysis of identity of
the primer sets to the sheep IL-18 sequence derived in this study revealed portions of
ambiguity in both the sense and antisense primer of set 1, and all possible versions of
the degenerate antisense primer (sets 3 and 4) (not shown). Together, it is likely that
the problem was associated with the inability of the primers to bind to their 'target'
under the conditions used in the PCR reactions described in this section. The primers
based on the sequence of cattle IL-18 (primer set 5), resulted in the amplification of
sheep IL-18 cDNA. Indeed, the sheep pro-IL-18 cDNA nucleotide sequence
displays 97% homology with the cattle sequence, nucleotide anomalies between the
sequences were not confined to a particular region indicating a general conservation
of IL-18 sequence between these species.
The RACE technique employed to obtain the primary sheep sequence utilised
specific primers and an adapted primer at the 3' and 5' ends of the molecule. The
synthesis of cDNA through the start codon utilised a specific primer, and
amplification of this product using nested PCR produced a single product. In
contrast, amplification of the 3' cDNA end resulted in non-specific product in both
the primary and secondary PCR reactions. cDNA synthesis in the 3' RACE reaction
utilised an oligo(dT)-adapter primer. The appearance of non-specific product is
generally due to mispriming of one or both of the PCR primers, and these products
will be amplified over increasing number of cycles, particularly where target
template is present only in small amounts. An absolute requirement for two rounds
of PCR amplification to obtain detectable levels of IL-18 RACE products indicated
that the target cDNA was indeed at low levels. The [MgCL] and annealing
temperature were adjusted, which resulted in a loss of products (not shown). It
appeared that the presence of spurious bands following amplification of the 3' region
was due to a lack of specificity of the antisense primer as the sense primers used in
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the nested PCR reactions displayed specificity for 100% homology to the sheep IL-
18 sequence (analysed using BLAST software www.hgmp.mrc.ac.uk). Thus, the
touchdown PCR strategy was employed for the primary PCR reaction of the 3' ends,
and IL-18 cDNA was isolated.
The peptide sequence of ovine IL-18, deduced from nucleotide sequence has
a high degree of identity to that of IL-18 of cattle, porcine and horse, and >70%
identity to human and mouse. The absence of a conventional signal peptide in proIL-
18 isolated from mice and humans (Ushio et al., 1996; Okamura et al., 1995b) makes
it probable that this peptide is not secreted by cells. Ghayur et al. (1997) generated a
mutant proIL-18 peptide with a single amino acid substitution at the caspase-1
cleavage site (Asp35 - Asn36) substituting the aspartic acid reside with an alanine
(Ghayur et al., 1997). Following in vitro synthesis, and incubation with caspase-1,
these mutant proteins failed to exhibit biological activity (measured by IFNy
production by mitogen-activated splenocytes) (Ghayur et al., 1997). These results
demonstrated a requirement for caspase-1 activity in IL-18 activity. In support of
this, Gu et al. (1997) showed that approximately 10% of the mature IL-18 was
exported from COS cells transfected with an expression plasmid for proIL-18 in
combination with one encoding wild-type ICE (caspase-1), whereas less than 1% of
pro IL-18 was exported when cells were transfected with proIL-18 plasmid DNA
alone (Gu et al., 1997). In agreement with this finding, it has been shown that
murine Kupffer cells isolated from P. acnes challenged mice produce a mature active
form of IL-18 intracellularly and also secrete the mature IL-18 into the culture
medium after LPS stimulation (Tsutsui et al., 1997). These results demonstrate that
caspase-1 cleavage ofproIL-18 is required for biological activity, and that mature IL-
18 is secreted from the cells as a mature functional protein, although the mechanism
of secretion is not yet known. As with human and murine IL-18 (Okamura et al.,
1995b; Ushio et al., 1996), the sheep amino acid sequence of the precursor proteins
appears to lack a conventional signalling sequence with no hydrophobic sites. Sheep
pro IL-18 contains a putative caspase-1 cleavage site at positions 36-37 (Figure 3.6),
suggesting that cellular handling of sheep IL-18 is similar to that for mouse and
human.
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The production of mouse and human IL-18 is reported to be primarily
attributed to cells of the monocyte-macrophage cell lineage (Okamura et al., 1995b;
Kohno et al., 1997). The amplification of sheep IL-18 cDNA from LPS stimulated
alveolar macrophages suggests a similarity in this species. Constitutive expression
for this peptide has been reported for human MoDCs (Gardella et al., 1999; Stoll et
al., 1998) murine DCs isolated from various tissues (Stoll et al., 1998), PBMC
(Marshall et al., 1999; Puren, Fantuzzi and Dinarello, 1999), and murine splenocytes
(Puren, Fantuzzi and Dinarello, 1999). To investigate these observations in sheep
lymph DCs, IL-18 was included in an RNase protection assay, the development of
which is described in the following Chapter.
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Chapter 4: The RNase Protection Assay: A Method For
Evaluating Ovine Cytokine Expression.
4.1 INTRODUCTION
Analysis of cytokine production has been somewhat limited in studies of
ruminants compared with those of rodents and humans. This is because of the
limitations of available reagents. Analysis of cytokine production is performed by a
number of methods, including radioimmunoassays (RIA), enzyme-linked
immunosassays (ELISA), cytometric bead assays or intracellular cytokine staining
and flow cytometry. These methods rely on the detection of proteins by mAb and to
date few ovine-cytokine-specifc mAb's are available. The development of assays for
sheep cytokines are also few; to date ELISAs have been developed for sheep IL-1 (3,
IL-6, IL-8, IL-12, IFNy, GM-CSF and TNFa (Eagan et al., 1994; Emery and Davey,
1995; Entrican et al., 1996; Haig et al., 1996, Hope et al., 2002, McWaters et al.,
2000; Rothel et al., 1997).
The next best opportunity to study a wide array of cytokine responses is the
evaluation of cytokine gene expression. The limitations of this are clear, in that
detection of mRNA does not necessary correlate with secreted protein. However,
many cytokine mRNA species are relatively short lived (Carter and Malter, 1991),
and not stored as accumulated cytokine proteins. This provides an important control
mechanism regulating the release of biologically potent mediators. The
demonstration of biological activity or the direct evaluations of cytokine secretion,
seem to correlate with the expression kinetics of certain cytokines such as IFNy,
TNFa and IL-1 ft (Entrican et al., 1992; Becker, Devlin and Haskill, 1989; Nash et
al., 1992). Methods of mRNA measurement include Northern blotting, quantitative
PCR methods such as competitive (QC-) RT-PCR and real-time PCR, and the RNase
protection assay.
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RT-PCR is a specific, highly sensitive method of mRNA transcript detection,
and theoretically can detect transcripts of one copy from the original mRNA mix.
The limiting factor in RT-PCR is the production of cDNA from RNA; incomplete
transcription missing the 3' end of mRNA molecules can account for wrong negative
results. Differences in the kinetics of each amplification; primer annealing
parameters, and sample unfolding and replication, mean that standard RT-PCR
cannot be used as a quantitative assay. Quantitative real-time PCR is becoming more
widely used, and permits direct quantification of mRNA transcripts in the starting
material. Amplification efficiencies are compared to standards, thus allowing a
calculation on the relative amount of starting material. To be comfortable that
differences in amplification kinetics are not compounded during amplification
reactions, multiple controls and samples are preferable. Approximately four
transcripts can be assessed by real-time PCR at one time. The materials required to
perform real-time PCR are rather expensive and this must be taken into account
when considering this technique.
Direct detection of RNA species by specific anti-sense labelled probes using
the Northern blotting technique is advantageous for identifying transcripts of
unknown size, and for analysing topological features of mRNA transcripts.
Degradation of the 3' and 5' ends of mRNA molecules is commonly a problem in
Northern blotting. Probe hybridisation is performed in a one-dimensional gel matrix,
therefore stringent hybridisation relies on homologous binding of full-length
transcripts by specific probes. In addition, background readings are strong, so the
sensitivity of this assay can be compromised.
The RNase protection assay (Section 4.1.2) negates some of the
disadvantages experienced with Northern blotting. Hybridisation of antisense probes
is performed in solution, resulting in stronger binding compared to targets within gel
matrices. High quality of RNA is not as crucial in the RPA compared to Northerns
because short segments (100 - 400 nt.) of the mRNA transcripts are targeted.
Because of these factors, the RNase protection assay is considerably more sensitive
than Northerns. In addition, a major advantage of the RPA over northern blotting
and QC-PCR is that multiple transcripts can be evaluated in one sample.
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4.1.2 The RNase Protection Assay
The RNase protection assay involves the hybridisation of cellular RNA to
complementary radiolabelled RNA probes (riboprobes) of known size. Un-
hybridised probes and RNA are removed using single-strand specific RNase's, such
as RNase A and RNase Tl. The RNase enzymes are then inactivated and the
purified double stranded RNA species, so called 'protected' molecules analysed by
PAGE, phosphorimaging and densitometry. This technique was first developed by
Melton and colleagues (1984) and was used as an alternative to nuclease SI
protection assays designed for mapping mRNA topological features, such as intron-
exon borders and sites of transcription initiation and termination. When a molar
excess of riboprobe is used, the amount of protected molecule is directly proportional
to the abundance of the transcript in the RNA sample. Specific transcripts can be
identified by size, and the quantity ascertained by normalisation to a house-keeping
gene. Because of the use of radiolabelled probes, the RNase protection assay is
extremely specific and highly sensitive, and provides a valuable tool for the
quantification of mRNA transcripts.
4.1.3 Chapter Aims
In collaboration with Dr. Anton Gossner, an RNase protection assay (RPA)
was developed specifically for eleven sheep cytokines (IL-ip, IL-4, IL-6, IL-8, IL-
10, IL-12, IL-18, GM-CSF, IFNy, TNFa and TG1TP), and two house-keeping genes
(GAPDH and ATPase). The aims of this chapter were to standardise the RPA, and
determine the quantitative nature and sensitivity thresholds of the assay. These were
achieved by analysing the abundance of specific transcripts in titrated samples of
RNA, and the use of plasmid expressed positive control RNA. Validation of the
RPA was undertaken by analysing the expression of sheep alveolar macrophages in
response to stimulation in vitro with LPS. Alveolar macrophages originate from
precursors in the bone marrow and blood (van Furth, Raeburn and van Zwet, 1979).
The same blood precursor has a bi-potenital for macrophage and DC development
(Reid et al., 1992; Caux et al., 1996), and macrophages and DCs share many
properties. In particular, kinetics of cytokine production and expression of surface
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molecules are similar for macrophages and DCs in response to innate signals such as
components of microorganisms including LPS (Ammon et al., 2000; Brodskyn et al.,
2002). The macrophage therefore, is an ideal candidate for the standardisation of the
RPA for the analysis of DC cytokine expression. DCs are a trace population in vivo,
whereas relatively large numbers of alveolar macrophages can be easily accessed by
bronchoalveolar lavage. The data generated from these experiments were used to test
the assumption that LPS induces the expression of cytokines in AM that are involved
in the innate inflammatory response.
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4.2. RESULTS
4.2.1 Establishment of the RNase Protection Assay (RPA)
4.2.1.1 Construction of Riboprobe Templates
RPAs depend on the hybridisation of target mRNAs with specific
complementary radiolabeled riboprobes. Riboprobes were generated in vitro from
cDNA sub-clones representing sequences in mature mRNA of various sheep
cytokines. When designing the cDNA clones, a number of factors were taken into
consideration:
• So that the hybridised probes could be clarified on a sequencing gel, the
cytokine cDNA fragments were selected to have sizes ranging from 100 -
350 bp. To allow resolution, the probes differed by at least 15 nucleotides
(nt).
• To avoid non-specific hybridisation, the probes could not contain significant
homology for other known ovine complementary DNAs. As such, the chosen
sequences were screened using BLAST software ( nirc,; ) and
those displaying less than 5% homology to other known mammalian cDNA
sequences were accepted.
• cDNA inserts did not contain sites for the restriction endonucleases BamH I,
EcoR I, Hind III and Sph I, because these enzymes were used for in vitro
RNA transcription. Exceptions to this were IL-1 (3 and IL-4 that could not be
designed without a Hind III and EcoR I restriction sites respectively.
A schematic for the cloning strategy used in the construction of template plasmid
DNA is shown in Figure 4.1, details of the cloning techniques used can be found in
Section 2C. Specific details of the cloning strategy used for the cytokine cDNA
clones are presented in Table 4.1. Once the panel of ovine cDNA templates were
generated, they were analysed by restriction digest with EcoR I, exceptions were the
TNFa and IL-4 clones which were digested with EcoR I & Hind III and BamH I and
Hind III, respectively (Section 2C.8); these sites are unique to the multiple cloning
site (MCS). The results are shown in Figure 4.2. The orientation and nucleotide
sequence of each probe template was confirmed by sequencing, and can be found in
83
Figure 4.1 Generation of cytokine template cDNA clones used
in the RNase protection assay. Cloned ovine cytokine cDNAs were
sub-cloned into pGEM®T-easy using PCR and 'TA' cloning The
orientation of the cDNA inserts were verified by automated
sequencing, those clones with inserts in a 5' - 3' direction were
selected. The cDNA inserts were then amplified by PCR using
vector-specific primers flanked with restriction sites allowing
directional cloning into pGEM®ll-ZF(+) in a 5' - 3' orientation.
The relevant features of the vectors are shown.
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Cloning vectors containing ovine
cytokine cDNAinserts.
J Amplify fragments of insert
I by PCR. PCR products
purified and inserted into
pGEM®T-easy using TA
cloning.
EcoR I cytokine cDNA EcoR I
I Amplify insert by PCR
1 Purify and digest with BamH I and
Sph I
Ligate into pGEM®-11-Zf(+)
BamH I ... Sph Icytokine cDNA
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Table 4.1 Cloning strategy for development of riboprobe templates for the RPA






























pGEM-T-easy sub¬ pGEM-XF vector MCS
clones pGEM-XR
PCR or endonuclease digest were used to generate templates for the RPA, as indicated. The
Taq enzyme used in the PCR experiments was purchased from Promega (5 U / reaction).
Templates for the PCR reactions were 10 ng of plasmid DNA. PCR primer sequences are
listed in Appendix 4. PCR primers were designed to have similar annealing temperatures.
Amplification parameters used in these reactions were: 94 0.5', 55 0.75', 72 0.5'; followed
by 1 cycle of extension; 72 6'. Following analysis by agarose gel electrophoresis, PCR
products were purified using a spin-bind column, or digested cDNA fragments excised and
purified using a spin-bind column. DNA fragments were cloned into pGEM-T-easy using a
'TA' cloning system (Promega). Amplified plasmid DNA was purified using purification
spin-bind columns (Qiagen), and positive clones sequenced to verify insert orientation.
Clones in a 5' - 3' orientation were subjected to PCR using the vector specific primers
pGEM-XF and pGEM-XR with incorporated restriction endonuclease sites Bam HI (pGEM-
XF) and Hind III (pGEM-XR), and cloned into pGEM-1 lzf in a 5' - 3' orientation. The
clones were verified by sequencing prior to use in the RPA. Sequences are presented in
Appendix 6.
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Figure 4.2 Analysis of sheep cytokine riboprobe template
cDNA clones. Cytokine cDNA clones used for the transcription
of cytokine riboprobes were analysed by restriction digest and gel
electrophoresis. Following the digestion of 10 ng of plasmid DNA
with Eco RI for the exception of the TNFa clone (EcoR I and Hind
III) and IL-4 clone (BamH I and Hind III). Products were analysed
by gel electrophoresis. Key for the lanes are shown in Table 4.2;









1 GAPDH 159 98
2 IL-ip 179 123
3 TNFa 187 148
4 IL-18 227 160
5 IL-6 229 173
6 TGF{3 258 217
7 IL-4 266 210
8 IFNy 300 246
9 IL-10 327 272
10 GM-CSF 351 288
11 IL-12 p40 386 332
12 IL-8 404 352
Table 4.2 The 'un-protected' and 'protected' sizes of the
riboprobes. 'Protected' length refers to the nt. length of
target mRNA bound by specific riboprobe, whereas 'un¬
protected' length refers to the nucleotide length of the
riboprobe.
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Appendix 6. The lengths of the 'un-protected' and 'protected' riboprobes are shown
in Table 4.2.
4.2.1.2 The Generation of Antisense RNA Probes and Complementary RNA.
A schematic illustrating the relevant features of template DNA preparation
and probe synthesis is presented in Figure 4.3. The RNA polymerase promoters T7
and SP6 were utilised for RNA synthesis. Following linearisation of the vector with
the appropriate restriction endonuclease, the synthesis of antisense riboprobes was
driven by SP6 polymerase; or sense RNA by T7 polymerase. When performing an
RPA, radiolabelled antisense probes were hybridised with complementary sense
synthetic RNA. This was utilised as a control for probe hybridisation and
degradation. In general, a pool of sense RNA transcripts containing 10 pg of each
RNA species was hybridised to the probe sets being used.
4.2.1.3 Sheep Cytokine Riboprobe Set.
As described in Figure 4.3, plasmid DNA templates were linearised with
BamH I, and antisense probes synthesised using the SP6 promoter. A set of
radiolabelled probes specific for sheep glyceraldehyde-3-phosphatase-dehydrogenase
(GAPDH), adenosine triphosphatease (ATPase), IL-1J3, IL-4, IL-6, IL-8, IL-10, IL-
12, IL-18, GM-CSF, IFNy, TGF(3, and TNFa were produced and resolved on a
sequencing gel. These are shown in Figure 4.4b (lanes 1 and 5). It was evident that a
probe was missing from the set, and taking into account the spacing between the
probes, the absent probe was either TNFa or IL-ip. The sequence of the TNFa
template cDNA is shown in Figure 4.5. The BamH I site used for vector
linearisation was situated adjacent to the 3' end of the cDNA insert. To establish
whether the proximity of the cut site to the insert cDNA was a factor affecting the
failure to generate a TNFa-riboprobe, an EcoR I site downstream of the BamH I site
was used in an independent probe synthesis reaction. The products of two individual
TNFa probe synthesis reactions, and an independent IL-ip probe synthesis reaction
were run on a gel along with the probe set synthesised previously. The results are
shown in Figure 4.4b. It was clear that the IL-1 (3 riboprobe was present in the








Antisense probe < SP6 polymerase
5' Cytokine cDNA fragment. 3'
b)
Hind III
T7 polymerase ^ Sense RNA
SRh I
I
5' Cytokine cDNA fragment 3'
Figure 4.3 Synthesis of antisense riboprobes and
complementary sense RNA.
a) Radiolabeled antisense probes are synthesised following
linearisation of template cDNA clones with the restriction
endonuclease BamH I. Transcription is driven by SP6
polymerase, and during synthesis, [32P] UTP nucleotides are
incorporated into the probe.
b) Complementary sense RNA is synthesised and used as target
for the hybridisation of radiolabeled probes. This provides a
positive control for hybridisation. cDNA were linearised with
Hind III, except for the IL-ip clone which contains an internal
Hind III site. In this case, the restriction endonuclease Sph I was
used to linearise the vector DNA.
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Figure 4.4 Un-protected probe set in the RNase protection
assay, a) The cloning vector pGEM®l 1-Zf(+) containing a TNFa
cDNA insert was linearised using BamH I or EcoR I restriction
endonucleases, and used as template for the transcription of
antisense radiolabeled RNA probes using the SP6 promoter b) A
set of radiolabeled probes for ovine cytokines were synthesised
from plasmid DNA templates linearised with the endonuclease
BamH I. Individual probe synthesis reactions were performed for
TNFa and IL-lp; templates were linearised using BamH I (TNFa
probe 1; IL-lp probe) or EcoR I (TNFa probe 2). The sizes of the
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Figure 4.5 Nucleotide sequence of TNFa sub-clone. A fragment of ovine
TNFa cDNA was cloned into the vector pGEM®l 1-Zf (+) in 5' - 3' orientation.
The vector sequence is shown in blue, TNFa in black. Sense RNA is synthesized
using the T7 promoter, antisense riboprobes from the SP6 promoter. To perform
and in vitro RNA transcription, the vector DNA is linearised using appropriate
restriction endonucleases. The restriction sites for BamH I and EcoRI are shown.
Linearisation using BamH I failed to produce a riboprobe, whereas the
linearisation using EcoR I successfully produced a TNFa specific probe (Figure
4.4).
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DNA was linearised using BamH I. In subsequent experiments, the plasmid
template used for the synthesis of the TNFa-specific probe was linearised with EcoR
I, whereas the plasmid clones used as templates for the synthesis of other probes in
the set (GAPDH, ATPase, IL-10, IL-4, IL-6, IL-8, IL-10, IL-12, IL-18, GM-CSF,
IFNy, and TGF|3) were linearised with BamH I.
4.2.2 Standardisation of the RPA.
4.2.2.1 Transcript quantification.
An experiment was performed to investigate the quantitative nature of the
RPA. Alveolar macrophages were cultured for 4 hours with 1 qg/ml Salmonella
typhimurium LPS, the RNA extracted and various amounts of the RNA (2.5 qg, 5
pg, 7.5 pg, 9.5 pg) hybridised against a probe set containing GAPDH, IL-1|3, IL-10,
IL-8 and IL-18. Un-bound RNA (single-stranded) was digested with RNase T1 and
RNase A, and 'protected' hybridised species resolved by PAGE. Following
resolution on a sequencing gel and phosphorimaging, the intensity of the bands was
evaluated using ImageMaster 3D software (Pharmacia), as described in Section
2C.12.8. The results are shown in Figure 4.6. Band intensity is expressed as
arbitrary units of pixel density. As shown in Figure 4.7, the intensity, or volume of
the GAPDH protected probes increases when increasing amounts of total RNA are
used, and as such correlate with quantity of target RNA. This correlation was also
evident for the IL-ip and IL-10 protected riboprobes (Fig. 4.7). However, the
volume of the IL-8 protected probe did not vary between samples and appeared to
have reached peak threshold levels on the gel exposure (Fig. 4.6). Band volumes of
each protected probe were normalised against the GAPDH band in each sample, and
expressed as a ratio of GAPDH levels (arbitrary units) in that sample, these are also
shown in Figure 4.7b. Normalised values for IL-ip mRNA and IL-10 mRNA are
similar for each sample, as would be expected from an individual RNA pool,
whereas the normalised value of the IL-8 probes varied between samples reflecting
small differences in band volume between the samples (Fig. 4.7b). Bands
corresponding to IL-18 protected probes were not detected in any of the samples
































Figure 4.6 Quantitative evaluation of the RNase protection
assay. Antisense radiolabelled probes for GAPDH, IL-lp, IL-18,
IL-10 and IL-8 were hybridised with 2.5 pg - 9.5 pg total RNA as
indicated with each lane, extracted from alveolar macrophages after
4 hours culture with 1 pg/ml LPS. After RNase treatment, the
RNA-protected probes were PAGE-resolved and visualised by
imaging on a phosphorimaging screen. The sizes of the protected
probes span 352 nt. (IL-8) to 98 nt. (GAPDH).
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Figure 4.7 Determination of the quantitative nature of the
RNase protection assay. The RPA was used to evaluate the
intensity of transcripts for IL-10, IL-lp, IL-18, IL-8 and GAPDH
in the same RNA sample using increasing amounts of target
RNA. (a) Band volumes are expressed using arbitrary
densitometric units, (b) The intensity of message is expressed as
arbitrary densitometric units relative to GAPDH mRNA.
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RT-PCR reaction was performed. This generated a product of expected size (Fig.
4.8), demonstrating that IL-18 mRNA was present in the RNA sample, but was
below the level of detection using the RNase protection assay.
4.2.2.2 Detection of IL-18 mRNA by the BPA
In order to determine the threshold of detection of the hybridised IL-18 probe
in the RPA, synthetic complementary RNA was synthesised and various amounts
were hybridised with a probe set containing IL-18. The results are shown in Figure
4.9. A single band of approximately 158 nt. was detected, demonstrating the
specificity of the IL-18 riboprobe. Bands were clearly evident when 50 pg - 1 pg of
target complementary RNA was used. Although a faint band was evident on the gel
exposure image presented (Fig. 4.9) using 1 pg of positive control RNA, this band
was easily detected by the software package used for analysis of the RPA gels.
Therefore, this experiment demonstrated that the RNase protection assay has a
sensitivity threshold of detecting 1 pg of IL-18 RNA.
4.2.3 Analysis of Cytokine Expression in Alveolar Macrophages (AM)
4.2.3.1 AM Culture and Stimulation
An initial set of experiments were performed to establish a protocol for in
vitro LPS stimulation and to determine the number of adherent bronchoalveolar cells
required to obtain sufficient amounts of RNA for RPA analysis. Bronchoalveolar
(BAL) cell culture is described in Section 2A.1, cells were cultured with or without
LPS (1 pg/ml) and adherent cells were recovered following culture durations of 1, 4,
6, 16 or 24 hours. Cell yield and viability were determined over the time course, the
results are shown in Figure 4.10a and 4.10b respectively. There was a gradual
decrease in the number of adherent cells recovered over 24 hours. The percentage of
viable cells fluctuated over time, reaching a minimum of 53% in LPS stimulated




























Figure 4.8 Analysis of IL-18 expression by alveolar
macrophages stimulated with LPS. RNA extracted from alveolar
macrophages after 4 hours culture with 1 pg/ml LPS was subject to
RPA analysis (Fig. 4.6) and RT-PCR amplification. RNA was
reverse transcribed in the presence of an oligo (dT) primer, then
10% of the cDNA sample was subject to PCR using primers
specific for ATPase or IL-18. The primer sequences are listed in
Appendix 3. PCR reactions were performed omitting template
DNA to control for reagent contamination (negative controls).
Analysis of the PCR reactions are shown. The IL-18 primers
amplify a region of cDNA 560 bp., the amplicon is indicated with
an arrow. The ATPase amplicon was 100 bp. in length and is also
indicated.
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Figure 4.9 Sensitivity of the RNase protection assay for the
detection of IL-18 transcripts. A probe set containing
radio labelled probes specific for IL-18, IL-ip, IL-4, IL-6, IL-8, IL-
10, IL-12, GM-CSF, IFNy, TNFa, TGFp, GAPDH was hybridised
with 1-50 pg. of synthetic sense IL-18 RNA. The amount (pg.) of
target RNA in the sample is shown with each lane. Samples were
RNase treated and resolved on a sequencing gel. The size of the
protected band shown was 158 nt.
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Figure 4.10 Bronchoalveolar cell culture. Cells were recovered
by bronchoalveolar lavage and cultured at 106 cells / ml with
culture medium or 1 pg/ml bacterial lipopolysaccharide (LPS). 4.5
x 106 cells were cultured for each time point. Following culture
the adherent cells were washed twice with PBS and recovered
using 5mM EDTA.
(a) Cell number and viability were determined by trypan blue
exclusion, and analysed microscopically, these are shown in
graphs (a) and (b).
(c) RNA was extracted from the cells using RNAzol B, the quality
and quantity determined as described in Section 2C.1.2. The
purity, as determined using spectrophotometry had a A2g0/A260
ratio of over 1.9 The 18S and 28S ribosomal bands were evident
by agarose gel electrophoresis, indicating the intact nature of the
RNA. Amounts of total RNA recovered are shown.
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Chapter 4 The RNase Protection Assay
4.2.3.2 Time-course Experiments
Transcripts expressed at low levels may be below the level of detection by the
RPA, as demonstrated for IL-18 (Section 4.2.2.2.). It was therefore important to
recover similar amounts of RNA from the cells at each time point so that the
sensitivity of the assay would be comparable between samples. Considering the
decrease in amount of RNA isolated from the cells over 20 hours (Fig. 4.10c), twice
the number of cells were used for the 16 hour and 20 hour cultures in subsequent
experiments. Each experiment was performed on BAL cells recovered from an
individual animal. Cells were cultured in medium supplemented with 1 qg/ml LPS;
cells cultured in medium alone were included to control for the affects of culture.
Experimental groups and culture durations are illustrated in Table 4.3.
Table 4.3 Experimental protocol for time-course experiments on
bronchoalveolar cells
Experimental group Volume cells (x)a Culture time
A l(x) 1 hour
B l(x) 4 hours
C l(x) 6 hours
D 2(x) 16 hours
E 2(x) 20 hours
a volume of cell suspension o
* lxl06 cells / ml divided by fr - stimulated and control
cells; five experimental groups.
4.2.3.3 Presentation of Data
The phosphorimages of the denaturing gels were transported into the
ImageMaster 3D package (Pharmacia). Standard curves were produced from the un-
hybridised probes by plotting probe size (nt.) (Logio scale) against distance migrated
in the gel (linear scale); examples are shown later in Figs. 4.13 and 4.25. The
migration distance of the probe : sample RNA hybrids ('protected' bands) were
determined from the standard curve. Band densities were then evaluated (Section
2C.12.8). Mean values of band density expressed as a ratio of GAPDFI mRNA
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levels (normalised values) were plotted. In many cases the number of replicate
samples were low (n = 1 - 4), so standard errors were not presented. Graphical
presentation of the effects of LPS stimulation on the expression of each transcript at
each time point was achieved by plotting the normalised value of each cytokine
mRNA in LPS stimulated versus control cells on a logio scale, and are shown in
Appendix 7. This illustrates fold-differences between the experimental groups.
Where no bands were detected in the control or stimulated cells, a value of 0 was
given, and were consequently not included in this type of analysis. The data from the
sheep in each experiment were pooled, and student T tests were performed. It should
be noted that with such a small sample group (n=4), the p values were not stringent,
but gave an indication of the effects of LPS stimulation on the cells.
4.2.4 Cytokine Expression in AM Prior to Culture
Macrophages enriched from bronchoalveolar lavage (BAL) cells (Section
2A.3) derived from sheep 1 were analysed by RPA. To inhibit RNA transcription
during the separation procedure, actinomycin D was added to the buffers. Duplicate
samples of 10 pg of RNA were subject to the RPA, the results from this one
experiment are shown in Figure 4.11. Transcripts for IL-8, IL-ip, IL-18 and TGFp
were detected. The expression of IL-8 was the highest of the cytokines detected,
whereas IL-ip mRNA levels were the lowest.
4.2.5 Cytokine mRNA Expression by Adherent Bronchoalveolar (BAL) cells
In the first series of time course experiments, the kinetics of cytokine mRNA
expression by BAL cells was analysed by RPA following exposure to 1 pg/ml LPS
for 1 hour, 4 hours, 6 hours, 16 hours and 20 hours. RNA was recovered from the
adherent cells. Cells derived from three donor animals were used, duplicate samples
of approximately 15 pg of RNA were analysed from sheep 1, whereas single samples
of around 20 pg of RNA were analysed from sheep 2 and sheep 3. Figure 4.12
shows the results of the RPA analysis of samples from sheep 1. Expression kinetics
of individual cytokine mRNAs over the time course of LPS treatment are shown in
Figures 4.13 - 4.24. Due to a sample handling error, no data is available from sheep









Figure 4.11 Expression of cytokines in freshly isolated
alveolar macrophages. Macrophages were enriched from
sheep bronchoalveolar lavage cells in accordance to density
(Section 2A.3). RNA was extracted and subjected to RPA
analysis. The levels of expression of each transcript were
determined by normalising against the levels of the
housekeeping gene GAPDH. The results presented are the
average of duplicate samples, in an experiment involving one
animal.
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Figure 4.12 Measurement of cytokine mRNA levels using the
RNase protection assay. Bronchoalveolar cells were cultured
over 20 hours with 1 pg/ml LPS, and the levels of mRNA's in
the adherent cells evaluated using a RNase protection assay. The
sizes of the unprotected probe set, shown in lane 1, spanned 404
nt (IL-8) to 154 nt (GAPDH). Lane 2: a synthetic set of sense
complementary RNA was hybridised with the radiolabeled
antisense probe RNA probes for the designated transcripts. At a
range of time periods over 20 hours, RNA was extracted from
the cultured adherent alveolar cells derived from sheep 1, and
aliquots of approximately 15 pg were analysed with the RNase
protection assay. The sizes of the protected probes span 352 nt
(IL-8) to 98 nt (GAPDH).
b) The standard curve used to identify protected bands.
Migration distance of un-protected probes was measured, and
plotted against the nucleotide length using non-linear regression
analysis. Curve goodness of fit is presented (r2 = 0.9938). The
position of the bands of interest (protected probes) on the gel
















































Figures 4.13 - 4.24 Kinetics of expression of cytokine mRNA.
The expression of a panel of cytokine mRNAs by adherent
bronchoalveolar cells cultured with LPS was assessed using an
RNase protection assay (see text for details). The mean
normalised value ofprotected radiolabelled probes for individual
cytokine transcripts were plotted in x-y graphs over a time
course. A comparison of mRNA levels between medium
controls and LPS stimulated cells is shown; the normalised value
of the mRNA transcript in each sample (LPS and medium
control) were plotted on a Log10 scale (y = LPS value, x =
control value). This type of analysis shows the levels of mRNA
in each sample analysed. An example is presented for IL-18
expression, the comparisons of expression of the other cytokine
mRNA transcripts are in Appendix 7.
4.13 IL-18: kinetics of expression (1-20 hours). IL-18
transcripts were not detected in cells derived from sheep 1.
4.14 IL-18: comparison of control cells and LPS stimulated cells
expression levels
4.15 IL-12 p40: kinetics of expression (1-20 hours)
4.16 IL-10: kinetics ofexpression (1 - 20 hours)
4.17 IL-6: kinetics ofexpression (1 - 20 hours)
4.18 GM-CSF: kinetics ofexpression (1—20 hours)
4.19 IL-8: kinetics ofexpression (1 - 20 hours)
4.20 IL-1 (3: kinetics of expression (1-20 hours)
4.21 TNFa: kinetics ofexpression (1-20 hours)
4.22 TGFP: kinetics ofexpression (1-20 hours)
4.23 IL-4: kinetics ofexpression (1-20 hours)
4.24 IFNy: kinetics of expression (1-20 hours)
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IL-18 mRNA expression: Sheep 2
IL-18 mRNA expression: Sheep 3
Figure 4.13 Expression of IL-18.
Ill
IL-18
Log10 (normalised value) medium
IL-18 mRNA levels ; 4 hours
Figure 4.14 Expression of IL-18.
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Figure 4.17 Expression of IL-6.
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GM-CSF mRNA expression: Sheep 1
Medium
LPS
Time in culture (hours)
GM-CSF mRNA expression: Sheep 2
Medium
LPS
5 10 15 20
Time in culture (hours)
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GM-CSF mRNA expression: Sheep 3
Medium
LPS
Time in culture (hours)
Figure 4.18 Expression of GM-CSF.
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IL-8 mRNA expression: Sheep 1
Medium
LPS
5 10 15 20
Time in culture (hours)
25
IL-8 mRNA expression: Sheep 2
Time in culture (hours)
IL-8 mRNA expression: Sheep 3
• Medium
— LPS
10 15 20 25
Time in culture (hours)
Figure 4.19 Expression of IL-8.
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Figure 4.20 Expression of IL-1 p.
118




Time in culture (hours)
25





Time in culture (hours)
Figure 4.21 Expression of TNFa.
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IL-4 mRNA expression: Sheep 1
Medium
LPS
Time in culture (hours)
IL-4 mRNA expression: Sheep 2
Time in culture (hours)
5 10 15 20 25
Time in culture (hours)
IL-4 mRNA expression: Sheep 3
Medium
LPS
Figure 4.23 Expression of IL-4.
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Figure 4.24 Expression of IFNy.
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4.2.6 Kinetics of Expression of Cytokine mRNA: Adherent BAL cells
There were no differences between cells derived from different sheep for the
kinetics of expression of IL-18, IL-12, IL-6, IL-10, IL-8 and IL-4 over the 20 hour
time-course (Figs 4.13, 4.15, 4.16, 4.17, 4.19, 4.23). Conversely, GM-CSF, IL-ip,
TNFa and TGF(3 were expressed with different kinetics between the animals (Figs.
4.19, 4.21, 4.22, 4.23). Expression of GM-CSF differed in each animal with high
levels in both control and LPS stimulated BAL cells detected in sheep 2 after 1 hour
culture, whereas none were detected in controls cells of sheep 1 and 3 and LPS
stimulated cells of sheep 1 (Fig. 4.18). GM-CSF levels showed an upward trend in
LPS stimulated cells from sheep 2 and 3, whereas they dropped to undetectable
levels in sheep 1 over the same time period. Patterns of expression of IL-1{3 over 20
hours (Fig. 4.19) were similar in BAL cells from sheep 1 and 3. Control BAL cells
from sheep 2 cultured in media alone expressed a spike of increased IL-1{3 levels at 6
hours culture, and this band was evident in all the samples (not shown). On the other
hand, TGF|3 expression kinetics differed in sheep 3 compared with sheep 1 and 2
(Fig. 4.22). Levels of TGF(3 showed an upward trend between 6 hours and 20 hours
culture in BAL cells derived from sheep 1 and sheep 2, whereas levels dropped in
cells from sheep 3. Peak levels of TNFa mRNA were detected after 1 hour culture
in cells from sheep 2, whereas maximal TNFa mRNA was detected after 20 hours
culture in BAL cells from sheep 3 (Fig. 4.21). Levels of TNFa mRNA detected in
both samples were very low; therefore differences may be enhanced at the low range
of pixel density analysis. IFNy was detected in cells from sheep 1 throughout the 20
hour time-course (Fig. 4.24).
Peak levels of most cytokine transcripts were detected after 1 hour in culture.
Exceptions were IL-4, reaching maximal levels after 20 hours in control cells, and
TGFp and TNFa which reflected variations between cells from different sheep.
Peak levels of TGF(3 and TNFa were detected after 20 hours in at least one of the
animals. IL-6 levels were the highest after 1 hour and 6 hours in LPS stimulated
cells, and differences in the kinetics of GM-CSF were reflected in peak levels
detected after 1, 4 and 20 hours in sheep 2, 1 and 3 respectively.
In general, LPS had minimal effects on the augmentation of cytokine
expression compared with controls (Appendix 7a). LPS induced an increase in IL-18
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expression at the 16 hour time point only, averaging 2 fold higher than controls.
Expression of IL-ip was generally higher in LPS stimulated cells over 1-16 hours
compared with controls. However, LPS failed to induce significant enhancements of
IL-4, IL-6, IL-8, IL-10, GM-CSF, IFNy, TGFp and TNFa expression.
It was evident that the adherent BAL cells expressed similar levels of
cytokine mRNA in response to culture with medium alone and with 1 pg/ml LPS.
Classically, LPS induces enhanced expression of pro-inflammatory cytokines,
particularly IL-ip and TNFa, and others such as IL-6 and IL-12 p40, so the
negligible effects of LPS in these experiments was surprising. This may have been a
consequence of culture of the mixed population of BAL cells. Macrophages
comprise 83% of the cells obtained by bronchoalveolar lavage of sheep; lymphocytes
make up 5%, and polymorphonuclear cells (PMNs) and mast cells the remainder
(Lujan et ah, 1993). It was possible that the presence of other cell types, such as
lymphocytes, had effects on the responses of the adherent cell population. In
addition, transcripts for IL-4 and IFNy were detected in LPS stimulated and control
cells, indicating the presence of activated lymphocytes (T cells producing IFNy and
IL-4) and other populations such as NK cells (producing IFNy) or mast cells
(producing IL-4) in the cultures.
4.2.7 Measurement of Cytokine Expression by AM
In the second series of experiments, alveolar macrophages were purified by
adherence in culture overnight before beginning the time course. Non-adherent cells
were removed by washing and the remaining adherent cells then cultured with or
without 1 ug/ml LPS for 1 hour, 4 hours and 12 hours. Evaluation of cytokine
expression by RPA, and the analysis and presentation of data were repeated as in the
previous set of experiments. The data presented below represents two experiments
involving two animals. Three or four samples of 15 - 20 pg of RNA from sheep 4
were analysed, whereas duplicate samples of 15 pg of RNA were analysed from
sheep 5 for each time point. Figure 4.25 shows the phosphorimage of samples from
sheep 4 after being subject to the RNase protection assay. The banding pattern on
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Figure 4.25 Measurement of cytokine mRNA levels in
alveolar macrophages using the RNase protection assay.
Alveolar macrophages were purified by adherence and then
cultured over 12 hours with 1 pg/ml LPS. Cytokine mRNA
levels were evaluated using a RNase protection assay (RPA).
The unprotected probe set is shown in lane 1, sizes of the probes
span 404 nt (IL-8) to 154 nt (GAPDH). Lane 2: synthetic
complementary RNA was hybridised with the radiolabelled
antisense probe RNA probes for the designated transcripts. At a
range of time periods over 12 hours, RNA was extracted from
the alveolar macrophages derived from sheep 4, and aliquots of
15 - 20 jig were analysed with the RPA. The sizes of the
protected probes span 352 nt (IL-8) to 98 nt (GAPDH).
b) The standard curve used to identify protected bands. The
migration distance of un-protected probes is measured, and
plotted against the nucleotide length using non-linear regression
analysis. Curve goodness of fit is presented (r2 = 0.9782). The
position of the bands of interest (protected probes) on the gel are
ascertained from the standard curve.
c) The macrophage RNA samples were analysed by agarose gel
electrophoresis prior to commitment to RPA analysis; 18S and
28S ribosomal bands were clearly evident and no RNA
degradation was apparent (not shown). Following RPA analysis,
aliquots (~ 500 ng) of the RNA samples were analysed to check
the integrity of the samples using the Agilent Nano system.
Trace readings showing the intact nature of each of the samples
are shown, peaks represent the 18S and 28S ribosomal bands. A
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Chapter 4 The RNase Protection Assay
the RPA gel differed to the previous experiment (Fig. 4.11) in that more bands were
evident. This may have been caused by degradation of the riboprobes or target
samples. No degradation / increased background intensity was evident in the
resolved riboprobe set (Fig. 4.26a lane 1) demonstrating that the riboprobes were
intact. To check the integrity of the RNA samples analysed by RNase protection
assay, aliquots of the samples were analysed following RPA analysis using the
Agilent Nano system. The results are shown in Figure 4.26c, and demonstrate the
intact nature of the RNA. Due to an unfortunate mishap after PAGE resolution, only
the bands of higher density were analysed from samples from sheep 5, bands of
lower densities were obscured as the polyacrylamide gel was not transferred in an
ideal fashion for drying and exposure.
4.2.7.1 IL-18
IL-18 mRNA was detected only in cells from sheep 4; the pattern of
expression is shown in Figure 4.27. LPS induced an increase in IL-18 mRNA
following 1 hour culture that was 1-fold higher than medium controls, reaching peak
levels after 4 hours, and decreasing following 12 hours. After 1 hour culture, control
cells expressed IL-18 mRNA, which dropped below the level of detection thereafter.
A comparison of the effects of LPS on IL-18 expression could only be made at the 1
hour time point (shown in Fig. 4.27), because IL-18 mRNA was not identified in
control cells at the later time points. As no IL-18 message was detected in control
cells, LPS induced a considerable increase in IL-18 expression during 12 hours
stimulation (Fig. 4.26).
4.2.7.2 IL-I2 p40
Alveolar macrophages isolated from the two sheep show similar expression
kinetics and levels of IL-12 p40 mRNA (Fig. 4.28). The kinetics and levels of IL-12
p40 mRNA expression in cells purified by adherence and stimulated with LPS are
similar to those in adherent BAL cells in the previous experiment (Fig. 4.15).
However, IL-12 p40 expression by control cells differed markedly between
experiments. Unlike in adherent BAL cells, the levels of IL-12 p40 mRNA
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Figures 4.26 - 4.34 Kinetics of cytokine mRNA expression in
alveolar macrophages. The expression of a panel of cytokine
mRNA by alveolar macrophages cultured with LPS was assessed
using an RNase protection assay (see text for details). The mean
normalised value of protected radiolabelled probes for individual
cytokine transcripts are plotted in x-y graphs over a time course. A
comparison of mRNA levels between medium controls and LPS
stimulated cells is shown; the normalised value of the mRNA
transcript in each sample (LPS and medium control) are plotted
against each other on a Log10 scale (y = LPS value, x = control
value). This type of analysis shows the levels of mRNA in each
sample analysed. An example is presented for IL-18 expression,
the comparisons of expression of the other cytokine mRNA
transcripts are in Appendix 7.
4.26 IL-18: kinetics ofexpression (1 - 12 hours)
4.27 IL-18: comparison of expression levels in control cells and
LPS stimulated cells
4.28 IL-12 p40: kinetics ofexpression (1-12 hours)
4.29 IL-10: kinetics ofexpression (1 - 12 hours)
4.30 IL-6: kinetics ofexpression (1 - 12 hours)
4.31 GM-CSF: kinetics ofexpression (1-12 hours)
4.32 IL-8: kinetics ofexpression (1-12 hours)
4.33 IL-ip: kinetics ofexpression (1 - 12 hours)
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Figure 4.26 Expression of IL-18.
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Figure 4.27 Expression of IL-18.
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Figure 4.29 Expression of IL-10.
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Figure 4.31 Expression of GM-CSF.
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Figure 4.32 Expression of IL-8.
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Figure 4.33 Expression of IL-ip.
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TGFp mRNA expression: Sheep 4
Figure 4.34 Expression of TGFp.
138
Chapter 4 The RNase Protection Assay
expressed in purified AM cultured in medium alone remained steady, and were
significantly lower than in LPS treated cells (p £0.02) (Fig. 4.28). LPS induced
enhanced IL-12 p40 expression at each time point (Appendix 7b, Fig. 1), averaging
2-fold above controls throughout the time course.
4.2.7.3 IL-10
Patterns of IL-10 mRNA expression in medium controls and LPS stimulated
cells were comparable (Fig. 4.29). LPS induced a peak in IL-10 mRNA levels after
4 hours culture, the cells from sheep 4 expressing higher levels of IL-10 mRNA
compared with sheep 5. IL-10 expression in controls cells remained steady over the
12 hours. AM exhibited similar patterns of LPS induced IL-10 expression when
compared with BAL cells in the previous experiment (Fig. 4.16). The effects of LPS
on IL-10 expression in macrophages are shown in Appendix 7b, Figure 2. LPS
induced elevated IL-10 mRNA expression that was an average of 2-fold above
controls.
4.2.7.4 IL-6
The expression of IL-6 mRNA during 12 hours LPS stimulation was
evaluated in AM from sheep 4 (Fig. 4.30). While AM cultured in medium expressed
relatively low levels of IL-6 mRNA compared with LPS stimulated cells throughout
the time course, LPS induced an upwards trend in IL-6 expression following 1 hour
culture, peaking after 4 hours, and dropping to levels comparable to 1 hour
stimulation after 20 hours. This pattern of expression was also seen in adherent BAL
cells during 4 hours and 16 hours LPS stimulation (Fig. 4.17). A prominent
difference seen in AM compared with adherent BAL cells was the significant
enhancement of IL-6 expression induced by LPS at each time point, averaging 3-fold
higher levels than controls (p £0.02) (Appendix 7b, Fig. 3).
4.2.7.5 GM-CSF
Figure 4.31 shows the kinetics of GM-CSF expression in cells from one
donor animal (sheep 4). GM-CSF mRNA levels increased after 1 hour culture with
LPS, reached peak levels after 4 hours and decreased following 12 hours stimulation.
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The levels of GM-CSF mRNA in control cells increased steadily over 12 hours.
Peak GM-CSF mRNA levels in AM were detected after 12 hours culture in medium
alone. As shown in Appendix 7b, Figure 4; LPS had nominal effects on GM-CSF
expression in AM; indeed, higher levels were detected in control cells at 1 and 20
hours culture. Whereas elevated levels of GM-CSF were expressed in LPS
stimulated cells at the 4 hour time point and were moderately higher than controls
(1.3-fold increase).
4.2.7.6 IL-8
The expression of IL-8 in LPS stimulated AM increased steadily over 12
hours (Fig. 4.32). The kinetics of IL-8 expression in AM were comparable to BAL
cells derived from sheep 1, 2 and 3 over 4 — 16 hours (Fig. 4.19). However, the
levels in BAL cells were higher than in AM. LPS had negligible effects on IL-8
mRNA levels in macrophages over 12 hours (Appendix 7b, Fig. 5)
4.2.7.7 IL-ip
AM derived from sheep 4 and sheep 5 displayed similar IL-1 (3 expression
kinetics over 16 hours in response to LPS stimulation. LPS induced an increase in
IL-ip mRNA levels following 1 hour culture, increasing to peak levels after 4 hours
and dropping following 12 hours stimulation (Fig. 4.33). Expression patterns and
levels of IL-ip mRNA in AM in response to LPS were comparable to BAL cells
over 4-16 hours (Fig. 4.20). LPS induced a significant increase in IL-1 (3 mRNA
over 12 hours (Appendix 7b, Figure 6). IL-1|3 levels were elevated 7-fold (p <0.01)
and 11-fold (p <0.01) above controls after 1 and 4 hours IL-1 (3 mRNA levels,
respectively. This increase dropped to 4-fold higher than controls after 12 hours
culture (p <0.02).
4.2.7.8 TNFa
TNFa mRNA was not detected in AM purified by adherence and cultured
with medium or LPS at any time point in either of the two sheep (Fig. 4.25).
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4.2.7.9 TGFp
The expression of TGF|3 by purified alveolar macrophages stimulated with
LPS is shown in Figure 4.34. Levels of TGF|3 mRNA increased sharply after 1 hour
culture, increasing by 3-fold to peak levels after 4 hours, and then dropping after 12
hours culture with LPS. Peak levels of TGF|3 mRNA were expressed after 4 hours
LPS stimulation, and were 11-fold higher than control cells at this time point (p
fsO.03). At other time points, expression of TGF|3 was comparable in both medium
controls and LPS stimulated cells (Appendix 7, Fig. 7).
4.2.7.10 IL-4, IFNy
The selection of AM by adherence resulted in no transcripts for IL-4 or IFNy
being detected by the RPA (Fig. 4.25).
4.2.8 The Effect of Purification by Adherence and LPS Stimulation on BAL
Cell Cytokine Expression
The two methods of preparation of BAL cells for cytokine expression
analysis showed marked differences in the kinetics and levels of cytokine mRNA,
particularly in the control cells cultured in medium alone. Experimental data was
pooled, and the level of cytokine mRNA expression induced by LPS was calculated
for each time point (Table 4.4). The greatest increase in expression of the cytokines
analysed was of TGF|3 mRNA in purified cells after 4 hours culture (13-fold higher
than basal). The effects of purifying AM by adherence were most apparent for the
expression of IL-ip and TGF(3. The levels of these transcripts were considerably
enhanced by LPS when compared with adherent BAL cells.
4.2.9 TNFa mRNA Detection
The RNA samples isolated from AM from sheep 4 were analysed by RT-PCR
for TNFa mRNA content. Detection of GAPDH was used as an internal control for
cDNA synthesis and PCR amplification. Negative controls were performed where
reverse transcriptase was omitted from the cDNA synthesis reaction and template
cDNA omitted from the PCR reaction; these reactions produced no product. Table
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Table 4.4 Cytokine expression by ovine adherent bronchoalevolar cells and

















IL-18 1 <2 >2 IL-ip 1 1 >7
4 >2 >4 4 <2 >10
6 1 1 6 <1.2 -
12/16 >2 >2 12/16 x 0.3 >3
20 1 - 20 <14 -
IL-12 p40 1 1 >2 TNFa 1 <1.5 -
4 >2 >2 4 >2 -
6 <1.2 - 6 1 -
12/16 >3 >2 12/16 1 -
20 <3 - 20 >3 -
IL-10 1 >2 >1.5 TGFp 1 <1.2 >1.4
4 >2 >2 4 <1.5 >13
6 >2 - 6 1 -
12/16 <3 >2 12/16 >2.5 >2
20 >1.3 - 20 <25 -
IL-6 1 >3 >3 IL-4 1 1 -
4 >2.5 >2 4 <1.3 -
6 >2 - 6 <1.2 -
12/16 1.2 3 12/16 <2 -
20 1 - 20 <8 -
GM-CSF 1 1 <1.5 IFNy 1 <2 -
4 >1.5 <2 4 1 -
6 >2 - 6 >1.2 -
12/16 >1.5 <2 12/16 1 -














Two experiments were performed on bronchoalveolar cells as follows; the time course
began following culture (adherent bronchoalveolar cells; aBAL), or alveolar
macrophages (AM) were enriched by adherence. Cytokine mRNA levels were analysed
by RPA. The data from three sheep (aBAL), or two sheep (AM) were pooled and the
abundance of cytokine mRNA in LPS stimulated cells was compared with medium
controls. A dash (-) indicates that no data was available for that time point, > = increase,
1 = identical, < = reduction.
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Table 4.5 PCR conditions for TNFa mRNA detection
Primers Target Cycle
No.
Incubation Extension Taq Polymerase
AF030943F2
AF030943R2 ovGAPDH











RT-PCR was used to analyse TNFa mRNA expression in alveolar macrophages.
Approximately 1 pg of total RNA was used as template for cDNA synthesis, and
1/10 volume used as substrate for PCR amplification. Primer sequences are listed in
Appendix 4. Following analysis by agarose gel electrophoresis, PCR products were
purified using a spin-bind column and cloned into pGEM-T-easy using the TA
cloning system (Promega). Amplified plasmid DNA was purified using Qiagen
purification spin-bind columns, and positive clones sequenced.
TNFa
GAPDH
Figure 4.35 Detection of TNFa mRNA in alveolar
macrophages. RT-PCR was performed on RNA isolated from
control (unstimulated) and LPS stimulated (LPS) alveolar
macrophages from sheep 4, as described in Table 4.6. PCR
generated products of expected size: GAPDH, 104 bp; TNFa 121
bp.
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4.5 shows the PCR cycling conditions used in these experiments. The results are
shown in Figure 4.35. TNFa mRNA was detected in medium controls and LPS
stimulated cells at each time-point (1, 4, 12 hours). The PCR product from the
cDNA sample of 4 hours LPS stimulation was purified using a spin-bind column
(Section 2C.4) and sequenced (MWG biotech). Analysis using GAP software (GCG
10) revealed 100% homology to sheep TNFa (X55152), and the reverse,
complementary sequence of the TNFa riboprobe (not shown).
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4.3 DISCUSSION
4.3.1 RPA Development
The quantification of RNA transcripts by RPA relies on the linear
relationship between band intensity and the concentration of target RNA species in
the starting material. Increasing amounts of cellular RNA were hybridised with
complementary riboprobes (GAPDH, IL-10, IL-10, IL-8 and IL-18) in a probe set
(Section 4.2.2.1). A direct correlation between band intensity and amount of
hybridised RNA was demonstrated for the detection of GAPDH, IL-10, IL-10 and
IL-18. The exception was IL-8, that showed a non-linear relationship to GAPDH
intensity (Section 4.2.2.1). The phosphorimage scan for this particular experiment
showed that the IL-8 probe signal was present at high levels, and peak thresholds on
the phosphorimage scan were met. It seems, therefore, for exceedingly high levels of
target RNA (such as IL-8 mRNA), the sensitivity of the RPA was compromised. IL-
8 was the most highly expressed cytokine in all experiments.
The sensitivity of the RPA for the measurement of transcripts expressed at
low levels was also a consideration. The riboprobes were labelled with [32P] which
allows the detection of small quantities ofmRNA. Direct labelling of mRNA targets
expressed at low levels may be below the detection levels of this assay. For
example, it was demonstrated that IL-18 was not detected by RPA analysis of a 10
qg sample of LPS stimulated macrophage RNA. However, IL-18 was demonstrated
in the RNA sample by RT-PCR (Section 4.2.2.2). As a positive control the use of
complementary RNA showed that 1 pg of plasmid expressed IL-18 mRNA was
detected by the RPA.
The primary function of alveolar macrophages in vivo seems to be the uptake
and neutralisation of environmental antigen. Although AM are considered the end
stage development of monocytes, they exhibit great functional activity related to
inflammation and antimicrobicidal activity such as the release of IL-10 (Nash et al.,
1992; Foss, Zilliox and Murtaugh, 1999), IL-6 (Andrews et al., 1993; Assoian et al.,
1987) and chemokines (Kopydlowski et al., 1999). Ovine AM cytokine expression
profiles determined by the RPA should reflect the inherent function of these cells.
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The data showed that:
• sheep alveolar macrophages constitutively expressed IL-8, IL-ip, IL-18 and
TGFp transcripts
• the immediate affects of culturing bronchoalveolar lavage cells (BAL)
induced peak expression levels of many cytokines
• in the absence of alveolar macrophages enrichment, cytokine expression by
the adherent cell population cultured in medium correlated with LPS
stimulation
• LPS induces the expression of cytokines in AM that have roles in innate and
adaptive immunity
Each of these findings is discussed below.
4.3.2 Measurement of Cytokine Expression in Resting cells
Freshly isolated AM derived from one sheep expressed IL-8, IL-ip, IL-18
and TGF(3. BAL cells were enriched for macrophages using a density media
separation protocol (Section 2A.3). It should be noted that these data were derived
from a single experiment involving one animal, which was not repeated due to time-
constraints of the project. Detection of IL-18 mRNA in the resting AM indicated
that IL-18 mRNA abundance was greater than 1 pg / 10 pg of total cellular RNA.
IL-18 is postulated to have a relatively long half-life compared to other cytokines,
due to a lack of destabilising elements in the UTR (Tone et al., 1997). It is regulated
at the post-transcriptional level by the expression of caspase-1 that is required for the
secretion of the bioactive protein. These results indicate that similar to macrophages
isolated from different antatomical locations (murine peritoneal exudates and liver)
(Okamura et al., 1995b; Puren, Fantuzzi and Dinarello, 1999), IL-18 is expressed
constitutively in sheep alveolar macrophages.
In the healthy lung, constitutive cytokine expression has been documented
which is thought to contribute to immune regulatory and homeostatic mechanisms.
TGFp has been found to be constitutively expressed in human AM (Assoian et al.,
1987) and in lymph draining sheep lungs (Perkett et al., 1990). Its role may be
associated with suppressor functions limiting T cell activation in epithelia and lung
mucosa. TGF(3 may also support cell homeostasis and repair (Yamauchi et al.,
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1988). Constitutive expression of IL-18 has been documented in rat lungs (Brieland
et al., 2000; Jordan et al., 2001), and freshly isolated AM express IL-8 (Strieter et al.,
1990) and IL-1 (Koretzky et al., 1983; Lamontagne et al., 1985). IL-8 is a potent
chemoattractant for many leucocytes. IL-1 (J and IL-18 enhance neutrophil
recruitment to tissue through enhanced expression of ICAM-1, vascular cell adhesion
molecule-1 (VCAM-1) and E-selectin (Jordan et al., 2001; Karmann et al., 1996).
The constitutive production of IL-8, IL-1 (3 and IL-18 in the lung may provide a
'chemoattractant reservoir' supporting the recruitment of circulating phagocytes and
lymphocytes.
4.3.3 Measurement of Cytokine Expression by Adherent BAL cells
Independent studies have reported that LPS induces a significant increase in
IL-1 (3, IL-6 and TNFa mRNA levels in AM compared to controls, with peak levels
observed 3-6 hours after stimulation (Andrews et al., 1993; Nash et al., 1992). In the
current study, there were two unexpected trends in cytokine expression of BAL cells.
First, peak levels of IL-1|3, IL-6, IL-8, IL-12 p40, IL-18, GM-CSF, TGFJ3 and TNFa
mRNA transcripts were found after 1 hour culture in AM from at least one of the
sheep. Primary cells require time to acclimatise to culture conditions and increased
cytokine expression by the BAL cells may in part be attributed to immediate
responses to culture. An important consideration is the effects of cell adherence to
the tissue culture flask. Attachment induces human monocyte / macrophage
expression of IL-1 p, TNFa and IL-6 (Brodbeck et al., 2002), and indeed peak levels
were seen for these transcripts in sheep adherent BAL cells after 1 hour culture.
Second, the levels of cytokine transcripts in medium controls were similar to cells
cultured with LPS. Moreover, IFNy and IL-4 mRNA were detected in both control
cells and LPS stimulated cells. IFNy is primarily expressed by activated T cells and
NK cells, but has also been documented to be produced by human AM stimulated
with LPS, phytohaemagglutanin (PHA), poly I:C (Nugent et al., 1985) or IL-12
(Fenton et al., 1997) and in lung macrophages from mice in response to
Mycobacterium bovis bacillus Calmette-Guerin plus IL-12 (Fenton et al., 1997). IL-
4, however, is produced by activated T cells and mast cells (Brown et al., 1987)
including lung mast cells (Gibbs et al., 1997); macrophage production of IL-4 has not
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been reported. The detection of IL-4 indicates that lymphocytes and / or mast cells
were present in the adherent BAL cells. In addition to contributing to the pool of
RNA analysed by the RPA, the presence of lymphocytes and mast cells in the
cultures may have influenced the responses of the adherent AM. In the absence of
LPS, inducible expression of IL-ip, IL-6 IL-12, IL-10 and TNFa, has been
documented following CD40-triggering of macrophages and DCs, and has been
shown to be dependent on IFNy and IL-4 (Maus et al., 1998; Nagayama et al., 2000;
Snijders et al., 1998; Hochrein et al., 2000; Kalinski et al., 2000; Ebner et al., 2001).
CD40L is expressed by CD8 T cells, eosinophils, mast cells, NK cells, but primarily
by activated CD4 T cells, and CD40 is expressed on B cells, DCs and activated
macrophages. CD40 ligation on macrophages or DCs induces an up-regulation of
the production of IL-ip, TNFa and IL-12 (Kato et al., 1996; Koch et al., 1996; Yang
and Wilson, 1996; Grewal et al., 1996; Stout and Suttles, 1996; Morelli et al., 2001).
AM in mice express low levels of CD40 (Zhang Hoover, Sutton and Stein Streilein,
2001) and whether this is true in sheep is not yet known. The indication of activated
lymphocytes provides a mechanism of CD40 triggering and the demonstration of IL-
4 and IFNy could contribute to increased cytokine production in the adherent BAL
medium control cultures.
4.3.4 Measurement of Cytokine Expression by AM Stimulated with LPS
In review of the data and the conclusions drawn above, a second series of
experiments were performed by purifying AM by adherence (Section 4.2.7). LPS
significantly enhanced expression of IL-18 (4-12 hours), IL-12 p40 (1-12 hours), IL-
1 (5 (1-12 hours), IL-6 (1-12 hours) and TGF{3 (4 hours). IL-18 and IL-12 p40 play
prominent roles in inducing IFNy production by NK cells and T cells, and the
development of antigen-specific cell mediated immunity (Th 1 -type__responses)
(Magram et al., 1996; Fantuzzi et al., 2000). LPS induction of IL-18 and IL-12 p40
contributes to protective immunity in both the early and late phases of the response.
In addition to IFNy production, IL-18 induces the synthesis of IL-ip and TNFa and
IL-8 (Puren et al., 1998), which contribute to the recruitment ofphagocytes.
During responses to intracellular infections affecting the lung, there is
enhanced production of IL-10 (Jacobs et al., 2000; Huang et al., 1999) and IL-6 (van
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der Poll et al., 1997). IL-10 is usually considered as regulatory and anti¬
inflammatory. Production of IL-ip, TNFa, IL-6 and IL-8 by AM can be inhibited
by IL-10 (Thomassen, Divis and Fisher, 1996). IL-6 is a pleitrophic cytokine that
can be considered has having pro-inflammatory and anti-inflammatory properties.
IL-6 has been demonstrated to be particularly important in regulating lung
inflammatory responses in vivo (Barton and Jackson, 1993; Xing et al., 1998; Ward
et al., 2000).
Thus, under the influence of culture and LPS stimulation, ovine AM
produced both pro-and anti-inflammatory cytokines, which may help maintain
immunological equilibrium in vivo.
4.3.5 Cytokine mRNA Expression Kinetics
The expression of IL-18 in AM showed similar kinetics to IL-1J3, IL-6, IL-10,
TGFp and GM-CSF in response to LPS. After treatment with LPS the amount of
specific RNA increased according to the levels measured in controls, levels peaked
after 4 hours and decreased thereafter. GM-CSF mRNA was moderately enhanced
by LPS compared to controls (Section 4.2.7.5), this has also been reported for murine
peritoneal exudate macrophages that seem to produce GM-CSF mRNA in response
to FCS in the culture medium (Thorens, Mermod and Vassalli, 1987). Increased
release of GM-CSF seems to be controlled by post-transcriptional mechanisms
(Thorens, Mermod and Vassalli, 1987), so measuring mRNA transcription levels
may not be an accurate way to quantify GM-CSF production.
LPS signals through CD 14 and a transducing receptor such as toll-like
receptor-4 (TLR4) (Poltorak et al., 1998; Qureshi, 1999). A schematic of the
signalling response of LPS is presented in Figure 4.36. Signalling through toll-like
receptors requires the adaptor protein MyD88 (Kawai et al., 1999; Adachi et al.,
1998). MyD88 functions to recruit down stream signalling molecules to the receptor
complex, such as IL-lR-associated kinase (IRAK)-l (Wesche et al., 1997). Upon
recruitment to the receptor complex, IRAK-1 is autophosphorylated and associates
with TRAF-6, leading to the activation of the MAP kinase (MAPK) pathways, ERK
1, 2 and 3 (p38) and c-Jun N-terminal kinase (JNK). Activation of MAPK pathways
leads to phosphorylation of IkB, dissociation of the IkB complex and the
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translocation of nuclear factor-kappa B (NFkB), and activation of activator protein-1
(AP-1). The activation of the transcription factors and NFkB and AP-1 culminates in
altered expression of a multiple genes. An additional adaptor signalling molecule of
TLRs is TIR domain-containing adapter protein (TIRAP) (Horng, Barton and
Medzhitov, 2001) that is also capable of regulating signals culminating in p38 and
NFkB activation as it can interact with MyD88. Independently of this pathway,
TIRAP can associate with IRAK2 and protein kinase receptor (PKR) driving the
production of IL-12 p40 (Fitzgerald, 2001; Horng, Barton and Medzhitov, 2001;
Kawai et al., 2001).
The IL-18, IL-ip, IL-6, TGF(3 and GM-CSF genes contain NFkB targets in
their enhancer regions (Droogmans et al., 1992; Hiscott et al., 1993; Guron,
Sudarshan and Raghow, 1995; Tone et al., 1997; Cruz et al., 2001), and IL-10
expression is activated by the p38 MAPK pathway (Ma et al., 2001). A common
pathway of gene activation could explain the simultaneous expression kinetics of IL-
18, IL-ip, IL-6, IL-10, TGFp and GM-CSF soon after LPS treatment in the current
study. With the exception of IL-18 (Tone et al., 1997), these mRNAs are rapidly
induced with a relatively short half-life (Carter and Malter, 1991), so their immediate
levels are a good reflection of gene induction. The early peak of cytokine transcript
expression in response to LPS presented here demonstrates the production of
cytokines with convergent roles in the innate protective response to gram negative
bacterial infection, and supports published data regarding the rapid activation of
endogenous signalling pathways in response to LPS. Murine liver and peritoneal
macrophages exhibit maximal activation of NFkB 1 horn after LPS treatment, but
decline after 3-6 hours (Velasco et al., 1997). During stimulation with LPS, TLR4
levels gradually decrease and are dramatically reduced following 24-hours pre-
treatment (Nomura et al., 2000), providing a mechanism for the down-regulation of
LPS-induced genes. In addition, Li et al. (2000) reported that a decrease in IRAK
levels are seen after 1-3 hours LPS stimulation of THP-1 cells. LPS-induced
MyD88-IRAK interaction persist until 1 hour after LPS stimulation. From the results
150
Figure 4.36 Toll-like receptor 4 signalling pathway. The Toll¬
like receptor (TLR) utilises common signalling molecules such as the
MyD88 adapter protein, the protein kinase IRAK (IL-1R-
associated kinase) and TRAF6 (TNF receptor-associated factor 6).
TRAF6 activates nuclear factor-k B (NFkB) and the MAP kinase
(MAPK) signalling pathways, p38 and c-Jun N-terminal kinase
(JNK). Another adapter molecule, TIRAP (TIR domain-containing
adapter protein) interacts with MyD88 and induces activation of
NFkB. TIRAP interacts with protein kinase receptor (PKR)
inducing activation of as yet un known signalling pathways that are
MAPK-independent and culminate in the induction of IL-12 p40
promoter activity. (Figure adapted from reviews; (Medzhitov,
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using the RPA presented in this chapter, a down-regulation of NFkB-activated genes
(IL-18, IL-ip, IL-6, IL-10, TGFp and GM-CSF) is evident after 4 hours stimulation.
This supports published data of the kinetics of NFkB activation following LPS
treatment (Velasco et al., 1997; Nomura et ah, 2000; Li et ah, 2000), and the IL-18
inducible promoter that exhibits maximal activation after 3-6 hours LPS treatment
(Kimetal., 1999).
4.3.6.1 IL-12 p40 and IL-8
The expression kinetics of IL-12 p40 and IL-8 differed from the other
cytokines. There was a gradual increase in IL-12p40 mRNA levels during the 12
hour LPS time-course (Section 4.2.7.2). Although NFkB and AP-1 drive IL-12 p40
gene expression (Grumont et ah, 2001; Zhu et ah, 2001), during IL-12 p70 synthesis
these transcription factors are activated by a MAPK-independent pathway involving
PKR (O' Neill, 2002). The data indicate that the regulation of IL-12 p40 differs to
other immediate response genes (IL-18, IL-1 (3, IL-6, IL-10, TGFp and GM-CSF) in
LPS stimulated AM. The expression of IL-8 showed a gradual increase during the
12-hour time-course, and in addition, IL-8 mRNA levels in medium controls were
not significantly different to LPS treated cells (Section 4.2.7.6). The non-linear
detection of IL-8 transcripts using the RPA showed that quantification using the
method as currently optimised is un-reliable. Therefore further optimisation of the
RPA for IL-8 transcript quantification is necessary. The kinetics of IL-8 mRNA
expression by ovine AM stimulated with LPS were similar to that reported for
porcine AM (Lin et al., 1994). Lin et al. (1994) also demonstrated that cultured AM
express detectable levels of IL-8 mRNA, and that LPS induces a significant increase
(4 fold) in specific mRNA. A possible explanation for the statistically non¬
significant increase in IL-8 mRNA in response to LPS reported here is that peak
thresholds were met, inhibiting the concurrent measurement of IL-8 message.
4.3.7 TNFa mRNA Detection
LPS induction of high levels of TNFa mRNA have been documented in AM
recovered from humans and sheep (Becker, Devlin and Haskill, 1989) (Nash et al.,
1992), thus non-detectable levels of TNFa mRNA using the RPA in both sets of
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experiments were unexpected. The efficiency of hybridisation of each riboprobe to
complementary RNA synthesised from plasmid DNA was demonstrated in each
experiment as a positive control, and the TNFa product was evident (not shown). To
determine the presence of 'target' mRNA in the cells, RNA samples were analysed
by RT-PCR, using primers within the riboprobe region, and TNFa mRNA was
detected (Section 4.2.9). It was possible that the TNFa riboprobe contained regions
of ambiguity for its target, so the PCR products were sequenced. The TNFa
message detected by RT-PCR was 100% complementary to the corresponding
riboprobe. It is possible that hybridisation conditions for this particular probe were
not optimal resulting in low hybridisation stringency and very low levels of
detection.
Out of the eleven cytokine probes tested, TNFa was not optimally functional
using this protocol.
4.3.8 Summary
The development of the RPA and its subsequent application to the
measurement of cytokine mRNA levels in alveolar macrophages was used as a
means of investigating the RPA quantitative nature and potential uses. Overall, the
the data indidcated that the RPA was developed successfully for the measurement of
the sheep IL-lp, IL-4, IL-6, IL-10, IL-12 p40, IL-18, GM-CSF, IFNy, TGFp with the
exception of TNFa, and possibly IL-8.
For the measurement of mRNA transcripts, the RPA displayed a sensitivity of
detecting ~1 pg of RNA in the target sample. To enable the detection of low level
transcripts, such as IL-18, at least 15 pg of macrophage RNA was required.
The data show that the determination of transcript abundance in replicate
RNA samples exhibited high reproducibility as demonstrated in the scatter graphs
displaying the relative ratio of mRNA levels at each time-point (Appendix 7).
In addition, the kinetics of expression of cytokine mRNA in response to LPS
stimulation were in agreement with published data for IL-ip (Nash et al., 1992; Foss,
Zilliox and Murtaugh, 1999), IL-6 (Andrews et al., 1993), IL-12 p40 (D'Andrea et
al., 1992; Marshall et al., 1999), IL-18 (Marshall et al., 1999), TGF|3 (Assoian et al.,
1987) and GM-CSF (Thorens, Mermod and Vassalli, 1987) expression by
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macrophages or peripheral blood monocytes. These data help validate the specificity
and measurement of ovine cytokine mRNA using the RPA.
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Chapter 5: Characterisation of Ovine Lymph Dendritic Cells
5.1 INTRODUCTION
5.1.1 Lymph DCs: Function and Sub-types
Ovine afferent lymph DCs stimulate strong allogeneic responses in resting T
cells, and moreover induce strong proliferative responses in T cell lines to antigen
collected in vivo (Bujdoso et al., 1989). These T-stimulatory characteristics have
also been documented for cattle lymph DCs (McKeever et al., 1991), and rat lymph
DCs draining the gut (MacPherson and Liu, 1993).
Two populations of cattle lymph DCs have been characterised based on the
expression of the signal inhibitory receptor-a molecule (SIRPa; originally named
MyD-1) (Howard et al., 1997). The major population, SIRPcf DCs, was more
proficient at stimulating allogeneic CD4 and CD8-responses than the SIRPa" DC
population at a range of ratios of DCrresponder cells. Stimulation of antigen specific
responses also differed between the DC populations, at high DC:responder ratio cell
(1:10), SIRPa" DCs induced a stronger proliferative response in memory CD4 T
cells, whereas at lower ratios (1:100-1000; DC:CD4 T cells) SIRPa+ DCs induced
slightly stronger antigen specific responses (Howard et al., 1997). It appeared that
the differences in the capacity for cattle lymph SIRPa DC populations to induce
CD8+ allogeneic responses was due to differential cytokine production, and may be
dependant on IL-la secretion by SIRPa+ DCs (Hope et al., 2001).
SIRPa DC populations have also been described in rat mesenteric lymph
(recognised by the mAb OX41 [Adams et al., 1998]). Freshly isolated rat SIRPa+
DCs were markedly more efficient at stimulating antigen-specific memory T cell
responses, and allogeneic responses at a range of DC:responder cell ratios (Liu et al.,
1998). Therefore, at least functionally, bovine and rat lymph SIRPa DC populations
appear to be similar.
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5.1.2 Signal Regulatory Protein-a
SIRPa contains a cytoplasmic immunoreceptor tyrosine-based inhibition motif
(ITIM), whereas SIRPp lacks an intracellular portion and its function is unclear
(Kharitonenkov et al., 1997). SIRP proteins have been designated signal regulatory
proteins, as it seems that SIRPa sequesters intracellular src-homology-1 -domain
containing protein tyrosine phosphatases (SHP)-l and SHP-2 away from protein
tyrosine kinases (PTKs) (Fujioka et al., 1996; Kharitonenkov et al., 1997; Veillette,
Thibaudeau and Latour, 1998). PTKs are involved in antigen-receptor signalling and
the positive and negative regulation of cell growth and differentiation, chemotaxis
and actin re-organisation (Hubbard and Till, 2000). Thus SIRPa has a potential role
regulating a variety of cellular functions.
SIRPa mRNA is ubiquitously expressed in most tissues in humans (heart, brain,
spleen, lung, liver, muscles, kidney and testis), being most abundant in brain and
spleen (Kharitonenkov et al., 1997). Using immunohistochemistry it has been shown
that SIRPa is strongly expressed on rodent myeloid cells (macrophages, monocytes,
granulocytes, DCs) and neurons (Adams et al., 1998). DC expression of SIRPa has
been demonstrated in a number of mammals including rodents, cattle and humans,
(Adams et al., 1998; Brooke, Parsons and Howard, 1998; Seiffert et al., 1999;
Dietrich et al., 2000; Huang et al., 2000; Hope et al., 2001; Latour et al., 2001).
Interactions with SIRPa and its ligand CD47 (integrin-associated protein) on T cells
seem to enhance cell-cell adhesion (Seiffert et al., 1999). A schematic representation
of SIRPa and CD47 signalling pathways is presented in Figure 5.1. SIRPa and
CD47 interactions result in 'bi-directional' signalling, activating a variety of
responses in the participating cells. Latour and colleagues (2001) demonstrated that
incubation of human MoDCs with an SIRPa antagonist (CD47Fc), suppressed the
secretion of IL-12, TNFa, IL-6 and IL-10 in response to bacterial products (Latour et
al., 2001). In addition, DC maturation was also suppressed, as measured by the
expression of CD40, CD80 and CD86 (Latour et al., 2001). CD47 engagement on T
cells down-regulated IL-12 receptor expression, and MoDCs incubated with CD47Fc
157
Figure 5.1 Signal regulatory protein-a and its ligand CD47:
intracellular pathways of activation. Activation of signal protein-a
(SIRPa), such as during interaction with its natural ligand CD47,
induces phosphorylation of its cytoplasmic domain-tyrosines creating
an immunoreceptor tyrosine-based inhibition motif (ITIM). The
activated ITIM recruits Src-homology 2 (SH2)-domain containing
tyrosine phosphatases, SHP-1 and SHP-2. SHP-1 and SHP-2 regulate
the MAP kinase (MAPK) signalling pathways, which are involved in
the activation of cellular processes, such as growth and differentiation.
Interaction of the extracellular region of SIRPa with CD47 transduces
'bi-directional' signalling Ligation of CD47 activates G protein-
mediated signalling pathways including an increase in intracellular
calcium, culminating in cell proliferation and differentiation. (Figure
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were markedly less efficient at inducing IFNy production in an allogenic MLR than
controls (Latour et al., 2001). These data suggest that during DC-T cell contact,
CD47-SIRPa interactions play a regulatory role in the production of inflammatory
cytokines and the development of Thl-type responses. Interestingly, as mentioned
previously SIRPa+ lymph DCs were more efficient at stimulating allogeneic and
autologous T cells than the SIRPa" cells (McKeever et al., 1991; Howard et al.,
1997; Liu et al., 1998). A SIRPa-specific mAb, IL-A24, blocked T cells binding to
SIRPa (MyD-1) transfected COS-7 cells and abrogated monocyte induced
proliferation of T cells (Ellis et al., 1988; Brooke, Parsons and Howard, 1998).
However, the addition of saturating concentrations of purified IL-A24 to DC co-
cultures with a T cell clone did not seem to have any effect on antigen induced T cell
proliferation (McKeever et al., 1991). It seems therefore, that SIRPa may have
differential functions depending on the cell type on which it is expressed, and the
activation state or activity of the cell.
5.1.3 Chapter Aims
Whether the SIRPa DC populations exist in ovine afferent lymph was not
known, and was the initial aim of these sets of experiments. This chapter will
describe similar SIRPa lymph DC populations in sheep as those described in cattle
and rat. Moreover, the molecular basis for the T stimulatory differences seen in
cattle SIRPa DC populations are not fully understood (Howard et al., 2002). Ex-vivo
sheep lymph SIRPa DC populations were characterised by surface phenotype at the
protein level, and patterns of cytokine expression at the mRNA level. These studies
aim to further or understanding of ovine DC populations and mammalian lymph DCs
in vivo.
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5.2 RESULTS
5.2.1 Animals and Experimental Procedures
Data presented in this chapter were derived from four sheep; Sheep 1
Sheep 2, Sheep 3 and Sheep 4 (Section 2.1)
Unless otherwise stated, the cells used in the experiments described in this
chapter were freshly isolated afferent lymph cells (lymph cells). Cell phenotype was
determined by immuno-labelling and flow cytometry. The monoclonal antibodies
(mAb) used in the experiments described in this Chapter are illustrated in Table 5.1,
and further details are given in Appendix 3. A description of immuno-labelling
procedures is given in Section 2B.8. Briefly, cells were single, or double labelled
with mouse mAb and biotin-conjugated mouse or rat mAb, or mouse / rat serum
(negative controls). Specific mAb were detected with anti-mouse IgG conjugated to
FITC, or biotinylated mAb with S:PE.
5.2.2 Flow Cytometry Analysis Parameters: Definition of Afferent Lymph
Leucocytes.
Afferent lymph contains a number of leucocyte types including T cells, B
cells, DCs (also termed afferent lymph veiled cells [ALVC]), and monocytes /
macrophages (Hopkins et al., 1985). Lymph cell populations were identified with
specific mAb: anti CD4 and CD8 (ST4 and SBU-T8, respectively (Maddox, Mackay
and Brandon, 1985) for CD4+ and CD8+ lymphocytes; mAb clone IAH-CC15
recognising the WC1 antigen on y5-T cells (Clevers et al., 1990); VPM30, which
reacts with surface antigens found primarily on B cells, but also on activated T cells
(CD25+ CD4+ / CD8+) (Campbell et al., 1998); anti-CDllb recognising monocytes
and macrophages, and the mAb OM1 specific for CDllc expressed on lymph DC
and macrophages (Gupta et al., 1995). Human and murine DCs also express CD1 lc
(O'Doherty et al., 1994; Vremec and Shortman, 1997), and this molecule is used as a
DC marker in mice.
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Lymph cells were analysed for reactivity to the mAb mentioned above. Positive
cells were gated and the light scatter properties determined, these are shown in
Figure 5.2b. As expected, T lymphocytes (CD8+, CD4+, yb T cells) displayed low
FSC vs. SSC (FSC 200 - 400; SSC 100 - 200), as they are generally spherical, dense
cells that are relatively small in comparison to other lymph cell populations. The
mAb VPM30 identified cells with light scatter properties indicative of small, dense
un-activated lymphocytes, and also cells with moderate FSC vs. SSC (FSC 400 -
500, SSC 200 - 400), which demonstrates they are larger, and possibly activated.
CDllc+ cells (DCs) displayed moderate-high FSC and SSC (FSC 400 - 1000; SSC
200 - 1000). CD1 lb myeloid cells fell in both low and moderate-high FSC, SSC
regions. Populations of cells expressing MHC II at intermediate (1 - 2-logs
fluorescence) levels versus high levels (2 - 3-logs fluorescence) were analysed (Fig.
5.2b). A major proportion of lymph cells (53.7%) expressed intermediate levels of
MHC II, and consisted primarily of small dense cells, but also with cells of
moderate-high FSC SSC, which collectively may represent B cells and macrophages.
The MHC II high population were large, complex cells (moderate - high FSC SSC),
comprising a similar proportion of afferent lymph cells as did CD1 lc+ cells (9.5% vs.
9%, respectively). Lymph cells expressing MHC II over 2-logs fluorescence
displayed similar light scatter properties to the CDllc+ population, and were thus
likely to represent lymph DCs.
5.2.3. Characterisation of Ovine Lymph DC Markers.
Previous studies demonstrated that ovine afferent lymph DCs display
moderate - high FSC SSC light scatter properties (Bujdoso et al., 1989), and express
high levels of MHC II, above that on B cells and macrophages (Hopkins et al., 1985).
The experiments described in Section 5.2.2. demonstrated that CD1 lc+ and MHC IIhl
cells display morphological characteristics (light scatter properties) indicative of
DCs. CD1 lc expression is modulated on murine and human DCs during maturation.
Mature DCs in lymphoid tissues express high levels of CDlie, whereas immature
DCs express CDllc with heterogeneity (Steinman, Pack and Inaba, 1997).
Similarly, surface MHC II expression is markedly up-regulated during DC
maturation (Cella et al., 1997).
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Figure 5.2 Phenotype and flow cytometric light scatter
properties of afferent lymph cell populations. Afferent lymph
cells were stained for MHC II using biotin-conjugated SW73.2
(Table 5.1), that was labelled with streptavidin-PE and detected on
the FL2 channel. Cells were double-labelled with a second, mouse
mAb and stained with anti-mouse IgGTTTC conjugate, and detected
on the FL1 channel. Negative controls samples were incubated with
normal mouse serum (1:500) or biotinylated normal mouse serum
(1:100) and secondary FITC and PE conjugates, respectively.
Details of the flow cytometers, cytometer settings, and analysis
parameters are given in Section 2B.8.4. 10 000 events were analysed
in each sample. Samples were performed in triplicate. The data is
representative of two independent experiments performed on cells
derived from Sheep 1.
a) Scatter profile of lymph cell populations. No gate was applied.
b) The antigen being analysed is shown with each histogram,
staining is shown in the coloured profile. Negative control staining
is shown as the open profile. Light scatter profiles of positive cells
are presented. Gates used for analysis are indicated on the







































Chapter 5 Characterisation of Ovine Lymph Dendritic Cells
DCs undergo maturation during migration to secondary lymphoid tissues. It was
helpful, therefore, to identify a molecule that could be utilised for identifying lymph
DCs at different stages ofmaturation.
Ovine lymph DCs and a small proportion of lymphocytes express the WC6
antigen (Dutia, Ross and Hopkins, 1993). To investigate whether lymph DCs could
be defined by light scatter properties and WC6 expression, lymph cells were stained
with anti-MHC ILbiotin and anti-WC6 mAb. As shown in Figure 5.3, 89.6% of
MHC IIhl DCs expressed WC6. Additionally, cells co-expressing WC6 and MHC II
at 2 - 3-logs fluorescence displayed light scatter properties indicative of DCs
(Section 5.2.2.). Based on these results, WC6 expression and moderate - high FSC
were useful characteristics for defining afferent lymph DCs.
5.2.4 Surface Phenotype of Lymph DCs
Surface marker expression of lymph DCs was characterised using the panel
of mAb listed in Table 5.1. Freshly isolated afferent lymph cells were gated for DCs
based on moderate - high FSC and WC6 expression at 1 - 2 logs fluorescence (Fig.
5.4). Percentage positive cells over that of negative controls (cells stained with
mouse serum and secondary conjugates) determined the degree of marker expression.
DC phenotype was analysed in three sheep with two independent experiments
performed on cells from Sheep 1, three experiments on Sheep 2, and a single
experiment on Sheep 3. Pooled data are presented in Figure 5.5 and are referred to in
the text below. Surface phenotype of DCs from Sheep 2 represented two out of three
animals tested (Section 5.2.5), therefore, the flow cytometric histograms derived
from Sheep 2 are presented in this section describing lymph DC phenotype.
Representative antigen expression profiles on DCs from Sheep 2 are shown in Figure
5.4.
DCs expressed the SIRPa molecule with marked heterogeneity (Fig. 5.4).
SIRPa expression clearly split the cells into positive and negative fractions, 51.4%
(± 4.3%) DCs expressed SIRPa as a single population, whereas the remainder
(48.6% ± 4.3%) were negative for this antigen. DC expression of CD1 lc was similar
to the experiments performed in Section 5.2.2, a large proportion were CDllc+
(83.5% [± 1.8%]) with levels detected at 1 - 2.5-logs fluorescence.
167
Figure 5.3. light scatter characteristics of WC6+ afferent
lymph cells. Freshly isolated afferent lymph cells were
analysed by flow cytometry following staining mouse anti
ruminant WC6 and anti-MuIgfFFITC (FL1 channel) and anti
ruminant MHC II (SW73.2: biotin) and streptavidin:PE (FL2
channel), a) Forward (FSC) and side (SSC) angle scatter of
afferent lymph cells. 10 000 events were analysed in each
sample, b) MHC II and WC6 expression on afferent lymph
cells. No gating was applied. Double positive cells displaying
high levels (> 3 logs fluorescence) of MHC II expression were
gated for analysis as indicated. FSC and SSC characteristics of
MHC IIhl WC6+ cells are shown, c) Cells with mod - high FSC
and MHC II levels at 3 logs fluorescence were gated and
analysed for WC6 expression. Negative control staining is
shown with the black histogram outline, staining with the red
histogram outline. Percentage positive cells are shown with each
profile. Cells were derived from sheep 2. The data shown is




Figure 5.4 Lymph dendritic cell surface phenotype. Afferent
lymph cells were stained with anti-WC6:biotin conjugate, labelled with
streptavidin-PE and detected on the FL2 channel. Cells were double-
labelled with a second, mouse mAb and stained with anti-mouse
IgG:FITC conjugate, and detected on the FL1 channel. Negative controls
samples were incubated with normal mouse serum (1:500) or
biotinylated normal mouse serum (1:100) and secondary FITC and PE
conjugates, respectively. Details of the flow cytometers, cytometer
settings, and analysis parameters are given in Section 2B.8.3. Dendritic
cells (DC) were gated as the WC6+ cell population with moderate - high
FSC, as shown (Rl). 10 000 events were analysed in each sample,
samples were performed in duplicate. The antigen being analysed is
shown with each histogram, staining is shown as the red profile.
Negative control staining is shown as the black profile. Percentage of
positive gated cells are shown with each histogram. The data is
representative of three independent experiments performed on cells
derived from Sheep 2.
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Figure 5.5 DC phenotype: A comparison of lymph DC from three sheep. Surface
phenotype of freshly isolated lymph DCs from three sheep (Sheep 1, Sheep 2 and Sheep
3) was analysed by flow cytometry. The level of antigen expression was determined by
the extent of staining (percentage [%] positive DCs) over cells stained with normal
mouse serum (1:500) and secondary conjugates as controls. Data represents the mean
and error bars standard error of the mean, level of expression from two experiments for
Sheep 1, three experiments for Sheep 2, and one experiment for Sheep 3 with duplicate
samples. An asterix (*) denotes a significant difference (p < 0.05; using a two-tailed t
test) in the mean level of expression for an antigen. The mAb against CD40, CD80 and








































Chapter 5 Characterisation of Ovine Lymph Dendritic Cells
DCs displayed low and intermediate expression of CD4 and CD8, low levels
were evident on 11.8% (± 0.3%) and 16.4% (± 3%) DCs, respectively (populations
indicated in Fig 5.4). The remainder of DCs positive for both CD4 (36.6% [± 0.8%])
and CD8 (18.7% [2.2%]) displayed levels over 2-logs fluorescence that appeared to
be single populations of cells (Fig. 5.4). This was surprising, as DCs have been
reported to express low levels of CD4 and CD8 in mouse and man (Olweus et al.,
1997; Pulendran et al., 1997; Anjuere et al., 1999; Cella et al., 1999; Trinite et al.,
2000) however, expression of these antigens at 2-logs fluorescence were indicative
of lymphocytes (Figure 5.2b). Afferent lymph DCs have been documented to
consistently form antigen independent clusters with lymphocytes (Pugh, MacPherson
and Steer, 1983; Hein, McClure and Miyasaka, 1987; Cumberbatch, Illingworth and
Kimber, 1991; Brand et al., 1999). Cytological preparations of afferent lymph cells
were analysed by microscopy following sequential double labelling with mAb as
performed for flow cytometric analysis. Cells of typical DC morphology were
evident clustered with cells of lymphocyte characteristics (Figure 5.6a).
Furthermore, WC6+ CD4+ and WC6+ CD8+ cells have light scatter properties
characteristic of DCs (ie. moderate - high FSC, SSC) (Figure 5.6b), which are not
typical of afferent lymph lymphocytes that display low FSC, SSC (Fig. 5.2).
Together, this evidence suggests the cells in the DC gate displaying CD4 and CD8
expression at 2-logs fluorescence probably represent DC:lymphocyte clusters.
Expression of CD45RA by lymph DCs showed marked heterogeneity (Fig.
5.4). Distinct positive and negative populations were demonstrated, 53.7% (± 5.8%)
of DCs expressed CD45RA over 2-logs fluorescence.
Of molecules involved in antigen detection and sampling, lymph DCs were
basically negative for CD 16 (2% [± 1%] positive staining), whereas considerable
proportions of DCs clearly expressed CD14 (31.6% [± 2.5%]) and CD206 (39.6 [±
4.2%]) (Fig. 5.4).
Most of the DCs expressed the co-stimulatory molecules analysed, population
shifts on FL1 were evident for CD40, CD80, CD86, and CD58 staining (Figure 5.4).
The highest expressed of these molecules was CD40, 96.5% (± 3.2%) DCs displayed
homogenous expression of CD40 at 2-logs fluorescence. DCs also expressed
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Figure 5.6. Demonstration of DC:Lymphocyte clusters. Following
sequential double immuno-labelling, afferent lymph cells were analysed
by cytocentrifugation and Giemsa staining (a) and flow cytometry (b).
a) Cells of typical DC morphology; irregular plasma membrane with
short processes and / or pseudopodia are evident, clustered with




b) Afferent lymph cells were stained with mAb against WC6 and
CD4, or CD8 and secondary conjugates. DCs with moderate-high FSC
and SSC were gated for analysis. Negative controls cells were
incubated with serum and secondary conjugates, and quadrants set so
99% of the negative control staining fell within the bottom left
quadrant. Discrete populations of double positive cells were gated
(R2), FSC SSC characteristics are shown in the dot plots.
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CD80 and CD86 as a single population, although expression levels differed in that
79.2% (± 2%) displayed positive staining for CD80, whereas 51.9% (± 4.9%) DCs
displayed CD86 staining above negative controls. Levels of CD58 were similar with
that of CD86 (1-2 logs fluorescence), although CD58 showed some heterogeneity
of expression (Fig. 5.4). Most of the DCs also expressed the adhesin CD 11 a,
expression was homogenous with expression on 92.7% (± 3.2%) DCs (Fig. 5.4).
5.2.5. DC Heterogeneity in Sheep
DC phenotype was compared between Sheep 1 and Sheep 2, and significant
differences in expression levels were demonstrated for CD4 (mean difference 30%,p
<0.001), CD 14 (mean difference 18%, p <0.01), CD206 (mean difference 22%, p
<0.05), and SIRPa (mean difference 20%, p <0.01). DC expression of MHC II,
CD8, CD16, CDlla, CD58 and CDllc were similar between Sheep 1 and 2 (Fig.
5.5).
DCs from Sheep 3 were analysed and compared with DCs from Sheep 1 & 2.
Other than CD45RA and WC6, levels of all other surface markers analysed were
significantly lower in Sheep 3 compared with both Sheep 1 and Sheep 2. The profile
of MHC II expression was markedly different for Sheep 3 compared with Sheep 1
and 2; 39.3% DCs from Sheep 3 expressed MHC II at 3-logs fluorescence whereas
over 80% of DCs from Sheep 1 and Sheep 2 expressed high levels of MHC II (Fig.
5.6). Similarly, 1% of afferent lymph cells expressed MHC II over 3-logs
fluorescence in Sheep 3, whereas 10% of these cells in Sheep 1 expressed MHC II at
high levels (Fig. 5.7). The proportion of WC6+: FSC moderate cells in Sheep 3 were
similar with Sheep 2 (85.4% [± 2.9%] vs. 96% [± 0.3%], respectively). However,
that a minor fraction (39.3%) of Sheep 3 DCs were MHC IIhl indicated that the DCs
from Sheep 3 were at an earlier stage of maturation, or, that the WC6:FSC moderate
population contained cells other than DCs, such as activated lymphocytes. Different
proportions of lymph leucocyte populations in Sheep 3 could reflect individual
physiological differences, or indicate the presence of infection. However, the
presences of infection (oedema, increase in polymorphonuclear cells [specifically
neutrophils] which would have high SSC, low FSC) were not evident.
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Figure 5.7 MHC II expression on DC from individual sheep.
Afferent lymph DC were gated according to WC6 expression and
moderate - high FSC, as indicated in Rl. Using identical gating
criteria on lymph cells derived from Sheep 1, Sheep 2 and Sheep 3,
MHC II expression was analysed on the FL1 channel. Staining with
mouse serum (1:500) and secondary conjugates is shown as the black
histogram. MHC II-positive cells were gated (Ml). Levels of MHC
II between 1 - 2 logs fluorescence (moderate [M3]) and over 2 logs
fluorescence (high [M2]) were gated. The percentage positive cells
are shown with each gate.
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5.2.6 SIRPa DC Populations
Afferent lymph cells from Sheep 1 and Sheep 2 were used to determine the
surface phenotype of SIRPa+ and SIRPa" DCs. DCs were gated with moderate to
high FSC and SSC (Section 5.2.2.), and analysed by two-colour flow cytometry
similar to previous experiments. Two independent experiments were performed on
cells from Sheep 1 and Sheep 2, and the data from duplicate samples pooled (n = 8).
Marker expression of SIRPa+ and SIRPa" DCs is presented in Table 5.2, these data
are referred to in the text. Flow cytometric dot plots and histograms from a
representative experiment are shown in Figure 5.8.
The DC populations differed significantly in CD1 lc expression (p = <0.05).
More or less all SIRPa+DCs were CDllc+ (99.8% [± 0.3%]), whereas 53% (±
4.1%) SIRPa" DCs did not express CD 11c, the CDllc+ fraction of SIRPa" DCs
displayed lower expression compared with SIRPa+ (Fig 5.7). Similarly, the majority
of SIRPa+ DCs expressed WC6 (92% [± 0.1%]), where as this antigen was found on
a significantly lower percentage of SIRPa- DCs (77.3% [± 4.7%]; p = <0.05).
While the proportions of CD4 staining on SIRPa+ and SIRPa" DC did not
differ significantly (p = 0.4; Table 5.2), patterns of CD4 expression showed
heterogeneity between the DC populations. As shown in Figure 5.7, the SIRPa" DC
fraction contained a higher proportion of CD4" (no shift on FL1) cells compared with
SIRPa+ DC (75.1% [± 3.9%] vs. 63.4% [± 11.6%], respectively), and a distinct
population of cells displaying CD4 staining at 1.5-logs fluorescence were more
evident in the SIRPa+ DC fraction. Both DC populations appeared to contain similar
levels of cells expressing low levels of CD4 (Fig. 5.7). CD8 reactivity in the DC
populations was similar (SIRPa+; 32.1% [± 10.4%] positive DC, and SIRPa"; 19.6%
[± 5.6%] positive DC; p = 0.8), as was patterns of CD8 expression (Fig. 5.7).
SIRPa+ and SIRPa" DC both contained CD8" cells, cells expressing low levels of
CD8 and fractions of CD8 expression 2-logs fluorescence (Fig. 5.7).
One of the most striking differences in marker expression between the SIRPa
DC populations was CD45RA expression (Fig. 5.7). SIRPa+ DC expression of
CD45RA was negligible (7% ± 0.5%) and from the dot plots seemed to represent
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Table 5.2 Surface marker expression on SIRPa+ / SIRPa" lymph dendritic
cells. Freshly isolated afferent lymph DCs were analysed following double immuno-
labelling, and flow cytometry, as described in the text. Percentage of positive cell
staining above controls was determined for each marker, and data pooled (n = 8).
Data were derived from four experiments performed on cells from Sheep 1 and
Sheep 2. Mean percentage expressions, ± standard error of the mean, and the p value
determined from unpaired two-tailed t tests are presented, p values less than 0.05
were considered significant.
Antigen % SIRPa+ DC % SIRPa DC p value
WC6 92 (±0.1) 77.35 (± 4.7) 0.020
CDllc 99.5 (± 0.3) 47 (±4.1) 0.006
CD4 36.6 (± 11.6) 24.9 (± 3.9) 0.401
CD8 32.1 (± 10.4) 19.6 (±5.6) 0.796
CD45RA 7 (± 0.5) 61.6 (±2.8) <0.001
CD16 4.5 (± 1) 1 (± 0.5) 0.022
CD14 41.62 (± 10) 3.6 (± 1) 0.011
CD206 56.9 (± 12.4) 6.2 (± 1.4) 0.017
MHC II 100 100 -
CD40 99.3 (± 1.7) 77.5 (± 2.2) <0.001
CD80 72.5 (± 9.3) 31.7 (± 1.7) 0.039
CD86 28.9 (± 8.5) 13.8 (±4.1) 0.163
CD58 87 (± 0.9) 53 (± 12.5) 0.054
CDlla 93 (± 1.7) 96.4 (± 0.5) 0.09
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Figure 5.8 Phenotype of SIRPa DC populations. Afferent lymph
cells were stained with anti-SIRPa:biotin conjugate, labelled with
streptavidin-PE and detected on the FL2 channel. Cells were double-
labelled with a second, mouse mAb and stained with ant i-mouse
IgG:FITC conjugate, and detected on the FL1 channel. Negative
controls samples were incubated with normal mouse serum (1:500) or
biotinylated normal mouse serum (1:100) and secondary FITC and PE
conjugates, respectively. Details of the flow cytometers, cytometer
settings, and analysis parameters are given in Section 2B.8.3. DCs
were gated as the moderate - high FSC SSC population (FSC 400 -
1000; SSC 200 - 1000), as shown (Rl). Density plots showing the
degree of antigen expression on the SIRPa+ / SIRPa* DCs are shown,
percentage of gated cells are shown with each quadrant. The DC
populations were gated: R2, SIRPa+; R3, SIRPa" and extent of FL1
staining presented in a histogram. The antigen being analysed is shown
with each histogram, staining is shown as the coloured profile; SIRPa+
DCs purple, SIRPa" DCs green. Negative control staining is shown
as the black profile. Percentage of positive gated cells are shown with
each histogram. 10 000 events were analysed in each sample, samples
were performed in duplicate. The data is representative of three
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Chapter 5 Characterisation of Ovine Lymph Dendritic Cells
'spill over' from mAb reactivity on SIRPa" DCs (Fig 5.7). Conversely, 61.5% (±
2.8%) SIRPa" DC expressed CD45RA over 2-logs fluorescence (p = < 0.001).
CD16, which was expressed at negligible levels on DCs (2%, Section 5.2.4),
was detectable on a minor portion of SIRPa+ DCs (4.5% [± 1%]), and absent on
SIRPa" DCs (1% [± 0.5%]). This pattern of expression on the DC populations was
also demonstrated for CD206 and CD 14 (Fig. 5.7). SIRPa+ DCs contained
significant proportions of cells positive for CD206 (56.9% [± 12.4%]) and CD 14
(41.6% [± 10%]) compared with SIRPa" DCs that were 6.2% (± 1.4%) (p = <0.02)
and 3.6% (± 1%) (p = <0.02) positive for CD206 and CD14 respectively.
SIRPa+ DCs all expressed MHC II, CD40, CD80 and CD86 (as determined
by FL1 shift; Fig. 5.7), whereas, while all SIRPa" DCs expressed MHC II, fractions
did not express CD40, CD80 and CD86 (Fig 5.7). Intensity of CD40 and CD86
expression was similar between the two DC populations, CD40 staining of the whole
population was significantly greater for SIRPa+ DCs than SIRPa" DCs (99.3% [±
1.7%] vs. 77.5% [± 2.2%], respectively; p = <0.001), whereas CD86 staining was
comparable (28.9% [± 8.5%] vs. 13.8% [± 4.1%], respectively; p = >0.1).
Expression of CD80 differed between the DC population both in intensity (Fig 5.7)
and proportions of staining, 72.5% (± 9.3%) SIRPa+ DCs expressed CD80 above
control levels, compared with 31.7% (± 1.7%) SIRPa" DCs (p - < 0.05).
CD58 and CDlla were expressed on a greater proportion of SIRPa+ DCs
than SIRPa" DCs, although this was not significant (Table 5.2).
5.2.7. Analysis of Constitutive Cytokine Expression by the SIRPa DC
Populations.
In addition to determining the phenotype of lymph DCs, the 'psuedoafferent'
lymphatic cannulation model was utilised to determine constitutive cytokine
expression by DC populations undergoing migration to the lymph nodes. The
following sections describe the enrichment of DCs from afferent lymph cells using a
discontinuous multi-layered sucrose gradient, and purification of SIRPa populations
by Fluorescence Activated Cell Sorting (FACS).
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5.2.7.1 DC Enrichment
DC enrichment was achieved using the sucrose density media Optiprep ™
(Axis-Shield). A protocol optimised for ovine lymph was developed from published
work describing the separation of monocytes from human blood (Graziani-Bowering,
Graham and Filion, 1997). Details of the enrichment protocol are given in Section
2A.3. Lymph cells were separated by floatation from a fraction containing 28.6%
optiprep, and a stepped gradient of 25% and 18.2 - 22% optiprep. Following
centrifugation, two fractions of cells were evident at the media interphases. Cells
were analysed by light microscopy, the upper fraction comprised cells of typical DC
morphology possessing an irregular plasma membrane and were thus easily
distinguishable from lymphocytes that are spherical and generally smaller and more
dense than are DCs (Figure 2.1).
In order to achieve the optimal enrichment of DCs, a range of densities for
the upper layer of Optiprep was tested. Decreasing the density of the upper gradient
would selectively enrich for larger and less dense cells. Afferent lymph cells were
separated using an upper layer consisting of 18.2%, 20% and 22% Optiprep, and
cells at the media / HBS interphase analysed by flow cytometry, the results are
presented in Figure 5.9. Cells with moderate - high FSC and SSC comprised 25%,
67% and 71% of cells isolated using 18.2%, 20% and 22% Optiprep, respectively
(Figure 5.9). Enriched cells were characterised by surface marker expression,
CD1 lc defined DC, CD1 lb defined monocytes / macrophages and B cells / activated
T cells defined by reactivity to the VPM30 mAb. The data are summarised in Table
5.3. The proportion of DCs recovered increased by lowering the density of the upper
layer of the Optiprep gradient, however at the lower density (18.2% Optiprep)
monocyte / macrophage and B cell enrichment also increased. In the experiment
presented above, the greatest enrichment of CDllc+ DCs was achieved using an
upper layer of 20% Optiprep, that represented 1% of the starting afferent lymph cells
(2 x 52/100). In subsequent experiments, 20% Optiprep was used as the upper layer
of density media for DC enrichment. Cell volumes of 2.5 ml or 10 ml at
concentrations of 1 x 106 - 2 x 107 cells / ml were separated with similar results.
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Figure 5.9 Flow cytometric assessment of lymph DC enrichment.
Afferent lymph cells were separated through a stepped gradient
mixture of Optiprep™, using various concentrations for the upper
layer. The low density cell fraction was collected and analysed by
flow cytometry, the light scatter plots are shown. Gates were set for
analysis, GateRl defines DCs. GateR2 defines lymphocytes.
a) Before purification. DCs comprise 4% of the cells, lymphocytes
90%.
b) 22% Optiprep: DCs 25%, lymphocytes 60%.
c) 20% Optiprep: DCs 67%, lymphocytes 16%.
d) 18.2% Optiprep : DCs 71%, lymphocytes 10%.
Data are representative of two experiments using cells derived from
one animal that was not used in other experiments presented in this
Chapter.
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a) Afferent lymph cells b) 22% Optiprep
ssc
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B cells (%) % cell yeild3
22 26 1 8 5
20 52 2 32 2
18.2 62 3 32 0.5
a
Percentage (%) cell yield is relative to the number of starting cells.
Cells were analysed following mAb staining and flow cytometry. Details of
experimental procedures are given in the text.
5.2.7.2 Purification of DCs by Negative Selection was Unsuccessful
Purification of DC using cell surface markers and magnetic activated cell
sorting (MACS) was investigated. MACS provides the advantages of high levels of
purity of seperated cells, and allows the purification of cell populations from
mixtures of >108 cells (Miltenyl Biotec). Negative selection of lymph DC was
necessary because of: 1) the lack of DC-specific markers required at least two rounds
of positive selection which may have resulted in a reduction of target cells collected,
and low levels of purity; 2) Positive selection using specific mAb and magnetic
beads would increase the likelihood of activating ligated receptors and modulating
DC function. Therefore, the following mAb were titrated and used to deplete cell
populations known to be present in afferent lymph: VPM30 (B cells / activated T
cells); IAH-CC6 (anti-CD2 - a0-T cells); IAH-CC15 (anti-WCl - yS-T cells); (see
Table 2.1 for further details). Details of the protocol used for MACS separations are
given in Section 2B.9. Cells eluted as the negative fraction were counted and
analysed by flow cytometry (not shown). The number of cells recovered was
approximately 10-fold lower than expected ie. 50% of DC enriched cells (Table 5.3).
DCs were subsequently analysed by flow cytometry for reactivity to the depletion
mAb. As shown in Figure 5.10, reactivity to mAbs VPM30 and IAH-CC15 was
negligible. However, 86% of afferent lymph DCs expressed CD2 (Fig. 5.10). This
193
Figure 5.10 DC expression of'lymphocyte markers'. Freshly isolated DCs
were analysed by flow cytometry following labeling with anti-MHC II:biotin
and streptavidin:PE, detected on the FL2 channel, and the mAb VPM30 (B cells
/ activated T cells), IAH-CC6 (anti-CD2) and IAH-CC15 (anti-WCl; y6 T cells),
followed by anti:IgFITC conjugates, detected on the FL1 channel. 10 000
events were analysed per sample. A gate (Rl) was set for DC analysis (FSC 400
- 1000; SSC 200 - 1000), as indicated on the dot plot. Negative controls were
stained with serum or biotinylated serum and secondary conjugates. An example
of negative control staining on FL1 vs. FL2 is shown. Dot plots show the extent
of staining and level of MFIC II expression, lymph DC express MHC II at > 3-
logs fluorescence. Extent of marker expression is shown in the coloured
histogram, negative controls are shown as the open histogram, percentage
positive cells is shown with each profile.
Results are representative of two independent experiments with duplicate
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was surprising because there was no published evidence of significant CD2
expression on DCs, and although CD2 expression by sheep DCs had been
demonstrated by flow cytometry, the authors proposed that mAb reactivity may be
due to absorption of the molecule (Bujdoso et al., 1989). The mAb specific for a|3-T
lymphocyte-restricted markers, (such as CD28 or CD3) were not available during
this study. Therefore the negative selection of DC from afferent lymph cell
populations was not possible. The following section describes the isolation of DC
populations using FACS.
5.2.7.3 Purification of DC Populations by FACS
WC6+ SIRPa+ and WC6+ SIRPa" DCs were purified using FACS. Following
density media enrichment as described in Section 5.2.7.1, DCs were stained for WC6
and SIRPa, and live cells sorted using a FACS Vantage, details are given in Section
2B.8.4. A representative experiment indicating the gate criteria for cell sorting is
shown in Figure 5.11. The cell fractions were analysed following sorting and the
SIRPa+ and SIRPa" cell fractions consistently >98% and 96% pure respectively,
based on the presence or absence of SIRPa (Figure 5.11).
5.2.8 Morphology of the SIRPa+ and SIRPa" DCs
DCs separated into SIRPa+ and SIRPa" populations were examined
following cytocentrifugation and staining with Giemsa stain, as described in Section
2A6. Representative images are shown in Figure 5.12. The SIRPa+ cells were
relatively large, containing spikey processes. In contrast, SIRPa" DCs were
generally smaller with blunt pseudopodia or veiled edges evident on a number of the
cells. These morphological distinctions were not entirely confined to the sub-
populations, and cells of intermediate morphology were evident in both fractions.
5.2.9 Constitutive Cytokine Expression by DC Sub-populations
To ensure gene expression was not modulated during collection and
processing of the cells, Actinomycin D was added to the afferent lymph collection
bottles to give a final concentration of approximately 1 pg/ml. Buffers contained
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Figure 5.11 Fluorescent activated cell sorting DC SIRPa sub-
populations. DCs were stained sequentially with anti-SlRPa then
FITC anti-Ig conjugate, followed by biotinylated WC6 and streptavidin-
PE. Staining was detected on the FL1 and FL2 channels, respectively.
The dot plot shows DC expression of WC6 and SIRPa. Cells were
gated for sorting; R5 defines the SIRPa" population; R6 the SIRPa+
population. Sorted cells were analysed for SIRPa expression and are
presented in the histograms, the negative cell fraction is shown in blue,
the positive in the open profile. This type of analysis demonstrated the
cell fractions were consistently 96% and 98% pure respectively, defined
by SIRPa staining and scatter profiles. Data is representative of ten






Figure 5.12 Morphological distinctions of SIRPa+ and SIRPa"
DCs. DCs were enriched from lymph by density media centrifugation
and separated into SIRPa positive and negative fractions by FACS.
Freshly isolated cells were assessed microscopically following Giemsa
staining.
a) SIRPa+ DCs display multiple short, fine processes.
b) SIRPa" DCs possess several longpseudopodia
These morphological distinctions are not entirely distinct, and cells of
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1 pg/ml Actinomycin D. Actinomycin D inhibits transcription by disrupting the
DNA helix (Chen, Liu and Patel, 1996). The concentration of Actinomycin D used
in these experiments was determined to be non-toxic to cells (by trypan blue
exclusion).
DCs were purified and SIRPa+ and SIRPa" cells isolated as described in
Section 5.2.7. Total RNA was isolated from DCs collected over 24 hour periods and
analysed. The advantage of analysing individual samples was to obtain a cohort of
samples from individual animals. The disadvantage, however, was the low yield of
extracted RNA, 2-3 x 105 SIRPa+ / SIRP" DCs yielded less than 250 ng total RNA.
The cytokine RPA (Chapter 4) was not suitable for the analysis of such low numbers
of cells. Therefore rtPCR was utilised detect IL-6, IL-10, IL-12 p40 and IL-18
transcripts expressed by the SIRPa+ / SIRPa" DC sub-populations. This technique
was employed because of its specific nature and ability to detect mRNA transcripts
in low abundance. Regrettably, time constraints of the project did not allow for
establishing a real-time PCR protocol, which would allow the quantification of
cytokine mRNA transcripts utilising internal controls. Detection of mRNA by
standard RT-PCR gives an indication of transcription of a particular gene, but no
information on the relative levels of expression and indeed the production of a
functional protein. This method is not quantitative and correlations of transcript
abundance between the two cell populations cannot be made. Accordingly these
experiments were carried out to confirm the presence or absence of cytokine
transcripts in freshly isolated DC populations.
5.2.9.1 Sheep DC SIRPa Populations Exhibit Differential Cytokine Expression.
RNA extracted from SIRPa+ and SIRPa" DCs (Section 2C.1) was treated
with DNase I. Samples were then concentrated by precipitation and centrifugation
under a vacuum, and re-suspended in 15 pi nuclease-free H2O. 5 pi of the RNA
sample from each cell population were pooled and analysed for genomic DNA
content (Section 2C.2). These were consistently negative (not shown). Positive
controls were 10 ng plasmid DNA containing cytokine cDNA, amplified for 30
cycles using the appropriate PCR primers. Template DNA was omitted to control for
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reagent contamination. PCR reactions were standardly optimised for [MgCL] and
dNTPs.
All primers were checked for specificity by rtPCR using LPS stimulated
macrophage RNA as template (not shown). Single products were purified, cloned
and sequenced (Sections 2C.4 and 2C.5). Analysis using GAP software (GCG 10)
confirmed the specificity of the primers. The IL-18 primers were confirmed for
specificity as described in Chapter 3.
Figure 5.12 shows the amplification products of rtPCR analysis of SIRPa+
and SIRPa" DC RNA. These results are representative of two independent cell
collections from Sheep 2. PCR reactions were performed in duplicate. GAPDH
amplicons were not detected during rtPCR analysis of RNA collected from Sheep 1,
and were therefore not utilised further. Similar levels of GAPDH PCR products
were evident in the SIRPa+ and SIRPa" DC RNA preparations derived from Sheep 2,
indicating similar amounts of intact cellular RNA. IL-12 p40 transcripts were easily
detectable from less than 250 ng total RNA isolated from SIRPa+ DCs, and were
absent in SIRPa" DCs. Similarly, IL-18 was detected in only the SIRPa+DC sample,
albeit at low levels. IL-6 and IL-10 transcripts were not detected in either DC
population.
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Figure 5.13. Analysis of constitutive cytokine expression by
SIRPa+ and SIRPa" DCs. Freshly isolated lymph DCs were purified
according to the presence or absence of SIRPa as described in Section
5.2.7. RNA was extracted, concentrated and subject to RT-PCR
analysis using 40 cycles of amplification utilising primers for GAPDH,
IL-6, IL-10, IL-12 and IL-18. Positive control reactions contained
plasmid DNA containing cytokine cDNA as template and were
amplified for 30 cycles, these are indicated with (+ ve), cDNA
template was omitted in negative controls (-ve). SIRPa positive cells
expressed transcripts for IL-12 p40 and IL-18. No cytokine products
were detected in the SIRPa negative cells. Data is representative of
duplicate PCR reactions from two independent cDNA synthesis
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5.3 DISCUSSION
Given the overall heterogeneity of DCs, it is accepted that the identification
of DCs relies on a combination of characteristics including: 1) morphology, with
existence of dendrites and / or long psuedopodia; 2) surface phenotype,
demonstrating expression of molecules involved in T cell activation; 3) T stimulatory
capacity (Steinman, 1991). The SIRPa DC populations fulfil the first two of these
criteria, and a previous study by our group (Bujdoso et al., 1989), demonstrated that
ovine lymph DCs were potent stimulators of allogeneic and autologous T cells,
therefore fulfilling the latter DC characteristic.
5.3.1 Biological Consequence of Lymph DC Population Phenotype
Both SIRPa+ and SIPRa" DCs expressed MHC II over 2-logs fluorescence,
expressed similar levels of CD11a, and all SIRPa+ DC and most SIRPa" expressed
CD58. MHC II interactions with antigen specific TcRs constitute 'signal one' in
DC-T cell interactions. Initial interactions during clustering with antigen-specific T
cells are in part mediated by CDlla and CD58 (Selvaraj et al. 1987; Breitmeyer et
al., 1987). Expression of MHC II, CDlla and CD58 indicates both ovine DC
populations were phenotypically equipped to participate in antigen presentation to
lymphocytes.
Lymph DC subpopulations displayed a dichotomy of expression of co-
stimulatory molecules required for sustaining T cell activation (Fig. 5.8). Based on
histogram staining shifts on FL1, all SIRPa+ DCs expressed CD40, CD80 and CD86,
whereas most SIRPa" did not express CD86, and levels of CD40 and CD80 were
significantly lower on the SIRPa" DC populations as a whole. However, expression
levels of CD86 were similar on the DC populations, and that CD86 has prominent T-
cell activation on DC (Caux et al., 1994; Inaba et al., 1994) indicates that prior to
cognate interactions with T cells, the populations have similar capabilities for
constitutively activating clustered T cells in the lymphatics. T cells activate DC via
CD40, leading to increased production of IL-12, IL-1, TNFa, and increased
expression of CD80 and CD86 (Cella et al., 1996; Grewal et al., 1996; Ridge, Di
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Rosa and Matzinger, 1998). That a fraction of SIRPa" DCs did not express CD40
suggests these cells require additional maturation signals to express CD40, initiate
cognate interactions with T cells and produce IL-12. Whether the CD40" SIRPa"
DCs were also negative for CD80 and CD86 was not established in this study, and
requires 4-colour flow cytometry to determine that.
Significant differences in the level of expression of molecules involved in
pathogen recognition and antigen uptake were found between the DC populations.
Expression of CD206, CD 16 and CD 14 was mainly confined to the SIRPa+ DC
population. Levels on the SIRPa" DCs were either low (CD206) or absent (CD 16,
CD14) (Fig. 5.8). CD14 functions as a co-receptor of TLR4 and is required for LPS
responsiveness (Haziot et al., 1996). Moreover, SIRPa+ DC, but not SIRPa" DC
express TLR4 (K. Mathews, Edinburgh University; personal communication),
suggesting that the former may be more responsive to LPS and IL-12 priming than
the latter.
CD206 and CD16 promote antigen loading into MHC Il-rich lysosomes,
resulting in highly efficient MHC II loading and presentation (Inaba et al., 1997).
Ligation and activation of CD 16 and CD206 or DC maturation induced by LPS,
CD40 or the cytokines IL-1 and TNFa results in the down-regulation of CD 16 and
CD206 expression, and a reduced capacity for antigen uptake (Sallusto et al., 1995;
delaSalle et al, 1997). These processes switch the DC from being highly efficient at
antigen uptake, to stable loading of MHC I and II molecules and presentation at the
cell surface of exogenous antigenic peptides. Low level CD 16 and CD206
expression on SIRPa+ DC suggests that the tissue DCs from which this population is
derived expressed CD 16 and CD206. That pathogen / antigen recognition receptors
present on a population of migrating ovine DCs may have functional consequences,
such as enhancing basal levels of cytokine expression, (discussed in further detail in
Chapter 6), may indicate SIRPa+ DCs are related to DC populations described in
mice and humans (Section 5.3.6).
CDllc is expressed on a major fraction of DCs in murine and human
peripheral lymphoid organs (Anjuere et al., 1999), which appears to be the situation
for sheep as 83.5% (± 1.8%) DCs migrating from cutaneous tissue expressed CD1 lc
(Fig. 5.4). SIRPa+ DCs expressed intermediate levels of CDllc, whereas SIRPa"
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DCs contained fractions of DCs with low level or undetectable CDllc expression
(Fig. 5.8). CDllc forms the a-subunit of complement receptor-4 (CR4,
CDllc/CD18), and promotes the phagocytosis of activated complement component
3b (iC3b)-opsonised products and contributes to the uptake of apoptotic cells by
splenic marginal zone DCs (Morelli et al., 2003). The function of ovine
CDllc/CD18 has not been established, and it would be important for tolerance-
directed therapies to determine if ovine DC utilise CD1 lc-dependant mechanisms for
the uptake of apoptotic cells. SIRPa+ DCs share certain analogies with LCs and their
lymphoid counterpart IDC (Section 5.3.6.1). LCs comprise a significant proportion
of marginal zone DC in lymph nodes (Anjuere et al., 1999), and, therefore, may have
a role in the uptake and presentation of cytoplasmic antigens in cells undergoing
apoptosis in the lymph nodes. Re-presentation of antigens by IDCs forms an indirect
mechanism of antigen presentation in vivo, and that SIRPa+ lymph DC population
could perform this function in sheep could be hypothesised based on conclusions
discussed in Section 5.3.6.1. Tracking studies using fluorescent-labeled antigens or
cells administered sub-cutaneously could be used to investigate this in future studies.
WC6 was used as a marker for DCs in this study, so it was unexpected that
the two DC populations differed significantly in WC6 expression: 92% (± 0.1%)
SIRPa+ DCs expressed WC6, whereas 77.3% (± 4.7%) SIRPa" DCs displayed
heterogeneous expression of WC6. Thus, 16% of afferent lymph DCs (mod - high
FSC vs. SSC [Budjoso et al., 1989]) were WC6", and further experiments are
required to determine if this cell fraction does indeed represent functionally active
DCs - such as displaying a high capacity for stimulating T cell proliferation in vitro.
The SIRPa" WC6" cells however have phenotypic characteristics of DCs, such as
moderate-high FSC vs. SSC (Bujdoso et al., 1989) and MHC II expression over 2-
logs fluorescence (Hopkins et al., 1985). This highlights that caution is required
when characterising ruminant DC populations on the basis of WC6 expression alone,
and more than one property for identifying DCs ex vivo is advantageous (as was used
in this study). Such an example was demonstrated in the mouse system, as the
characterisation of DCs in secondary lymphoid organs based entirely on CDllc
expression resulted in plasmacytoid DCs not being identified (Ardavin, 2003).
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Both DC populations reacted with antibodies against CD4 and CD8 antigens
(Fig. 5.6). DCs have been shown to express both CD4 & CD8 (Vremec et al., 2000)
and not display reactivity by the passive uptake from T cells. Murine DC subsets are
classified by expression of the CD8aa homodimer, and as the reactivity of the anti-
CD8 mAb SBU-T8 has not been classified to a particular chain of CD8, whether this
mAb is useful for determining DC lineages in sheep is not known. As discussed in
Section 5.2.4., it is likely that proportions of the CD4 and CD8 staining represented
mAb reactivity with activated lymphocytes that spontaneously form clusters with
DCs in afferent lymph, that were evident following antibody staining (Fig 5.6).
CD1 la and CD58 expressed by both DC populations could contribute to constitutive
DC:lymphocyte clustering in situ.
CD45RA, the high molecular weight isoform of the common leucocyte
antigen CD45, was expressed by a major fraction of the SIRPa" DC sub-population,
whereas SIRPa+ DCs did not express this antigen. Human pDCs and DC/NK cell
precursors are the only DC subsets reported to express CD45RA (Canque et al.,
2000; Liu et al., 2001), which may be relevant for making comparisons with ovine
lymph DC subsets, as discussed in Section 5.3.6. CD45 is a transmembrane tyrosine
phosphatase, its primary molecular targets are the Src-family kinases (Thomas and
Brown, 1999). CD45 negatively regulates cytokine and interferon receptor mediated
activation (Irie-Sasaki et al., 2001), and is important in down regulating kinase
activity during integrin-mediated adhesion in macrophages (Burns et al., 1994). The
differential expression of CD45RA on DCs suggests functional consequences.
Because of the role of CD45 in the regulation of cellular events during adhesion, it
would be interesting to investigate the function of CD45RA+ compared to CD45RA"
DCs during DC:T cell interaction.
5.3.2 SIRPa DC Populations
The data indicate that ovine SIRPa" DCs were markedly more heterogeneous
than SIRPa+ DCs. SIRPa+ DCs expressed MHC II, CD40, CD80, CD86, CDllc
and WC6 as a single population. Expression of CD 16, CD 14, CD206 were low or
absent on SIRPa+ DCs, and may have been modulated (Section 5.3.4). SIRPa+ DCs
contained cells with two levels of expression of CD58 and CD 11 a. Conversely,
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SIRPa" DC expression of MHC II ranged from intermediate to high, and this DC
population contained proportions of cells that were negative for CD58, CD40, CD80
and CD86. Expression of CD1 lc and WC6 were heterogeneous or absent on SIRPa"
DCs. Only CD1 la expression produced a unimodal histogram. It appears therefore,
that both SIRPa+ and SIRPa" DCs may comprise cells at different stages of
maturation, or of different sub-populations - particularly SIRPa" DCs. This
observation differs with that reported for cattle DCs. Bovine lymph SIRPa" DCs
were reported to be homogenous, whereas cattle SIRPa+ DCs were heterogeneous
(Howard et al., 1997). In that study the cattle DC populations were not assessed for
markers investigated in the current study, and heterogeneous expression of CD5,
CD21 and WC10 indicated bovine SIRPa+ DCs were a mixed population. These
molecules were not investigated in this study, and the disparity between ovine and
bovine DCs may be due differences in the molecules analysed. CDlla expression
however, differed markedly between cattle and sheep DCs: CDlla was expressed
only by SIRPa+ DCs in cattle (Howard et al., 1997), whereas SIRPa+ and SIRPa"
DCs in ovine lymph expressed CDlla at similar levels. More data is required on
DCs from both species if conclusions are to be made regarding their relativity to each
other.
5.3.3 Animal Variation
Patterns of cytokine expression were determined in cells from an individual
animal (Sheep 2). DCs from Sheep 2 presented a phenotype representative of three
animals, and may therefore be also representative for determining cytokine
expression. However, these experiments should be repeated in an additional two
animals to confirm constitutive cytokine mRNA patterns in SIRPa DC populations.
MHC II expression differed significantly in Sheep 3, as did DC phenotype. This
could reflect actual individual differences, or physiological differences such as
infection. Signals of infection, such as lymph leucocytosis (determined by flow
cytometric scatter plots), or oedema around the surgical site were not evident.
However, this cannot be discounted. Inflammatory cytokines produced in response
to infection would induce the recruitment and activation of blood leucocytes into the
tissue, and afferent lymph. Activated lymphocytes express WC6 (Dutia, Ross and
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Hopkins, 1993) and increase FSC SSC readings, and could have been included in the
DC gate during analysis of cells from Sheep 3.
5.3.4 Maturation Status of the Ovine DC Sub-populations
Due to high-level expression of MHC II, and CD40, CD80 and CD86,
SIRPa+ DCs resembled mature DCs. SIRPa" DCs, however, display lower
expression of MHC II and co-stimulatory molecules and therefore resembled a more
immature DC. On the other hand, SIRPa+ DCs also expressed CD 14, CD 16 and
CD206, which represents an immature phenotype in mice (Sallusto et al., 1995). It
may however, be presumptuous to conclude that expression of CD 14, CD 16 and
CD206 on sheep DCs indicates an immature phenotype, because porcine monocyte-
derived DCs (cultured with GM-CSF and IL-3) retained CD14 and CD16 expression
after maturation in vitro (Carrasco et al., 2001). Overall therefore, high
homogeneous expression of molecules involved in antigen presentation and
activation of T cells is a strong indicator that SIRPa+ DCs were at a mature stage of
differentiation, which could relate functionally to increased T-stimulatory potential.
5.3.5 Cytokine Production
The biological relevance of constitutive expression of IL-12 and IL-18 by
migrating DCs in vivo is not fully understood. IL-12 and IL-18 are expressed
constitutively by LCs (Kang et al., 1996; Stoll et al., 1998), and mediate rapid Thl-
mediated responses in the skin (contact hypersensitivity) (Wang et al., 2002). Not
surprisingly, IL-12 and IL-18 transcripts are detected at basal levels in mouse lymph
nodes (Stoll et al., 1998; Wang et al., 2002). However the release of biologically
active IL-12 and IL-18 are tightly regulated (Ghayur et al., 1997; Trinchieri, 1998).
The IL-12 molecule is a heterodimer consisting of two disulphide-bonded subunits,
IL-12 p40 and IL-12 p35, encoded on separate genes, that must be expressed at the
same time to produce the bioactive molecule (Gately et al., 1998; Trinchieri, 1998).
In DCs, maturation signals induce IL-12 p40 production, and CD40 triggering results
in IL-12 p35 induction (Schulz et al., 2000). Expression of IL-12p40 in migrating
ovine DCs provides further evidence SIRPa+ DC are mature. Production of high
levels of IL-12 p70 and the generation of Thl cells requires cognate CD40
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interactions (Cella et al., 1996; Koch et al., 1996), which occur transiently during the
activation of antigen-specific T cells (Macatonia et al., 1995; Koch et al., 1996).
Production of IL-18 is regulated by endogenous pathways, requiring the
cleavage of biologically inactive proIL-18 by caspase-1 (ICE) (Ghayur et al., 1997;
Gu et al., 1997). Expression of IL-12p40 and IL-18 by SIRPa+ DCs indicates the
cells are primed for production of these cytokines, and implies they may mediate
Thl-biased responses. Low-level IL-12 and IL-18 production may also promote the
activation of T cells clustered with DC in afferent lymph. In general, the production
of IL-12 by DCs produces a Thl-type response (production of IFNy) (Macatonia et
al., 1995; Hilkens et al., 1997), and IL-18 enhances Thl cell development (Ushio et
al., 1996).
The absence of IL-12, and the presence of IL-6, IL-10 and IL-4 contribute to
a Th2-type response (production of IL-4 and IL-5) (Paul and Seder, 1994; Rincon et
al., 1997), and the suppression of IL-12 production (Trinchieri, 1998). IL-10 and
IL-6 were not detected in either DC population, indicating there were no effects on
IL-12 at the basal level of expression in SIRPa" DCs. In addition, lack of cytokine
detection in SIRPa" DCs infers that this population were not biased to promote the
development of a particular type of T helper cell.
5.3.6 Ovine Lymph SIRPa DC Populations Have Similarities With Murine
DC Populations
5.3.6.1 SIRPa+ DCs
Cells in the epidermis and dermis express SIRPa (Adams et al., 1998),
indicating that SIRPa+ lymph DCs are derived from these locations. Phenotypically,
ovine SIRPa+ DCs resembled interstitial DCs (IDCs) of lymph node T cell areas.
IDCs express high levels of MHC II, CD40, and CD80, and low levels of FcRs, and
derive from epidermal LCs (Anjuere et al., 1999; Salomon et al., 1998; Henri et al.,
2001). IDC represent 65% of lymph node DCs (Salomon et al., 1998), which is
comparable to the proportion of SIRPa+ DCs in ovine afferent lymph (71.2% ±
2.5%). Moreover, LCs express IL-12 and IL-18 constitutively (Kang et al., 1996;
Wang et al., 2002). Therefore, surface phenotype and constitutive cytokine
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expression by SIRPa+ DCs suggest that this population derives, at least in part, from
epidermal LCs. Following cognate interactions with antigen-specific T cells, LCs
induce strong Thl-biased development (Everson et al., 1996; Kang et al., 1996; Stoll
et al., 1998). That SIRPa+ DCs may be the migratory stage of LCs, be equivalent to
IDC of murine LNs, and express IL-12 and IL-18 transcripts, strongly suggests that
this population would have potent T-stimulatory capacity in vivo, and may be
important for cell mediated immunity against intracellular pathogens. Further
evidence to support this hypothesis is required; such as in vivo activation with
maturation stimuli - such as microbial adjuvants or cytokines, and the cytokine
responses of SIRPa+ DCs determined. If indeed this population produces high levels
of IL-12, and induces high levels of IFNy production by T cells in vitro, strategies for
targeting this population in vaccination regimens could be developed.
5.3.6.2 SIRPa" DCs
A major fraction of SIRPa" DCs expressed CD45RA (61.6% ± 2.8%).
Human pDC are the only DC population reported to express CD45RA (Liu et al.,
2001). Further phenotypic similarities can be made with fractions of ovine SIRPa"
DCs and murine lymphoid B220+ pDCs (Asselin Paturel et al., 2001) (which may
more closely represent lymph DCs). These include, low levels of CD40 and CD80
expression; low and heterogeneous MHC II and CD lie expression, lack of CD86,
CD 14 and other myeloid markers. This study did not determine the phenotype of
sub-populations within SIRPa" DCs. In addition, there is no functional data at this
time to determine the biological functions of ovine SIRPa DCs in vivo. Therefore,
links between ovine DCs and murine DCs are tentative, but still, intriguing. Murine
pDCs characteristically produce high amounts of type I interferons (Asselin Paturel
et al., 2001), and have tolerogeneic effects on T cells in vitro (Martin et al., 2002;
Bilsborough et al., 2003), leading the authors to conclude they may function to
support peripheral tolerance in vivo. Interestingly, SIRPa" DCs in rat lymph have
also been hypothesised to process and present endogenous antigen, and function to
support peripheral tolerance (Huang et al., 2000). Rat lymph DCs (Liu et al., 1998)
share similarities with ovine lymph DC populations. Both SIRPa+ and SIRPa"
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subpopulations express CD 11c, MHC II and CD80, and the DC populations are
morphologically equivalent, in that SIRPa+ DCs are more 'spikey' in appearance
than SIRPa" DC that appear 'frilly'. However, like with bovine DCs populations,
more evidence is required to determine whether ovine and rat DCs are equivalent.
Evidence in cattle however, suggests SIRPa" DCs are not plasmacytoid in
nature. Following activation with virus or dsRNA in vitro, bovine SIRPa" DCs did
not produce type I interferons after activation with virus, as determined by a gene
reporter assay (Stephens et al., 2003). However, the SIRPa" DC populations in
sheep and cattle appear different (Section 5.3.2), and SIRPa" cattle DC were reported
to have a mature phenotype (Howard et al., 1997). Whether the ovine SIRPa" DCs
that co-express CD40, CD80 and CD86 are a separate cell fraction that are
phenotypically more equivalent to cattle SIRPa" DCs remains to be elucidated.
Moreover, SIRPa+and SIRPa" cattle DCs both express IL-12 and IL-18 (Stephens et
al., 2003), whereas these cytokines were only detectable in sheep SIRPa DC and
not SIRPa" DCs. These may reflect actual differences between these two closely
related species, or differences in lymphatic cannulations, collection of cells, and
methods of analysis. In the study of Stephens et al. (2003) DCs were collected in the
acute stages following surgery, when injury induced danger signals, such as HSPs
could activate the DC (Basu et al., 2000), and skew resting cytokine responses. In
addition, the bovine DCs were analysed following cryopreservation that could affect
both cytokine and surface marker profiles. The ovine DCs described in this project
were analysed immediately following 24 hour collections from chronically
cannulated sheep. This was limiting for the availability of sample (for example
mRNA), however it was highly desirable for the analysis of constitutive biological
characteristics of lymph DCs migrating to the lymph nodes under steady-state
conditions. Therefore, because of differences in experimental procedures, cattle and
sheep lymph DC populations cannot be directly compared. Further experiments are
required to determine if ovine SIRPa" DCs have pDC characteristics, such as high
levels of IFNa production following stimulation with virus. Plasmacytoid DCs are
suppressive in nature, and have been identified as ideal candidates for DC based
therapies against autoimmune diseases (Kuwana, 2002), such as multiple sclerosis
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and type I diabetes. Therefore investigations into these cells have great therapeutic
impacts on human health and disease, and the requirement of knowledge of the
physiological characteristics of these cells support the use of ex vivo systems such as
ovine lymphatic cannulation.
5.3.7 Signal Regulatory Protein-a (SIRPa)
The presence of an ITIM in the SIRPa cytoplasmic tail (Brooke, Parsons and
Howard, 1998) suggests it plays a role in modulating signalling pathways in lymph
DCs. Human SIRPa functions in both a positive and negative manner
(Kharitonenkov et al., 1997), thus, SIRPa presence on sheep DCs may regulate their
function. SIRPa is particularly effective at regulating IL-12p70 release following
the activation of human monocyte-derived DCs with Staphylococcus cowan extract
(SAC) or LPS (Latour et al., 2001). SIRPa and CD47 interactions have been
proposed to act as a negative feedback mechanism during T cell activation
(Waclavicek et al., 1997), which may be due to control of IL-12 release.
Interestingly, SIRPa is expressed on the ovine DC population that is 'primed' for IL-
12 release (see below).
The role of SIRPa on un-stimulated DCs is less clear. SIRPa may play a
role in the activation of T cells. Interactions with its ligand CD47 have been shown
to enhance T cell proliferation in a CD3-dependant manner (Ticchioni et al., 1997;
Reinhold et al., 1997; Waclavicek et al., 1997), enhancing low level thresholds of
anti-CD3 stimulation (Reinhold et al., 1997). Acting in concert with CD28 co-
stimulation (Waclavicek et al., 1997), CD47 positively regulates IL-2 production,
thus supporting T cell proliferation (Ticchioni et al., 1997; Reinhold et al., 1997).
Together this evidence suggests that in healthy states SIRPa does not seem
to play a role in the modulation of DC functions, and may enhance T cell stimulatory
functions in presence of low antigen doses. However, in response to microbial
challenge DC are primed for high level production of IL-12 p70, and SIRPa ligation
can provide a negative feedback mechanism for prolonged IL-12 p70 production
during DC:T cell interactions. In that the SIRPa + DCs expressed IL-12 p40 and IL-
18, and are possibly 'primed' for activating cellular immune responses, the presence
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of an inhibitory receptor, that modulates IL-12 expression could have an important
role. The synergistic affect of IL-12 and IL-18 are in part mediated by IL-12
induction of IL-18 receptor (IL-18R) expression on T cells (Ahn et al., 1997). IL-12
and IL-18 have sequential affects of CD4+ T cells; IL-12 is necessary for and
precedes IL-18 action (Okamura et al., 1998). It seems that control of IL-12
production is necessary to prevent uncontrolled cell mediated responses and
pathology, and SIRPa may provide an important mechanism for this in vivo.
5.3.8 Summary
Sheep afferent lymph contains SIRPa+ and SIRPa" DCs. Both DC
populations expressed MHC II, CD40, CD80, CD86, CD58 and CDlla that are
typically expressed by DC in secondary lymphoid tissues. SIRPa+ and SIRPa" DC
differed
, in phenotype, the expression of individual markers and basal cytokine
expression. SIRPa+ DCs appeared more homogenous than did SIRPa" DCs.
Moreover, SIRPa+ DCs phenotypically represented a more mature DC than SIRPa"
DCs. A major finding was that freshly isolated SIRPa+ DCs expressed mRNA
transcripts for IL-12 p40 and IL-18, whereas these cytokines were undetectable in
SIRPa" DCs by PCR. Neither DC population appeared to express IL-6 or IL-10.
These data suggest that ovine SIRPa+ DCs may be prone to inducing protent T cell
reponses with a Thl phenotype. SIRPa" DCs, on the other hand, may be suppressive
for T cell activation. This latter hypothesis is supported by the demonstration of
apoptotic epithelia engulfments in SIRPa" DCs in rat mesenteric lymph.
Further studies are needed to elucidate the biological roles of lymph DCs that
selectivley express SIRPa. The current study indicates that DC populations
defending epithelial tissues may have different biological roles in vivo.
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Chapter 6: Final Discussion
It can be concluded that; 1) Two populations of DCs exist in sheep afferent
lymph based on the presence or absence of SIRPa. 2) These DC populations differ
in the expression of receptors involved in T cell stimulation and antigen detection
and uptake. This may relate to cells being at different stages of maturation, or cells
with distinct functions in vivo. 3) The SIRPcC and SIRPa" sheep lymph DCs
displayed differential constitutive cytokine expression; the SIRPa+ population
expressed transcripts for IL-12 p40 and IL-18, whereas these were not detected in the
SIRPa" DCs. These findings support the hypothesis that different DC populations
preferentially bias T cell responses in vivo (Maldonado-Lopez et al., 1999; Hochrein
et al., 2001).
SIRPa+ DCs were essentially CD58+, CDlla+, WC6+, CD45RA", expressed
CD 16, CD 14, CD206, CD4 and CD8 at low levels or on minor sub-populations, and
as a single population expressed higher levels of CD 11c, CD40, CD80, CD86 and
MHC II than did SIRPa" DCs. SIRPa" DCs were CD 16", CD 14", CD206", CD4",
CD8", CDlla+ and displayed heterogeneity of expression of CD58, CD 11c, WC6
and CD45RA. The expression of MHC II, co-stimulatory molecules (CD40, CD80
and CD86) and adhesion molecules (CD58, CDlla) by SIRPa+ DCs and significant
proportions of SIRPa" DCs suggests that both populations possessed the capacity to
interact with lymphocytes and participate in antigen presentation. These molecules
may contribute to constitutive clustering of lymphocytes in situ. Additionally, the §2
integrins CD1 la and CD1 lc, which are essential for leucocyte recruitment to tissues
(Shuster et al., 1992) and homing to peripheral lymph nodes (Berlin-Rufenach et al.,
1999), were expressed by both lymph DC populations and may be important for
trafficking to the draining lymph nodes.
Expression of IL-12 p40 and IL-18 transcripts by SIRPa+ DCs and not
SIRPa" DCs may be related to phenotype characteristics. Expression of CD206,
CD 16 and CD 14 by SIRPa+ DCs may be an important factor. CD206 and CD 16
have been demonstrated to act as signalling receptors triggering DC maturation and
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IL-12 production (delaSalle et al., 1997; Shibata, Metzger and Myrvik, 1997). These
receptors may interact with products of commensal bacteria of the skin, or circulating
immune complexes. LPS, which uses CD 14 as a binding receptor, enhances IL-18
expression in macrophages (Sections 3.2.6.1 and 4.4.7.1) and IL-12 p70 production
in murine DCs (Reis e Sousa et al., 1997; Morelli et al., 2001). A component of
gram negative bacterial cell walls, LPS is a potent stimulator of innate and
inflammatory responses and instigates rapid innate immune responses (Ulevitch and
Tobias, 1999). It is therefore unlikely that this pathogen-associated glycolipid plays
a role in the constitutive expression of IL-12 p40 in this model where DCs were
isolated from healthy sheep. This is not with counting however, that CD 14, which
signals through TLR4 and TLR2 may be involved in some other capacity. Data
indicates that CD 14 can also interact with numerous other peptides and lipids and is
suggested to play a role in inflammatory responses to non-infectious injury (Pfeiffer
et al., 2001). Thus, due to basal immunologic stimuli, or past infections, the
expression of antigen receptors by the IL-12 p40, IL-18 expressing DC population
(SIRPa+), implies a role in this function.
DCs provide important therapeutic targets (Vecchione et al., 2002).
Understanding how the DC populations respond to in vivo activation signals, the
capacity of DCs to present antigen to T cells, and the type of responses they induce is
crucial for targeted manipulation in vivo, and the manipulation of DCs in vitro for in
vivo adminsitration. Because of the high level of understanding of murine DC
biology, it was useful to correlate ovine lymph DCs with murine DC populations.
The phenotype and constitutive expression of IL-12 p40 and IL-18 suggests that
SIRPa+ DCs may be related to the T-stimulatory CDllc+ population described in
murine secondary lymphoid organs (that inpart comprises the mature form of
Langerhans' cells in the lymph nodes). CD45RA expression, a lack of 'myeloid'
markers and no detectable IL-12 p40 or IL-18 transcripts suggests that sheep SIRPa"
DC may be comparable with murine CD8a+ / B220+ pDCs. A number of in vitro
investigations are imperative to test these hypotheses, such as the capacity for type I
interferon production during exposure to virus, and the T cell-cytokine profiles
induced in primed T cells following antigen-speicifc interactions with SIRPa+ and
SIRPa" DCs.
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Different murine DC populations respond to pathogens and endogenous
mediators differentially (Maldonado-Lopez et al., 1999). The lymphatic cannulation
model could be utilised to investigate how lymph DCs respond to the activation of
PAMP or endocytic receptors at the molecular level. SIRPcC DCs expressed CD 16
(FcR) and CD206 (mannose receptor), and these receptors could be ligated and
activated with anti-CD16 and anti-CD206 -coated polystyrene beads. Levels of
cytokine mRNA could be analysed using the RPA (following collection of lymph
DCs and cryopreservation; or pooling DC RNA over time). Furthermore, in the
interests of DC biology, it would be interesting to investigate the role of SIRPa and
CD45RA on the DC populations. That the lymph DC populations differentially
express these molecules may indicate a role in regulating DC responses and cytokine
production. Cytokine responses could be analysed using the RPA (following the
considerations mentioned above) following activation of DCs by antigen or
microbial products, and the subsequent ligation and cross-linking of SIRPa and
CD45RA. In addition, the uptake of apoptotic cells has major implications for
antigen-specific tolerance. Differential expression of CD1 lc on the DC populations
indicates a difference for a capacity for apoptotic cell uptake, and cross-presentation
of endogenous antigen to CD8 T cells. Whether ovine lymph DCs are capable of
inducing antigen specific tolerance is not known, and could be investigated by a
series of in vitro experiments using primed T cells as targets (Martin et al., 2002).
The development of a RNase protection assay for nine sheep cytokines,
including IL-18 provided a valuble technique for assessing cytokine mRNA levels
concordantly. This system has been utilised for analysing the responses of antigen-
specific lymphocyte populations in vivo (Gossner et al., 2002), and provides a
valuable tool for quantifying levels of cytokine expression in sheep. Ability to
measure IL-18 expression has important implications for innate immune responses,
and enhancing IL-18 during vaccination trials enhances DC immunogenicity
(Tastsumi et al., 2002; Goto et al., 2002). The capacity to measure IL-18 levels in
ruminants could promote work to enhance immunogenicy to antigens, and be
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Appendix 1 General Solutions
Appendix 1: General Solutions
Unless otherwise stated, all chemicals were obtained from Sigma or Merck. All
solutions were prepared in sterile distilled H2O.

































10 mM Tris-HCl (pH8.0)
1 mM EDTA
LB Agar















Appendix 2 Commercial suppliers
Appendix 2: Commercial Suppliers
Agilent Technologies (UK) Ltd., Lakeside, Cheadle Royal Business Park,
Stockport, Cheshire, SK8 3GR.
www.agilent.com
Amersham Pharmacia Biotech (UK) Ltd., Amersham Place, Little Chalfont,
Buckinghamshire HP7 9NA
www.apbiotech.com
Axis-Shield PoC AS, P.O. Box 6863 Rodelokka, Oslo, Norway N-0504
www.axis-shield-poc.com
Beckman Coulter (UK) Ltd., Oakley Court, Kingsmead Business Park, London
Road, High Wycome, Buckinghamshire, HP11 1JU
www.beckman.com
Becton Dickinson (UK) Ltd., Between Towns Road, Cowley, Oxford, Oxfordshire,
OX43LY
www.bd.com
Bio-Rad Laboratories Ltd., Bio-Rad House, Maylands Avenue, Hemel Hempstead,
Hertfordshire HP2 7TD
www.bio-rad.com
Biowhittaker (UK) Ltd., 1 Ashville Way, Wokingham, Berkshire, RG41 2PL
European collection of cell cultures (ECACC), CAMR, Porton Down, Salisbury,
Wiltshire, SP4 OJG
www.ecacc.org.uk
Fisher Scientific (UK) Ltd., Bishop Meadow Road, Loughborough, Leicesterhire,
LE115RG
www.fisher.co.uk
GraphPad Software, San Diego, California, USA
www,graphpad.com
Invitrogen Life Technologies, Invitrogen Ltd, 3 Fountain Drive, Inchinnan Business
Park, Paisley, PA4 9RF
www.flowgen.co.uk
Merck Ltd., Hunter Boulevard, Magna Park, Lutterworth, Leics, LEI7 4XN
www.merckeurolab.ltd.uk
Appendix 2 Commercial suppliers
Millipore (U.K.) Limited, Units 3&5 The Courtyards, Hatters Lance, Watford
WD 18 8YH
www.millipore.com
Miltenyl Biotec Ltd. Almac House, Church Lance, Bisley, Surrey, GU24 9DR
www.miltenylbiotech.com
MWG Biotech AG, Mill Court, Featherstone Road, Wolverton Mill South, Milton
Keynes, NK12 5RD
www.mwg-biotech.com
Nalgene Nunc International, 75 Panorama Creek Drive, P.O. Box 20365,
Rochester, NY 14602-0365
www,nalgenenunc .com
National Diagnostics, Unit 4, Fleet Business Park, Itlings Lane, Hessle, Hull HU13
9LX
www.nationaldiagnostics.com
New Englands Biolabs (UK) Ltd., 73 Knowl Piece, Wilbury Way, Hitchin,
Hertfordshire, SG4 OTY
www.neb.com
Philips electronics UK. Ltd., The Philips Centre, 420-430 London Road, Croydon,
Surrey, CR9 3QR.
www.philips.com
Promega UK Ltd., Delta House, Chilworth Research Centre, Southampton, SO 16
7NS
www.promega.com
Roche Diagnostics Ltd. Bell Lane, Lewes, East Sussex, BN7 1LG
http://biochem. roche.com
QIAGEN Ltd., Boundary Court, Gatwick Road, Crawley, West Sussex, RH10 2AX
www.qiagen.com
Sigma-Aldrich Company Ltd., The Old Brickyard, New Road, Gillingham, Dorset,
SP8 4XT
www,sigma-aldrich.com
ThermoHybaid, Action Court, Ashford Road, Ashford, Middlesex, TW15 1XB
www.thermohvbaid.com
Appendix 3 mAb
Table 1 Specificity and source of monoclonal antibodies (mAb). The panel of mAb
using in flow cytometry and MACS experiments is shown. mAb isotype, antigen
specificity and original references are listed. The mAb preparation is indicated in green;
saturated hybridoma supernatant, S/S; ascitic fluid, A/F, and the dilution used for staining
of cells for flow cytometry and / or MACS is shown in blue; 1:1 indicates that the mAb
preparations were used un-diluted. Some mAb recognise antigen that have no established
CD homologue but have been given workshop cluster (WC) numbers at the International
Ruminant Leukocyte Antigen Workshops (1991, 1993) (Parsons et al., 1993,; Howard et
al., 1991). SIRPa is the ruminant homologue of human signal inhibitory receptor protein
(Brooke et al.,1998). m, murine; r, rat.
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APPENDIX 3: MONOCLONAL ANTIBODIES
mAb Code Isotype" Antigen Reference
VPM5
A/F 1:100
mlgM ovCDlb Budjoso et al. (1989)
36F
A/F 1:150
mIgG2a ovCD2 Mackay et al. (1988)
ST4
S/S 1:1
mIgG2a ovCD4 Maddox et al. (1985)
SBU-T8
S/S 1:1
mIgG2a ovCD8 Maddox et al. (1985)
F10-150
S/S 1:1
mlgGi ovCDlla Gupta et al. (1993)
ILA-15
S/S 1:1
mlgGj ovCDllb Gupta et al. (1993)
OM1
S/S 1:1
mlgGi ovCDllc Gupta et al. (1993)
VPM67
A/F 1:1000
mlgGi ovCD14 Hopkins and Gupta (1996)
VPM64
S/S 1:1
mlgGi ovCD23 Hopkins and Gupta (1996)
VPM63
S/S 1:1
mlgGi ovCD32 Hopkins and Gupta (1996)
ILA-156
A/F 1:50




mlgGi ovCD45RA Dutia et al. (1993)
T11TS
S/S 1:1
mlgGj ovCD58 Hunig et al. (1985)
ILA-159
A/F 1:1000








mlgGi bovCD206 Howard et al. (1997)
SW73.2
A/F 1:2000
rIgG2a ovMHC II 0 chain Hopkins et al. (1986)
VPM54
S/S 1:1
mlgGi ovMHC II Dutia et al. (1995)
IAH-CC15
A/F 1:200
mIgG2a ovWCl Clevers et al. (1990)
ILA-53
A/F 1:100
mIgG2a ovWC6 Dutia et al. (1993)
ILA-24
S/S 1:1




mlgM ovPan B cell Bird et al. (1995)
Appendix 4 Primer Sequences




















































































GCGCTGGTCTGCTTACTGGTATG Ovine IL-4 cDNA 86
- 108 nt.















































22 — 42 nt.
AJ401033R
Antisense
CCTGGCTAATGAAGAGAACTTG Ovine IL-18 cDNA
342 - 362 nt.
X54796F
Sense












GT CAAGGAGCCC GTG Ovine GM-CSF
cDNA 283 - 297 nt.
X52640F
Sense
CTCTCTCCTAAACGATGAAATACAC Ovine IFNy cDNA
42 - 66 nt.
X52640R
Antisense
AAGTAGAAGGAGACAATTTGGCT Ovine IFNy cDNA
263 - 285 nt.
X76916F
Sense




















ACCCAGGAGCAACCAGAAGAG Ovine TNFa cDNA
260-280 nt.








































































Appendix 6 Riboprobe Temple Sequences
APPENDIX 6: RIBOPROBE TEMPLATE SEQUENCES
Sequences of the cDNA clone templates for riboprobe synthesis in the sheep cytokine
RNase protection assay are presented below. Regions of the vector pGEM®-T-easy are
















































































Appendix 7(a). Ratio of cytokine mRNA levels in adherent
bronchoalveolar cells (non-purified); LPS stimulated versus
medium controls.
The RPA was used to evaluate cytokine mRNA abundance in sheep adherent
bronchoalveolar cells cultured with or without 1 ng/ml LPS. The levels of
individual transcripts were normalised relative to GAPDH expression, and
expressed as an arbitrary unit. The ratio of expression of each cytokine in
LPS stimulated cultures is plotted relative to medium controls on a log,0 scale,
individual samples are plotted as a single point. Where no transcripts were
detected in either the control or LPS stimulated cells, a value of zero is given,
therefore comparisons of the log10 value of these data cannot be made, and are
not included in these graphs. Fold differences of cytokine expression between
experimental groups are indicated on the graphs. These experiments involved
cells isolated from three sheep. The figures are as follows:
la IL-12 p40: 1, 4, 6 hours
lb IL-12 p40: 16, 20 hours
2 1L-10: 4, 6, 16 hours
3 IL-6: 4, 6, 16 hours
4a GM-CSF: 1,4 hours
4b GM-CSF: 6, 16 hours
5a IL-8: 1, 4, 6 hours
5b IL-8: 16, 20 hours
6a IL-lp: 1, 4, 6 hours
6b IL-ip: 16, 20 hours
7 TNFa: 1 hour
8a TGFp: 1,4 hours
8b TGFP: 6, 16 hours
9a IL-4: 1,4, 6 hours
9b IL-4: 16, 20 hours
10a IFNy: 1,4, 6 hours
lOblFNy: 16, 20 hours
Fold difference
IL-12p40 mRNA levels: 1 hour^
Log10 (normalised value) medium
IL-12p40 mRNA levels: 6 hours
Logi0 (normalised value) medium
Figure la. Expression of IL-12 p40.
 
IL-10 mRNA levels: 4 hours Fold difference
Log10 (normaSsed value) medium
Figure 2. Expression of IL-10.
IL-6 mRNA levels: 4 hours
Fold difference
Log10 (normafised value) mecfiuvn
IL-6 mRNA levels: 6 hours
5
1
4 3 2 1
0.1 1








IL-6 mRNA levels: 16 hours
1 10
Log10 (normalised value) mecfium
Figure 3. Expression of IL-6.
Fold difference
GM-CSF mRNA levels: ihour <c
Log10 (normalised value) medium
GM-CSF mRNA levels: 4 hours
Log10 (normaised value) medium
Figure 4a. Expression of GM-CSF.
GM-CSF mRNA levels: 6 hours Fold difference
<-
Log10 (normalised value) medium
0.1 1 10
Log10 (normatsed value) medium
GM-CSF mRNA levels: 16 hours
12









Log10 (normafised value) medium
IL-8 mRNA levels: 4 hours
10 100









IL-8 mRNA levels: 6 hours
Figure 5a. Expression of IL-8.
IL-8 mRNA levels: 20 hours
Log10 (normalised value) medium
Figure 5b. Expression of IL-8.




IL-10 mRNA levels: 1hour
IL-10 mRNA levels: 4 hours
5 4 3 2 1
Log10 (normalised value) medium
1 10 100
Log10 (normalised value) medium
IL-10 mRNA levels: 6 hours
Figure 6a Expression of IL-10.
Fold difference
IL-1P mRNA levels: 16 hours
0.1 1 10
Log10 (normalised value) medium









Figure 6b Expression of IL-1 p.





Log10 (normalised value) medium
Figure 7. Expression of TNFa.
TGF0 mRNA levels: 1 hour Fold difference
<
Log10 (normalised value) medium
Figure 8a. Expression of TGF0.
Fold difference
TGF0 mRNA levels: 6 hours ^
Log10 (normalised value) medium
TGF0 mRNA levels: 16 hours
Log10 (normalised value) medium
Figure 8b. Expression of TGFp.
Fold difference
IL-4 mRNA levels: 1 hour
_ 100t
10 100
Log10 (normalsed value) imdium
IL-4 mRNA levels: 4 hours
1 10
Log10 (normalised value) medium
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Figure 9b* Expression ofIlr4.
IFNy mRNA levels: 1 hour
Fold difference
10 100
Log10 (normalised value) medium
IFNy mRNA levels: 4 hours










IFNy mRNA levels: 6 hours
Log10 (normalised value) medium
Figure 10a. Expression of IFNy.
IFIMy mRNA levels: 20 hours
Log10 (normalsed value) medium
Figure 10b. Expression ofEFNy.
Appendix 7b. Ratio of cytokine mRNA levels in alveolar
macrophages enriched by adherence; LPS stimulated versus
medium controls.
The RPA was used to evaluate cytokine mRNA abundance in sheep adherent
alveolar macrophages cultured with or without 1 pg/ml LPS. The levels of
individual transcripts were normalised relative to GAPDH expression, and
expressed as an arbitrary unit. The ratio of expression of each cytokine in
LPS stimulated cultures is plotted relative to medium controls on a log10 scale,
individual samples are plotted as a single point. Where no transcripts were
detected in either the control or LPS stimulated cells, a value of zero is given,
therefore comparisons of the log10 value of these data cannot be made, and are
not included in these graphs. Fold differences of cytokine expression between
experimental groups are indicated on the graphs. These experiments involved
cells isolated from three sheep. The figures are as follows:
1 IL-12 p40: 1,4, 12 hours
2 IL-10: 1,4, 12 hours
3 IL-6: 1,4, 12 hours
4 GM-CSF: 1,4,12 hours
5 IL-8: 1,4, 12 hours
6 IL-ip: 1, 4, 12 hours
7 TNFa: 1,4, 12 hours
8 TGFP: 1,4 hours
IL-ip mRNA levels: 1 hour Fold difference
<-
11 10 8 6 4 2 1
1 10
Log10 (normaSsed value) medium
IL-ip mRNA levels: 4hours
11 10 8 6 4
0.1 1 10









Log10 (normalised value) medium




iL-6 mRNA levels: 1 hour
1 10
Log10 (normalised value) mecSum
IL-6 mRNA levels: 4 hours
4 3 2 1
1 10
Log™ (normafised value) mecfium
IL-6 mRNA levels: 12 hours









Log10 (normalised value) medium
Fold difference
IL-12 p40 mRNA levels: 1 hour <-
Log,0 (normalised value) medium
IL-12 p40 mRNA levels: 12 hours
Log10 (normalised value) medium
Figure 4 Expression of IL-12 p40.
~ec mDUA Fold difference-CSF mRNA levels: 1 hourGM-
0.1 1
Log,o (normalised value) medium
GM-CSF mRNA levels: 12 hours
Log 10 (normafised value) medium
Figure 5 Expression of GM-CSF.
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Figure 6 Expression of IL-10.
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TGFp mRNA levels: 12 hours
Log10 (normaRsed value) medium
Figure 7 Expression of TGF|3.
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Abstract
Large-scale lymphocyte recirculation occurs only at the level of secondary lymphoid tissue. Cells enter lymph nodes via
afferent lymph from the tissue and via arterioles from the blood. They exit only via the efferent duct. Afferent and efferent
lymphocytes have distinct phenotypes; afferent lymphocytes have a 'memory' phenotype, being CD62L/CD45RA- and
expressing high levels of CD2 and CD1 la; efferent cells are largely 'naive', being CD62L+/CD45RA+ with low levels of CD2
and CDlla. We will show that functionally the efferent lymphocytes, like cells from the blood and spleen, can be activated in
vitro only by dendritic cells. However, afferent lymphocytes are less stringent in their activation requirements and can be
stimulated by both macrophages and dendritic cells. To explain these functional differences we have developed a multiprobe
RNAase protection assay for 13 sheep cytokines (IL-ip, IL-2, IL-3, IL-4, IL-6, IL-8, IL-10, IL-12, IL-18, GMCSF, IFNy, TGFp
and TNFa) and two housekeeping genes (ATPase and GADPH). We have used this assay to measure the constitutive expression
of cytokine mRNA in MACS-purified CD4+ and CD8+ T lymphocytes from both lymphoid compartments. © 2002 Elsevier
Science B.V. All rights reserved.
Keywords: Cytokines; T lymphocytes; Memory figure
1. Introduction
The physiological processes of the immune system,
especially adaptive immune responses, are dynamic
processes dependent upon the co-ordinated interaction
of antigen-trapping accessory cells and lymphocytes
in specialised peripheral lymphoid organs such as
lymph nodes. The patterns of lymphocyte recircula¬
tion through different immunological compartments
have been well defined in the sheep. Blast cells from
peripheral nodes home to the spleen and lymph nodes,
and within this small recirculating lymphocyte pool
Corresponding author. Tel.: +44-131-650-6169;
fax: +44-131-650-6511.
E-mail address: john.hopkins@ed.ac.uk (J. Hopkins).
there are subsets which preferentially recirculate thor¬
ough the skin, peripheral nodes or mucosal associated
lymphoid tissue (Mackay et al., 1988; Abernethy et al.,
1991). The afferent lymph selectively conveys T
lymphocytes, a small proportion of B lymphocytes,
afferent lymph dendritic cells (ALDCs) and macro¬
phages (Hall and Morris, 1965; Smith et ah, 1970).
The ALDCs are professional APCs involved in the
carriage of antigen in an immunogenic form from the
skin to the draining lymph node.
Efferent lymph contains only lymphocytes that enter
the lymph node, either from the blood or the afferent
lymphatics of the node and leave via the efferent,
lymphatics within the lymph plasma, ultimately back
into the blood (Hall and Morris, 1962; Smith et al.,
1970). The lymph node is a central focus of the immune
0165-2427/02/$ - see front matter © 2002 Elsevier Science B.V. All rights reserved.
PII: SO 165-2427(02)00050-8
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system and the use of cannulation of the afferent
and efferent lymphatics provides a unique approach
to the in vivo analysis of immune cell populations within
the different immunological microenvironments of
single lymph nodes in the sheep. There are considerable
phenotypic and functional differences between the
cells in blood and afferent lymph suggesting that there
is selectivity in the extravasation of cells from the blood
across the endothelium into the peripheral tissues.
Emigration of afferent and efferent T lymphocytes,
with their distinct phenotypes and function, can be
demonstrated by the circulation of naive and memory



















































Fig. 1. Proliferation of CD4+ lymphocytes from both afferent and efferent lymph in vitro. In vitro proliferation assays of CD4+ T cells from
afferent (A and B) or efferent (C and D) lymph stimulated with 25 pg/ml ovalbumin (A and C) or allogeneic APC (B and D). 5 x 104
lymphocytes were cultured with irradiated afferent DC (DC) or mammary macrophages (Mcj)) for 5 days and then labelled with 3H-thymidine
for 5 h.
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The blood contains T lymphocytes of both naive
and memory phenotypes though afferent lymph T
lymphocytes are mainly of the memory cell phenotype
and efferent T lymphocytes draining the lymph node
are mainly of a naive phenotype. Mature lymphocytes,
both CD4+ and CD8+, recirculate between the blood
and the tissues via the lymph nodes. Immunological
memory is disseminated from the node via the efferent
lymph, where exit of T lymphocytes following antigen
stimulation is non-random despite the fact that cells
from the efferent lymph have a 'naive' phenotype.
A total of 90% of the lymphocytes within a lymph
node are derived from the blood, the remainder are
from lymphocyte proliferation within the node and
afferent lymph (Hall and Morris, 1965). CD4+ cells
are selectively enriched over CD8+ T lymphocytes in
lymph nodes.
To investigate the relationships between functional
activities of lymphocytes and their migratory proper¬
ties, we have developed a multiprobe RNAase protec¬
tion assay (RPA) for 13 sheep cytokines (IL-1(3, IL-2,
IL-3, IL-4, IL-6, IL-8, IL-10, IL-12, IL-18, GMCSF,
IFNy, TGFP and TNFa), as well as two housekeeping
genes (ATPase and GADPH). Cannulation of the
prefemoral "pseudo-afferent" and efferent lymphatics
of sheep allows the isolation of 'resting' trafficking
lymphoid cells to be analysed for their constitutive
cytokine mRNA expression.
2. Naive, memory and effector lymphocytes
DQ and CD25") are CD45RA+ and express low
levels of adhesion molecules (Mackay et al., 1990,
1992; Abitorabi et al., 1996). These T lymphocytes are
highly responsive to both soluble antigen and alloanti-
gen when presented by ALDCs. They respond very
weakly to soluble antigen presented by macrophages
and are non-responsive to allogenic macrophages in a
mixed leukocyte reaction (Fig. ID).
Using MACS-purified CD4+ and CD8-I- T lym¬
phocytes from afferent and efferent lymph, the con¬
stitutive expression of cytokine mRNA in both cell
populations using a multiprobe RPA was analysed.
Preliminary results identified T lymphocytes from
"resting" afferent lymph that expressed mRNA for
the cytokines IL-1P, IL-3, IL-8, IFNy, TNFa and TGFP
using this assay system (Fig. 2). With T lymphocytes
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Afferent lymph contains ALDCs, T lymphocytes
and B lymphocytes, all migrating from the tissues to
the local lymph node. The afferent T lymphocytes
express an activated phenotype (CD2m CD58m
CD44hi CD 11 aHI, high level expression of MHC II
DQ+ and CD25) and high levels of adhesion mole¬
cules but are CD45RA- compared to efferent lymph
cells (Mackay et al., 1990, 1992; Abitorabi et al.,
1996). In terms of function they respond to soluble
antigen (Fig. 1A) and alloantigen presented by both
ALDCs and macrophages (Fig. IB).
Efferent lymph contains >99% lymphocytes with a
high proportion of CD4+ T lymphocytes and B
lymphocytes compared to CD8+ and y5 T lympho¬
cytes. T lymphocytes isolated from efferent lymph
(CD2lo CD58lo CD44lo CDllaLO, class II MHC
Fig. 2. Measurement of cytokine mRNA levels using an RNAase
protection assay. The RNAase protection assay is a sensitive and
specific method for the quantitation of mRNA species. The probe
templates were generated by RNA polymerase directed synthesis of
32P-labelled anti-sense RNA from a cDNA template. The purified-
labelled probes were hybridised with the target RNA isolated from
both afferent (lanes 9-15) and efferent (lanes 3-8) lymph cells.
After hybridisation was completed, ribonucleases specific for
ssRNA digested unhybridised RNA and probe. The "RNAase-
protected" probes and undigested probe markers (lanes 1 and 2)
were resolved on a denaturing PAGE and were visualised by
phosphor imaging. Probe set 1 was used with the samples in lanes
3-5 and 9-12. Probe set 2 was used with the samples in lanes 6-8
and 13-15.
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from "resting" efferent lymph expressed mRNA for
the cytokines IL-2, IL-3, IFNy, and TNFot were
detected (Fig. 2).
3. Discussion
'Resting' efferent lymph T lymphocytes with their
naive phenotype require activation by ALDCs to
respond to soluble antigen, yet 'resting' afferent
lymph T lymphocytes do not require ALDCs for
activation, as they are activated by macrophages,
though they still also respond to ALDCs. This clearly
demonstrates that afferent lymph responder cells have
'immunological memory', thus enabling them to
respond to antigen presentation by macrophages. Con¬
versely with 'resting' efferent lymph, there are few
unprimed responder cells able to respond to soluble
antigen without stimulation by ALDCs. Thus afferent
lymph T lymphocytes demonstrate a lower activation
threshold, i.e. 'memory', which is functionally illu¬
strated by their ability to respond both to ALDCs and
mammary macrophages. In contrast efferent lymph
T lymphocytes have a higher activation threshold,
confirmed by their ability to respond to ALDCs but
not macrophages. Both sets of lymphocytes act in
response to stimulation from ALDCs and yet have
distinctly different phenotypes.
The responder cells of efferent lymph with their
naive phenotype have recirculated from the blood but
have no 'immunological memory' and a higher acti¬
vation threshold, which is only overcome by presenta¬
tion of both soluble antigen and alloantigen by ALDCs
and not macrophages. 'Naive' T lymphocytes travel to
areas of secondary lymphoid organs in search of
antigen presented by dendritic cells. T lymphocyte
memory is demonstrated by afferent lymph cells
ability to proliferate in response to soluble antigen
presentation by macrophages but the presence of
memory effector cells is demonstrated by their ability
to respond to alloantigen presentation by both ALDCs
and macrophages though to a lesser extent than with
soluble antigen.
Further work needs to be done to map and define
naive, memory and effector cells before the issue of
naive and memory phenotype and distribution can be
resolved. These new RPA multiprobe sets provides
valuable tools for the simultaneous quantitative deter¬
mination of gene expression of multiple ovine cyto¬
kines of both constitutive and inducible type.
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